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ABSTRACT 
HIV-1 has been suggested to use lipid rafts for assembly and budding. 
Lipid rafts can be separated from the bulk membranes by extraction 
with non-ionic detergents, such as Triton X-100 at cold, followed by a 
density gradient centrifugation. The analysis of intracellular Pr55
gag
 on 
iodixanol density gradients yielded intermediate density buoyant 
complexes while raft-associated proteins floated to the light-density 
fractions. Extracellular virus-like particles (VLPs) showed a similar 
intermediate flotation pattern after TX-100 extraction suggesting that 
Pr55
gag 
was not a genuine raft-associated protein. The lipid analysis of 
TX-100 extracted VLPs suggested that the intermediate buoyant 
complexes were largely devoid of membrane cholesterol and 
phospholipids. We also tested the extractability of the membranes with 
Brij98 which has been shown to detect rafts at physiological 
temperatures. Our analyses showed that intracellular Pr55
gag
 as well as 
VLPs were largely resistant to Brij98-extraction. We concluded that 
Pr55
gag
 associates with lipid microdomains distinct from the classical 
TX-100-resistant lipid rafts. 
We also analyzed the intracellular targeting of Pr55
gag
. It has been 
under an intense debate at which cellular membrane the productive 
assembly takes place, as Pr55
gag
 has been seen to accumulate at both 
the internal membranes and the plasma membrane depending on the 
cell type. To resolve this issue, we performed our analyses in HeLa 
H1-cells, where the Pr55
gag
 can be found both at the plasma membrane 
and the internal membranes. We employed pulse-chase studies and a 
subcellular fractionation assay by which an efficient separation of the 
plasma membrane from the internal membrane fraction is achieved. 
The kinetic analyses revealed that in the HeLa H1-cells newly 
synthesized Pr55
gag
 is exclusively targeted to the plasma membrane. 
To our surprise, the plasma membrane-associated Pr55
gag
 was 
subsequently endocytosed, if the viral accessory protein Vpu was 
defective in our proviral construct. Our work was the first to implicate 
that Vpu had an important role in the subcellular localization of 
Pr55
gag
. 
We probed by which mechanism the Pr55
gag
 is taken up into the cells 
in the absence of Vpu. Our analyses implicated that neither clathrin-
mediated endocytosis nor macropinocytosis was involved in Pr55
gag
 
uptake. In contrast, the cholesterol depletion affected the uptake of Gag
 
thus suggesting the possibility that cholesterol-mediated uptake might 
be involved. However, cholesterol depletion had a more pronounced 
effect if it was applied before the maximal membrane insertion and at 
least some level of the higher-order multimerization of Pr55
gag
 were 
achieved. This implicated that the cholesterol-dependent uptake 
pathway was only indirectly associated with the endocytosis of Pr55
gag
 
as cholesterol depletion most likely interfered with Gag 
multimerization and virus assembly. 
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1 INTRODUCTION 
 
1.1 MOLECULAR BIOLOGY OF HIV-1 
 
1.1.1 The virus 
 
Viruses are obligate parasites that are critically dependent on the functions provided 
by a living cell for their replication. Virus particle (the virion) is essentially a gene-
transfer vehicle that is needed for the transportation of the viral genome from one cell 
to another and is thus the means of the spreading of infection within an individual 
and between individuals. 
 
To fulfil their genome transport function viruses encode a set of structural proteins 
that are capable of forming new viral particles together with newly synthesized viral 
genomes. Structural proteins assemble into a shell-like capsid structure wherein the 
viral genome is enclosed. The capsid is supposed to protect the viral genome from 
harsh conditions in the extracellular environment and deliver the genome safely into a 
new cell. Also, for some viruses capsid structure provides a suitable environment to 
start a new replication cycle by concentrating essential viral components to the site of 
initial steps of multiplication. In addition to structural proteins, some viruses (e.g. 
retroviruses) encode enzymatic proteins and accessory proteins that are needed for 
successful replication. The viral envelope, a host cell derived lipid bilayer is an 
essential structural component of some virus families. Viruses that are not surrounded 
by a lipid envelope are referred to as naked viruses. 
 
As viruses are intracellular parasites they have evolved to exploit host cell machinery 
for their multiplication and spreading. Virtually all the steps in the virus life cycle are 
dependent on the interactions with the host cell components in a way or another. Host 
cell surface proteins, carbohydrates and lipids are used by viruses to attach and enter 
into the susceptible cells. Then, the host cell nucleic acid and protein synthesis 
machineries are then taken over by viruses in order to direct the synthesis of viral 
genomes and proteins. After synthesis, the viral structural proteins must assemble 
into the appropriate capsid structures with all essential components included and 
nascent virus particles must be released from the host cells. 
 
Although the viral structural proteins in general contain all the information needed 
for the assembly of new viral particles, it has become evidently clear that host cell 
components are as well needed to orchestrate the assembly process and the release of 
progeny of virions. During past few years, at least in the case of retroviruses, the 
knowledge of interactions between host cell components and assembling virus 
particles has expanded enormously. However, still much controversy has remained 
concerning exact molecular interactions required for successful particle assembly and 
productive release. 
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1.1.2 HIV-1 and AIDS 
 
The first reports of a new clinical syndrome among previously healthy homosexual 
men in the United States were published 1981 (Gottlieb et al. 1981). Two years later 
the causative agent of this syndrome, an acquired immunodeficiency syndrome 
(AIDS), was isolated (Barre-Sinoussi et al. 1983, Gallo et al. 1984) and later named 
as Human Immunodeficiency Virus type-1 (HIV-1). In 1986 a new HIV type, now 
referred to as HIV-2 was isolated (Clavel et al. 1986). 
 
HIV-1 comprises of at least of three, possibly four distinct virus groups, termed M 
(Main), O (Outlier), N (non-M-non-O) and P (designation pending) (Plantier et al. 
2009) with the predominant M-group of viruses being responsible for over 90% of 
reported HIV/AIDS cases. The group M is further divided into distinct genetic 
subtypes named by the letters A to K. Subtypes are classified on the basis of the 20-
30% interclade differences that are present in envelope (env) nucleotide sequences 
(Louwagie et al. 1993). In addition to subtypes mentioned, several intersubtype 
mosaic viruses generated by genetic recombination have been described (Laukkanen 
et al. 2000, Liitsola et al. 1998, Robertson et al. 1995).  
 
Current evidence suggests that both HIV-1 and HIV-2 entered the human population 
as a result of multiple cross-species transmission events from simian 
immunodeficiency virus (SIV)-infected non-human primates (Hahn et al. 2000). 
HIV-1 is most closely related to SIVcpz isolated from the chimpanzee subspecies 
Pan troglodytes troglodytes (Gao et al. 1999) while it is believed that HIV-2 is a 
result of transmission of SIV from sooty mangabeys (SIVsm) to humans (Gao et al. 
1994, Hirsch et al. 1989).The oldest confirmed HIV-1 positive human blood sample 
dates back to 1959 and to central Africa where HIV-1 has been thought to have 
originated (Zhu et al. 1998). Careful evolutionary analysis of this sample estimated 
that last common ancestor of M-group viruses arose near year 1930 (Korber et al. 
2000). Based on another sample from Kinshasa 1960 it was found that different 
subtypes were already well-established at 1930’s implicating that both viruses 
analysed from these samples evolved from a common ancestor circulating in Africa 
near the beginning of the 20
th
 century (Worobey et al. 2008). 
 
At the end of year 2009, it has been estimated that approximately 33.5 million people 
around the world are living with HIV (AIDS epidemic update 2009, UNAIDS) 
(http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf). Every 
year there are nearly 3 million new infections taking place which makes around 8000 
newly infected persons each day. Approximately two million people lost their lives 
during the year 2008 because of AIDS. The most affected regions are Sub-Saharan 
Africa (representing 67% of HIV infections worldwide) and Caribbean, where 5.2 % 
and 1.0 % of the adult population carries HIV infection respectively. In western and 
central Europe there were approximately 850 000 infected individuals at the end of 
2008 (UNAIDS). According to the Swedish Institute for Infectious Disease Control 
there were 8935 reported HIV-infections in Sweden by the end of 2009 
(http://www.smittskyddsinstitutet.se/statistik/hivinfektion/). The corresponding figure 
in Finland was at end of March 2011 2809 reported HIV cases (www.thl.fi). 
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1.1.3 Retroviruses  
 
Retroviruses are enveloped single-stranded RNA viruses that replicate through a 
DNA intermediate by virtue of a virus encoded RNA-dependent DNA polymerase, 
also called reverse transcriptase (RT). According to the International Committee on 
Taxonomy of Viruses (http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/index.htm) the 
family of Retroviridae is divided into seven distinct genera as shown in Table 1. The 
first three genera comprises of simple retroviruses as they possess only three open 
reading frames (ORFs), named gag, pol and env. These abbreviations stand for the 
group-specific antigen (gag), polymerase (pol) and envelope (env), respectively. The 
last four genera are considered as complex retroviruses as they carry additional ORFs 
along to ones carried by the simple retroviruses. These additional ORFs vary between 
different complex retroviruses. As seen in the examples of each genera of 
retroviridae, this family of viruses has a broad host range. 
 
Genus Example 
Alpharetrovirus Avian leucosis virus 
Betaretrovirus Mouse mammary tumour virus 
Gammaretrovirus Xenotropic murine leukemia-related 
virus 
Deltaretrovirus Human T-lymphotopic virus 
Epsilonretrovirus Walleye dermal sarcoma virus 
Lentivirus Human immunodeficiency virus type-1 
Spumaretrovirus Human foamy virus 
 
Table 1. The family of retroviridae. 
 
1.1.4 Virion architecture and gene products of HIV-1 
 
As shown in table 1, HIV-1 is a member of the lentivirus genus of the Retroviridae 
family (Chiu et al. 1985) (Latin; lentus, slow). HIV-1 virions are spherical in shape 
and have a diameter of approximately 110 nm. An infectious virion contains two 
identical copies of single-stranded RNA, about 9500 bases in length each with 5’ cap 
structure and 3’ poly-A-tail. Genomic RNA has a positive polarity, i.e. it can directly 
function as a messenger-RNA (mRNA). 
 
Viral genome is surrounded by a protein capsid structure which consists of gag-gene 
products. The dimeric RNA is incorporated into virus particles via interactions of 
zinc finger motifs in nucleocapsid (NC)-domain of the Gag protein and the cis-acting 
packaging sequence located in the untranslated region of the genomic RNA 
(Berkowitz et al. 1996). The outermost layer of a virus particle is composed of a host 
cell-derived lipid envelope. Viral surface glycoproteins (spike proteins) are 
embedded in the envelope together with proteins acquired from the host cell 
membranes.  
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Fig.1. HIV-1 virion. 
 
The genomic structure of HIV-1 is similar to that of other retroviruses, including 
genes gag, pol and env encoding for structural and enzymatic proteins. As distinct 
from simple retroviruses, HIV-1 encodes two regulatory proteins (Tat and Rev) and 
several accessory proteins (Nef, Vif, Vpr and Vpu). The gag gene encodes for the 
major structural protein precursor (Pr55
gag
) which is later cleaved to form mature 
virion core proteins matrix (p17, MA), capsid (p24, CA), nucleocapsid (p7, NC) and 
p6-proteins. The pol gene encodes for the precursor of three enzymatic proteins, 
protease (PR), reverse transcriptase (RT) and integrase (IN). In common with other 
retroviruses pol is translated from the genomic length viral mRNA to produce a 
polyprotein Pr160
Gag-Pol
. The gag and pol genes overlap and the pol gene is in –1 
reading frame relative to that of gag. A ribosomal frameshift which occurs at a low 
frequency ( 5%) allows expression of the pol gene (Jacks et al. 1988). 
 
Viral membrane proteins are encoded by the env gene. Envelope proteins are 
translated as a precursor protein gp160 which is subsequently cleaved by cellular 
proteases into mature surface (gp120, SU) and transmembrane (gp41, TM) subunits. 
Env gene products are transported to the cellular membranes via the secretory 
pathway (Doms et al. 1993) and these proteins are heavily glycosylated (Freed et al. 
1990, Mizuochi et al. 1990). The mature form of the envelope glycoprotein is critical 
for receptor recognition and fusion of the virion envelope with the host cell plasma 
membrane (Apte and Sanders 2010).  
 
The major receptor for HIV-1 is a cellular transmembrane protein CD4 (Lifson et al. 
1986). In addition to CD4, two additional co-receptors have been described for HIV-
1, namely chemokine receptors CCR5 and CXCR4 (Doranz et al. 1997). In addition 
to receptor recognition and membrane fusion the env precursor gp160 also 
contributes to downregulation of the surface expression of CD4 by blocking the 
journey of newly synthesized CD4 at the endoplasmic reticulum (Crise et al. 1990, 
Willey et al. 1992b). 
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Fig.2. Genomic organization of HIV-1. 
 
HIV-1 genome is flanked by 5’ and 3’ long terminal repeat (LTR) sequences. The 
major function of LTR sequences is to provide signals recognized by the cellular 
transcription machinery. LTR domains have adopted complex secondary structures 
including several stem loop-folded domains. In addition to recognition sequences for 
cellular transcription complexes, LTR also contains an enhancer sequence called 
trans-activating response element (TAR), which is a binding site for a virally encoded 
transactivator protein Tat. Tat increases the production of full-length viral mRNAs 
from 5’LTR up to several hundred fold and is consequently essential for the viral 
replication (Pumfery et al. 2003, Romani et al. 2010). Besides Tat, another regulatory 
protein, Rev, is encoded by the HIV-1 genome. This protein directs the transport of 
incompletely spliced or unspliced viral transcripts from the nucleus to the cytoplasm 
for translation. Rev functions as a homo-oligomeric complex by binding to the Rev 
responsive element (RRE)-site located in the env coding region. The nuclear export 
signal in Rev interacts with host proteins, such as Exportin1/Crm1, that are essential 
cellular mediators of nuclear export (Fukuda et al. 1997). 
 
Nef 
 
Nef is a membrane-associated, N-terminally myristoylated 27-35 kDa protein that is 
critical for the high levels of viremia and the progression of HIV-infection to AIDS 
(Deacon et al. 1995, Kestler et al. 1991, Kirchhoff et al. 1995). Nef is abundantly 
produced at early stages of virus life cycle and the global effect of this protein is 
enhancement of viral replication and infectivity (Chowers et al. 1994, Miller et al. 
1994). At molecular level, Nef has been hypothesized to function as a molecular 
adaptor that is capable of altering multiple cellular pathways, such as protein 
trafficking events, signal transduction and apoptotic cascades via various protein-
protein interactions thus contributing to HIV-1 pathogenesis (Foster and Garcia 2008, 
Roeth and Collins 2006).  
 
The first and comprehensively characterized function of Nef was the ability to 
downmodulate the surface expression of CD4, the primary receptor of HIV-1 
(Anderson et al. 1993, Garcia and Miller 1991). Nef has been shown to induce an 
adaptor protein 2 (AP-2)-mediated capture of cell surface-associated CD4 to clathrin-
coated pits leading to enhanced internalization of CD4 to an acidic compartment for 
degradation (Chaudhuri et al. 2007, Craig et al. 2000, Lindwasser et al. 2008, Piguet 
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et al. 1998, Piguet et al. 1999). The removal of CD4 from the cell surface facilitates 
the incorporation of the viral envelope proteins into the virions, enhances the release 
of particles and increases the virus infectivity (Lama et al. 1999, Ross et al. 1999). 
 
In multiple studies, the surface expression of various other membrane-associated 
proteins, such as MHC-I, MHC-II, CD8, co-stimulatory molecules CD80 and CD86 
has been also shown to be downregulated by Nef (Chaudhry et al. 2005, Le Gall et al. 
2000, Schwartz et al. 1996, Stove et al. 2005, Stumptner-Cuvelette et al. 2001). The 
downmodulation of MHC-I molecules from the cell surface or early in the secretory 
pathway by Nef renders infected cells less susceptible for the attack by cytotoxic 
CD8+ T-lymphocytes by preventing the effective antigen presentation and thereby 
promoting the immune evasion of infected cells (Kasper et al. 2005, Yang et al. 
2002). The withdrawal of MCH-II from the surface of professional antigen 
presenting cells, such as dendritic cells and macrophages have been implicated to 
have an adverse effect on the induction of antiviral immune responses (Stumptner-
Cuvelette et al. 2001). 
 
In contrast to downregulation of cell surface-associated molecules, some membrane 
proteins, such as lectin DC-SIGN (Dendritic Cell-Specific Intercellular adhesion 
molecule 3-Grabbing Nonintegrin) are specifically retained at the plasma membrane 
of an infected cell by Nef (Sol-Foulon et al. 2002). Early studies proposed that DC-
SIGN-expressing dendritic cells bind glycans on HIV Env and carry viral particles as 
stowaways to the adjacent T-cells and even to peripheral lymphoid tissues that 
harbour populations of HIV susceptible cells without being productively infected 
themselves (trans infection) (Geijtenbeek et al. 2000, Kwon et al. 2002). However, 
recent data have expanded the consequences of HIV-DC-SIGN interaction. It has 
been suggested that DC-SIGN can promote the infection of dendritic cells themselves 
and progeny virions released can then infect nearby target cells (cis infection). 
Furthermore, binding of HIV to DC-SIGN has been suggested to trigger signal 
transduction events that promote the production of immunosuppressive cytokine IL-
10 which compromises the maturation of dendritic cells (Shan et al. 2007, Tsegaye 
and Pohlmann 2010). 
 
Nef is known to interfere with various intracellular trafficking pathways by 
interacting with a number of proteins associated with endocytic transport pathways, 
such as clathrin adaptor protein complexes (APs) (Craig et al. 2000, Janvier et al. 
2003). These interactions have been shown to alter the morphology of early 
endosomal compartment and affect the multivesicular body (MVB) biogenesis (Costa 
et al. 2006, Madrid et al. 2005). Besides interactions with endocytic trafficking 
apparatus Nef has a complex role in modulating multiple signal transduction events 
and apoptosis pathways in HIV-1 infected as well as in bystander immune cells. By 
altering signal transduction cascades originating from T-cell surface Nef modulates 
the activity of CD4+ T-cells, their chemotactic properties via inhibiting actin 
remodelling (Fackler et al. 2000, Greenway et al. 2003, Pulkkinen et al. 2004, Stolp 
et al. 2009, Stolp et al. 2010) and controls for apoptotic events within infected cells 
and in nearby microenvironment (Greenway et al. 2002, Wolf et al. 2001, Xu et al. 
1999). Taken together, by means of inducing alternations in intracellular milieu and 
   7 
membrane trafficking Nef is capable of both directly and indirectly enhance the 
pathogenic effects of HIV-1 infection. 
 
Some studies have proposed additional roles for Nef. It has been shown that Nef 
increases the transcription of cholesterogenic enzymes and the biosynthesis of 
cholesterol. Nef binds to the newly synthesized cholesterol and transports it to the site 
of virus assembly. Virions produced in the presence of Nef have a high content of 
cholesterol and are more infectious than virions released from cells infected with a 
nef-defective virus (Zheng et al. 2003). In another study, Nef was found to 
specifically interact with Gag-Pol. It was speculated that interaction of Nef with HIV-
1 structural proteins leads to the entrapment of these proteins to the cholesterol-
enriched assembly sites (Costa et al. 2004). 
 
Vif 
 
Viral infectivity factor (Vif) has been characterized as improving the infectivity of 
HIV-1 virions by overcoming a host cell restriction, mediated by apolipoprotein B 
mRNA editing enzyme, catalytic polypeptide-like 3G (APOBEC3G). APOBEC3G 
belongs to a family of cytidine deaminases that remove an amino group from 
cytosine bases on single-stranded DNA hence creating uracil bases (Yu et al. 2004). 
Activity of APOBEC3G was speculated to introduce hypermutations into the viral 
nucleic acid during the minus strand synthesis in order to block HIV-1 replication in 
target cells (Sheehy et al. 2002, Zhang et al. 2003). On the other hand it has been 
reported that APOBEC3G-induced deamination actually had little effect on viral 
cDNA synthesis, but promoted the degradation of newly synthesized viral cDNAs 
before the integration of the provirus into the target cell genome (Mariani et al. 
2003). According to a general consensus, Vif physically interacts with APOBEC3G 
and prevents its incorporation into virions (Goila-Gaur and Strebel 2008). It has been 
also suggested that Vif accelerates the degradation of APOBEC3G by ubiquitin 
ligase complex and proteosomes thus reducing the intracellular pool of APOBEC3G 
available for packaging into virus particles (Mehle et al. 2004, Sheehy et al. 2003, Yu 
et al. 2003). However, these implications have been also recently challenged (Dang et 
al. 2008, Kao et al. 2007, Opi et al. 2007). 
 
Vpr 
 
As with other HIV-1 accessory proteins, the viral protein R (Vpr) has been assigned 
for many diverse functions. Vpr, a 14 kDa protein is readily packaged into 
assembling virus particles through interactions with LXXLF-motif located at the C-
terminal part of Pr55
gag
 p6-domain (Bachand et al. 1999, Kondo and Gottlinger 
1996). Vpr enhances the replication of HIV-1 in differentiated macrophages which is 
attributed to the activity of Vpr in facilitating the import of HIV-1 preintegration 
complex (PIC) from the cytoplasm to the nucleus through nuclear pores early in the 
virus life cycle (Popov et al. 1998, Vodicka et al. 1998). Vpr also enhances the 
replication of HIV-1 by transactivating the promoter region in the viral LTR and by 
arresting the cell cycle to the G2-phase (Goh et al. 1998, Kino and Pavlakis 2004). 
The latter function is executed by Vpr through inactivation of cell division cycle 
protein (Cdc25C) that controls the G2/M transition (Elder et al. 2001, Goh et al. 
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2004). Other major functions reported for Vpr include the induction of intrinsic 
apoptosis pathway in different cell types, suppression of immune responses, 
facilitation of reverse transcription, reduction of HIV-1 mutation rate and 
contribution to cytopathogenicity via an ability to form ion channels on the 
membranes (Romani and Engelbrecht 2009). 
 
Vpu 
 
Vpu is a 16 kDa (81-residue) constitutively phosphorylated protein that is expressed 
in the late stage of virus replication from a bicistronic vpu-env mRNA. Vpu is an 
integral membrane protein consisting of an N-terminal membrane anchor (residues 1-
27) and C-terminal cytoplasmic domain. Vpu homo-oligomerizes at cellular 
membranes (Strebel et al. 1989) forming monovalent cation selective ion channels 
(Schubert et al. 1996b). Vpu is not incorporated into HIV-1 particles implicating that 
Vpu action must be executed within an infected cell. Vpu gene is found exclusively in 
HIV-1 and two strains of SIVs (SIVcpz and SIVgsn) but not in other lentiviruses such 
as close relative HIV-2 (Bour and Strebel 2003, Bour and Strebel 2003, Bour and 
Strebel 2003). In primate lentiviruses that do not encode for Vpu, the functions of this 
protein are conducted, at least partially, by viral proteins Env and Nef (Le Tortorec 
and Neil 2009, Zhang et al. 2009). 
 
Initial studies suggested that Vpu catalyses at least two apparently independent 
functions, binding and degradation of intracellular viral receptor CD4 (Willey et al. 
1992a) and enhancement of virus particle release from the cell surface (Klimkait et 
al. 1990). These two functions have been mapped to Vpu cytoplasmic and N-terminal 
transmembrane domains, respectively (Schubert et al. 1996a). According to one 
report, these two functions of Vpu may actually be interconnected, since the presence 
of CD4 at the cell surface was found to interfere with particle release (Bour et al. 
1999). In addition to these two functions Vpu has been reported to induce apoptosis 
in infected cells by inhibiting the degradation of a cellular signal mediator protein 
I B. The suppression of I B degradation by Vpu leads to constitutive inactivation of 
a nuclear transcription factor NF- B. When NF- B remains inactive, the expression 
of anti-apoptotic genes, such as Bcl-2 family proteins is blocked (Akari et al. 2001). 
 
Vpu exerts the downregulation of CD4 surface expression together with two other 
viral proteins Env precursor (gp160) and Nef. While Nef is engaged in the 
endocytosis of cell-surface associated CD4, Env precursor forms complexes with the 
newly synthesized CD4 in the ER and blocks the transport of CD4 to the plasma 
membrane (Crise et al. 1990, Jabbar and Nayak 1990). Vpu interacts simultaneously 
with the cytoplasmic domain of ER-trapped CD4 and beta transducine-repeat 
containing protein ( -TrCP) in SCF
-TrCP
 E3 ubiquitin ligase complex. This 
interaction leads to ubiquitination and translocation of CD4 to the cytoplasm and 
subsequent degradation by the cytoplasmic proteosomes (Binette et al. 2007, 
Margottin et al. 1998, Meusser and Sommer 2004, Schubert et al. 1998). Vpu itself 
somehow escapes ubiqitination and degradation, thus serving only as an adaptor 
protein for proteosomal degradation of CD4. Consequently also, the transport of Env 
precursor then resumes towards the cell surface and after processing the mature 
envelope glycoprotein is incorporated into the viral particles. Vpu has also recently 
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shown to bind the invariant chain of MHC-II and reduce the expression of this 
protein on the cell surface. This apparently reduces the antigen presentation and 
contributes to attenuated immune responses and viral persistence (Hussain et al. 
2008, Nomaguchi et al. 2008). 
 
The enhancement of virus particle release by Vpu transmembrane domain remained 
poorly understood for years after it was first implicated (Klimkait et al. 1990) 
although several studies were made in order to understand the biology behind the 
Vpu action. For instance it became evident that the ability of Vpu to promote particle 
release was dependent on the cell confluency and growth conditions (Deora and 
Ratner 2001) and critically dependent on cell type (Geraghty et al. 1994, Neil et al. 
2006, Varthakavi et al. 2003). Also, an intriguing correlation between the ability of 
Vpu to form ion conductive channels on the membranes and its ability to enhance 
virion release (Schubert et al. 1996b) evoked speculations over molecular mechanism 
behind the Vpu action. It was then implicated that Vpu, through forming ion channels 
could either globally modify the cellular environment to favour the particle assembly 
or modulate the local electric potential of the plasma membrane leading to the 
facilitated formation of budding structures and release of virus particles from the cell 
surface (Bour and Strebel 2003, Hsu et al. 2010). In accordance with these 
speculations were the findings that Vpu shares homology with a background 
potassium channel TASK-1 (Twik-related acid-sensitive K
+
-channel) (Hsu et al. 
2004). It was suggested that Vpu, mechanistically through a molecular piracy 
intercalates with TASK-complexes and interferes with the inherent activity of the 
channel as well as induces an accelerated degradation of TASK-1 by βTrCP-
mediated ubiquitin-proteosome pathway. A recent study was in agreement with the 
earlier speculations of Vpu modulating the membrane potential of the budding 
membrane (Hsu et al. 2010) while others have been shown that the abolishment of 
the ion channel activity of Vpu did not interfere with Vpu-mediated augmentation of 
virus release (Bolduan et al. 2011). 
 
The suggestion that Vpu could operate through an intimate interaction with a host 
cell component was not novel per se as it was earlier implicated that Vpu action may 
be involve a cellular 34 kDa protein Ubp (Vpu binding protein) (Handley et al. 
2001). It was speculated that Ubp might function as a negative factor in viral particle 
assembly by inhibiting the proper transport of Gag to the site of assembly. The role of 
Vpu would be to relieve this restriction of Gag transport by binding Ubp and 
removing it from interfering the intracellular Gag trafficking. Although this study did 
not provide any conclusive data to support these implications, it was a step forward in 
understanding the mechanism of Vpu action.  
 
It was soon suggested that Vpu counteracts a host cell restriction factor which 
impedes the particle production (Varthakavi et al. 2003). It was found that human, 
but not simian cells possess an activity that restricts efficient particle release in the 
absence of Vpu. This restrictive activity was dominant also in human-simian 
heterokaryons but could be alleviated by expression of Vpu. This study was the first 
to give an explanation why the ability of Vpu to enhance particle release was cell 
type-dependent but failed to give more detailed information about the nature or 
identity of this restrictive factor present in human cells. Comparable results 
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suggesting that Vpu acts through the interactions with host cell components rather 
than being responsible for enhancement of virion release alone were obtained from 
studies showing that Vpu, but not Pr55
gag
 co-localizes with recycling endosomes and 
disruption of trafficking through these structures abolished the ability of Vpu to 
augment the particle release (Varthakavi et al. 2006). Furthermore, expression of Vpu 
was shown to prevent the endocytosis of plasma membrane associated Pr55
gag
 and its 
accumulation into intracellular compartments without inducing a general block in 
endocytic trafficking. This data suggested that Vpu counteracts cellular activity that 
normally leads to the internalization of Pr55
gag
 or virions from the plasma membrane 
(Neil et al. 2006). Interestingly, the endocytosis of Pr55
gag
 was found to be dependent 
on functional late (L)-domain in Pr55
gag
. 
 
The conclusive evidence of the mechanism how Vpu enhances virion release from 
the cell surface came from recent studies suggesting that Vpu antagonizes an 
interferon-  induced host cell factor called tetherin/CD317/BST-2 (Neil et al. 2007, 
Neil et al. 2008). Tetherin is a type II single-pass glycosylated transmembrane protein 
with C-terminal GPI-anchor and homodimerisation sites in its ectodomain (Sauter et 
al. 2010). Tetherin traps nascent fully formed virions on the surface of the host cells 
and blocks their release as cell-free virus particles (Fitzpatrick et al. 2010, 
Hammonds et al. 2010, Perez-Caballero et al. 2009). Following surface tethering, 
trapped virions are subsequently endocytosed to CD63+ compartments and directed 
to lysosomal degradation (Miyakawa et al. 2009, Neil et al. 2006, Van Damme and 
Guatelli 2008). In addition to restricting HIV-1 release from the cells, tetherin has 
been shown to possess similar activity against broad spectrum of other enveloped 
viruses such as diverse retroviruses, filoviruses and herpesviruses (Jouvenet et al. 
2009a, Sauter et al. 2010). 
 
The molecular mechanism by which the particle entrapment at the plasma membrane 
is reversed by Vpu is currently under intense investigation. In some reports it has 
been implicated that Vpu counteracts the tetherin-mediated virus retention by 
blocking the insertion of the tetherin N-terminal transmembrane domain into virion 
envelopes thereby preventing the bridging of virus particles to the plasma membrane 
(McNatt et al. 2009, Perez-Caballero et al. 2009). This model of direct bridging of 
viral particles to the plasma membrane by tetherin dimers have been however 
questioned as it has been shown that virions cannot be released from the plasma 
membrane by cleaving the C-terminal GPI-anchor (Fitzpatrick et al. 2010). 
Furthermore, electron micrographs taken from the cells infected with Vpu-deleted 
virus suggest that particles are linked together by long filamentous structures that 
clearly cannot be formed by tetherin dimers alone (Hammonds et al. 2010). It has 
been also suggested that the function of Vpu is to relocate tetherin from the plasma 
membrane to the intracellular compartments hence sequestering it away from the site 
of productive particle assembly (Dube et al. 2009, Dube et al. 2010, Habermann et al. 
2010, Mitchell et al. 2009, Van Damme et al. 2008). In addition, it has been reported 
that Vpu targets internalized tetherin for proteosomal or lysosomal degradation by -
TrCP-dependent mechanism (Andrew et al. 2011, Douglas et al. 2009, Goffinet et al. 
2009, Mangeat et al. 2009, Mitchell et al. 2009) although opposing reports suggest 
that neither tetherin degradation nor translocation from the plasma membrane is 
required for theVpu-mediated enhancement of particle release (Goffinet et al. 2010, 
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Miyagi et al. 2009, Tervo et al. 2011). A recent report implicated that instead of 
relocalizing tetherin from the cell surface Vpu acts in post-ER compartment and 
interferes with resupply of the newly synthesized tetherin from within the cell 
(Andrew et al. 2011). 
 
In contrast to Vpu, tetherin is incorporated into viral particles both in the presence or 
absence of Vpu expression (Fitzpatrick et al. 2010, Habermann et al. 2010) 
suggesting that there may be alternative mechanisms behind the action of Vpu. While 
still highly speculative, a recent report suggested that tethered particles are precursors 
for extracellular VLPs and Vpu may execute its action after the budding has already 
been completed (Karetnikov and Suomalainen 2010). 
 
1.1.5 An overview of the HIV-1 replication cycle 
The replication cycle of HIV-1, which takes approximately 52 hours in productively 
infected CD4+ T-cells (Murray et al. 2011) begins with the attachment of a virus 
particle to target cell surface. The trimeric, surface gp120 protein (SU) on the virion 
surface engages CD4 on the host cell, including conformational changes that promote 
further binding to chemokine receptors, CCR5 or CXCR4 depending on virus isolates 
(Greene and Peterlin 2002). The sequential interactions between SU, CD4 and 
chemokine co-receptor eventually leads to a conformational change in gp41 which 
exposes the N-terminal hydrophobic, trimeric coiled-coil structure called fusion 
peptide. The fusion domain inserts itself into the target cell membrane and 
subsequent hairpin formation promotes the fusion of lipid bilayer of the viral 
envelope and the plasma membrane of a target cell. Following the membrane fusion, 
HIV viral core is released into the target cell interior (Chan and Kim 1998). Of note, 
a recent report suggested that instead of a direct fusion at the plasma membrane HIV-
1 enters cells via clathrin- and dynamin-dependent endocytosis followed by fusion 
with the endosomal membrane (Miyauchi et al. 2009). 
 
Once inside the cell, viral uncoating takes place. This step in retroviral replication 
cycle has remained poorly understood but refers to events that immediately follow 
the viral membrane fusion and penetration but precede the reverse transcription of the 
viral genome. During this process at least a part of the proteinacious viral core 
structure is released into the host cell cytoplasm (Freed 2001). An in vitro study of 
purified viral cores showed that uncoating is dependent on the activation of T-cells, 
suggesting that activated cell lysate harboured a host factor that was essential for 
uncoating (Auewarakul et al. 2005). 
 
Successful uncoating generates the viral reverse transcription complex (RTC) and 
this high molecular weight assembly is liberated from the entry site. RTC docks with 
actin microfilaments (Bukrinskaya et al. 1998) and associates with other cellular 
components, such as cyclophilin A (Towers et al. 2003, Trkola 2004). During this 
step the viral RNA genome is converted to a double-stranded linear DNA. This 
process is catalysed by the RT-enzyme (Freed 2001). 
 
Upon completion of reverse transcription, the preintegration (PIC) complex is formed 
and transported to the nucleus along the microtubules (McDonald et al. 2002). 
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Nuclear import is guided by viral determinants (e.g. MA, IN, Vpr, central DNA-flap) 
as well as host cell proteins, such as importin 7 (Fassati et al. 2003). Integration of the 
HIV genome is promoted by the viral integrase (IN). Host factors are also required, 
such as barrier to autointegration, but the precise mechanism of the host components 
has remained unknown (Greene and Peterlin 2002). Integration leads to either a 
transcriptionally latent or an active form of infection. 
 
Integrated DNA, referred to as a provirus, behaves essentially like a cellular gene. In 
the host cell genome the 5’ LTR functions like other eukaryotic transcriptional unit, 
containing promoter and a number of regulatory elements important for RNA 
polymerase II-driven transcription. The basal transcriptional activity from the HIV 
LTR is low. The viral mRNA synthesis is greatly increased in the presence of the 
viral transcriptional transactivator protein Tat. Tat binds to the transactivation 
response element TAR in the nascent viral transcript and functions as an adaptor 
protein for cellular protein complex called positive transcription-elongation factor b. 
RNA polymerase II is phosphorylated by transcription-elongation factor b and this is 
a signal for transition from transcription initiation to elongation. Thus, the function of 
Tat is to promote the formation of an elongation competent transcription complex 
and as a consequence the processivity of RNA polymerase II is enhanced (Bannwarth 
and Gatignol 2005). 
 
The viral protein Rev is an essential regulator of HIV-1 mRNA and protein 
expression. Rev binds to Rev responsive element (RRE) in the viral RNA transcript 
and promotes the nuclear export of incompletely spliced mRNA and increases the 
association of these mRNAs with polyribosomes (D'Agostino et al. 1992). In the 
cytoplasm these mRNA-species are then employed in the translation of viral 
structural proteins and only the unspliced genome-length mRNA is packaged into 
progeny virus particles. A recent study implicated that Rev may also play a role in 
removing an inhibitory ribonucleoprotein complex from the viral transcript therefore 
allowing a more efficient translation of viral proteins and promoting encapsidation of 
unspliced viral transcripts (Blissenbach et al. 2010). 
 
Following the synthesis of the full complement of viral proteins the assembly process 
can begin. Assembly of HIV-1 is driven by the viral core protein precursor Pr55
gag
 
but is also influenced by Env and the viral genome (Freed 1998) as well as a series of 
host cell factors. Assembly of HIV-1, as other C-type retroviruses, takes place at 
cellular membranes. At the site of assembly Gag and a minor core component, Gag-
Pol, attach to the membrane and oligomerize into immature viral cores. The nascent 
immature virions contain an electron dense, doughnut-shaped layer under the lipid 
envelope. In these particles, Pr55
gag
 forms hexameric ring-like arrays and individual 
molecules are radially arranged with N-terminus facing to the membrane while C-
terminus is extended towards the center of the particle (Huseby et al. 2005, Wilk et 
al. 2001). 
 
The terminal steps in replication cycle are budding of a nascent particle through the 
cellular membrane and virus maturation. The maturation takes place during or shortly 
after budding and is defined as an ordered array of cleavages of Pr55
gag
 executed by a 
virus-encoded protease. The cleavage is followed by subsequent rearrangements of 
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the cleavage products. NC and the dimeric RNA genome first condense into a 
complex at the center of the virion. CA assembles then into a conical shell that 
surrounds the NC/RNA complex whereas majority of MA remains associated with 
the viral membrane (Wiegers et al. 1998). The p6-protein appears to locate outside 
the conical core in the mature virus particle (Welker et al. 2000). In addition to four 
distinct Gag proteins, two spacer peptides p1 and p2 are also cleaved (Henderson et 
al. 1990). The precise role of these peptides and location in a virus particle have 
remained uncovered, but it has been suggested that the spacer peptide p2 is critical 
for correct assembly phenotype (Gross et al. 2000, Morikawa et al. 2000) while p1 
confers to the ESCRT-dependence (Endosomal Sorting Complexes Required for 
Transport) of HIV-1 budding (Popova et al. 2010).Virus maturation is required for 
the infectivity of nascent virions. 
 
1.2 CELLULAR PATHWAYS LINKED TO THE ASSEMBLY AND 
BUDDING OF HIV-1 
1.2.1 The raft concept 
 
An early work of Singer and Nichols proposed that the lipid bilayer of a cell 
membrane functions as a neutral two-dimensional solvent for membrane proteins 
having little influence on their function (Singer and Nicolson 1972). More recently, 
the cell membrane has been proposed to exist at least at three different chemical 
states that are critically dependent on the temperature and lipid content of the 
membrane. A membrane can possess “frozen” gel-like properties, but this state is 
thought to exist only below the melting temperature of the lipids. More relevant 
biological states are liquid-ordered, a crystalline phase of the membrane (Lc) and 
liquid-disordered (Ld) phase, which in turn describes membrane areas that are not 
specifically arranged to any higher-order, Lc-like structure (Brown and London 
1998). It has been suggested that the liquid-ordered phase (Lc) acts as a concentration 
platform for certain proteins thus assigning these domains for specialized membrane 
functions (Simons and Ikonen 1997). This model of functional ordered domains 
floating in the less-ordered sea of bulk lipids has gained wide agreement among the 
scientist, even though the direct evidence for the existence and exact function of these 
domains are often uncritically evaluated (Lai 2003, Munro 2003, Shaw 2006). 
 
The term lipid raft is coined to these ordered membrane domains that are rich in 
sphingolipids and cholesterol (Brown and London 1998, Simons and Ikonen 1997). 
These domains are insoluble in non-ionic detergents such as Triton X-100 at low 
temperatures and can be separated on the basis of this property from the bulk 
membrane by using density gradients (Brown and Rose 1992). The detergent 
resistance and low buoyant density of lipid rafts is based on relative tight packing of 
saturated sphingolipid hydrocarbon chains and cholesterol on these membrane 
patches compared to more loose and disordered packing of less saturated 
glycerophospholipids on the bulk membranes (Brown and London 2000).  
 
The first direct suggestions of the existence of lipid rafts came from early studies of 
polarized epithelial cells (Simons and van Meer 1988, van Meer et al. 1987). In these 
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studies it was proposed that sphingolipids might aggregate into a distinct domain in 
the Golgi complex, from where they are subsequently transported to the apical side of 
an epithelial cell as a single unit, as a membrane patch. GPI-anchored proteins were 
found to be sorted to the apical surface of the epithelial cells by the same means as 
sphingolipids (Lisanti et al. 1988) and the first operational definition for these entities 
as detergent-resistant, cholesterol-dependent and glycolipid-enriched membrane 
subdomains came with an extensive study of GPI-anchored protein placental alkaline 
phosphatase (Brown and Rose 1992). 
 
Lipid rafts are considered to be small (<50 nm), highly dynamic sterol enriched lipid-
protein assemblies that float freely on the plane of the exoplasmic leaflet of the 
plasma membrane (Pralle et al. 2000, Simons and Ikonen 1997). The inner leaflet has 
been speculated to be coupled to the outer leaflet by interdigitation of long fatty acid 
tails present in outer leaflet sphingolipids (Simons and Toomre 2000). One report 
provided an indirect evidence of the existence of discrete microdomains also in the 
inner leaflet of the plasma membrane. It was observed that inner leaflet membrane 
proteins concomitantly clustered upon cross-linking the outer leaflet GPI-anchored 
raft proteins (Prior et al. 2003). However, a lipidomics study of detergent resistant 
membranes suggested, that lipid rafts are largely outer leaflet structures with 
substantially less rigorously selected inner leaflet lipids (Pike et al. 2005). On the 
other hand though a study using model lipid bilayers demonstrated that manipulation 
of one leaflet of the membrane induces changes in the other leaflet as well, 
suggesting strong interleaflet interactions (Collins and Keller 2008). 
 
Lipid rafts have been suggested to participate in various cellular processes, such as 
numerous signal transduction events (Simons and Toomre 2000), T-cell activation 
and signalling (Simons and Gerl 2010) and intracellular trafficking and sorting of 
lipids and lipid-anchored proteins (Ikonen 2001, Simons and Gerl 2010). In addition 
to roles in normal cellular function, lipid rafts have also been suggested to act as 
entry platforms for a wide range of pathogens and toxins (Simons and Ehehalt 2002) 
as well as serve as assembly sites for various enveloped viruses, such as HIV-1, 
Influenza A and Ebola (Suomalainen 2002). In addition to exploitation of lipid rafts 
by infectious agents, membrane microdomains have been linked to various human 
diseases, such as neurological disorders, autoimmune diseases and lipid metabolism 
related problems (Simons and Ehehalt 2002). 
 
Lipid rafts and associated components have been traditionally studied by using non-
ionic detergent extractions at cold temperatures followed by density centrifugation. 
Triton X-100 has been most widely used, but others, such as Brij-series and Lubrol 
WX (Drevot et al. 2002, Roper et al. 2000, Schuck et al. 2003) have also been 
introduced. Another biochemical approach to probe raft involvement is the 
manipulation of lipid raft constituents. Cholesterol can be sequestered from the 
membranes by sterol-binding drugs, toxins or detergents or alternatively, rafts can be 
disrupted by loading cells with exogenous lipids (Simons and Toomre 2000). Any of 
these biochemical methods however, does not necessarily give reliable information 
about rafts or raft-associated proteins, since methods described above are very prone 
to artifacts caused by reagents or conditions used (Ikonen 2001, Lai 2003). For 
instance, cholesterol extraction may indeed increase the size of membrane 
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microdomains (Pike 2006) instead of dissolving them indicating the artifical nature of 
these methods. In addition, the usage of different detergents with differential 
solubilisation abilities yields easily variable data of lipid raft composition (Schuck et 
al. 2003). 
 
Lipid rafts are not easy to visualize, since they are too small to be studied by standard 
light microscopy. Antibody-mediated patching of raft-associated components 
followed by immunofluorescence microscopy (Harder et al. 1998) has been used to 
detect coalesced raft domains. This method however, does not necessarily provide 
any direct information of what kind of assemblies rafts exists in the native 
membranes. 
 
After reconciliation with biochemical methods yielding inconsistent data, more 
sophisticated techniques, such as Fluorescence Resonance Energy Transfer 
(Kenworthy et al. 2000), Single Particle Tracking (Kusumi et al. 2004, Pralle et al. 
2000), Fluorescence Recovery After Photobleaching (Kenworthy et al. 2004) and 
immunoelectron microscopy of native membrane sheets (Prior et al. 2003, Wilson et 
al. 2004) have been applied to study rafts at molecular level in living cells. Results 
from these studies suggested that lipid rafts are small, probably in the low nanometer 
range and partitioning of molecules to raft domains is highly dynamic. However, 
depending on technique used, the estimations of exact size of rafts and their temporal 
stability yielded variable data, indicating that the raft field still lacked consensus over 
the basic aspects of the nature and function of these lipid microdomains. A report 
from Keystone Symposium on lipid rafts and cell function stated that “Membrane 
rafts are small (10-200 nm), heterogenous, highly dynamic, sterol- and sphingolipid-
enriched domains that compartmentalize cellular processes. Small rafts can 
sometimes be stabilized to form larger platforms through protein-protein and protein-
lipid interactions” (Pike 2006). 
 
Advanced high-resolution microscopy-based techniques have been recently applied 
to visualize lipid rafts in living cells (Simons and Gerl 2010). These studies have 
revealed the existence of dynamic cholesterol- and sphigolipid-dependent nanoscale 
clusters at the plasma membrane harbouring GPI-anchored proteins and other 
membrane proteins. These clusters have been seen to coalesce into functionally 
relevant ordered assemblies (Eggeling et al. 2009, Lingwood and Simons 2010, 
Meyer et al. 2006, Pinaud et al. 2009, Sharma et al. 2004, Simons and Gerl 2010). 
Moreover, analyses of lipid contents of these microdomains have supported the 
conclusion of selective inclusion of raft-associated lipid in these clusters as well as in 
intracellular raft carriers (Klemm et al. 2009, Zech et al. 2009).This new data 
strongly imply that ordered lipid domains can be formed in the context of native 
membranes. It remains however to be determined to what extend do the physico-
chemical properties of transmembrane proteins such as attraction of certain lipid 
species or formation protein-protein interactions and networks actually rule the 
composition of these nanoassemblies (Douglass and Vale 2005, Lingwood and 
Simons 2010). 
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1.2.2 Endocytosis and MVB biogenesis 
 
Endocytosis is a complex process in which a portion of the plasma membrane buds 
inwards towards the cytoplasm and forms vesicles that contain cellular membranes 
and proteins as well as extracellular fluid. The endocytic membrane trafficking has 
an essential role in delivering membrane components, receptor-bound ligands and 
solute molecules to various intracellular destinations. Given that endocytosis also 
plays a central role in regulation of cellular signalling and downregulation of cell 
surface receptors, it can be extremely selective: a subset of lipids and proteins are 
internalized whereas others seem to be actively retained in the plasma membrane 
(Gong et al. 2008). The endocytic pathway basically consists of a complex network 
of repeated cycles of membrane deformation with or without coat protein assembly 
and disassembly, vesicular transport and membrane fusion to the target 
compartment. 
Eucaryotic cells exhibit at least three main endocytic pathways that are clathrin-
mediated endocytosis (CME), macropinocytosis/phagocytosis and clathrin-
independent endocytosis (CIE). The latter can be further divided either into 
dynamin-dependent and dynamin-independent uptake pathways or according to the 
small GTPases that regulate the given uptake route (Mayor and Pagano 2007). 
Regardless of the specific terminology assigned, it has become clearly evident that 
CIE consists of several distinct uptake pathways of which each mediates the 
endocytosis of different set of cargo molecules and carries their contents into 
different intracellular destinations (Howes et al. 2010, Mayor and Pagano 2007). 
Endocytosis begins at the cell surface with the deformation and vesiculation of a 
region of the plasma membrane into which membrane associated cargo is sequestered 
(Johannes and Mayor 2010). The newly formed vesicle is then transported to and 
fuses with a membraneous intracellular organelle called early endosomal 
compartment (EE), although some pathways may use intermediate itineraries in the 
way to the EE, such as GPI-anchored protein-enriched early endosomal 
compartments (GEECs) (Howes et al. 2010, Mayor and Pagano 2007). The main 
function of early endosomal compartment is to redirect the incoming cargo either via 
tubular recycling compartment back to the plasma membrane or along the endosomal 
pathway for degradation (Saftig and Klumperman 2009, Traub 2010). Cargo destined 
for degradation is subsequently delivered to the late endosomal compartment which 
matures to form a multivesicular body (MVB) upon budding of vesicles from the 
limiting membrane to the intraluminal region (Traub 2010). Ultimately, the late 
endosomal compartment/MVB fuses with lysosomes where intraluminal vesicles of 
MVBs are degraded by lysosomal hydrolases (Felder et al. 1990, Saftig and 
Klumperman 2009). 
 
Sorting signals determine the location and fate of endocytosed proteins. These signals 
can be carried within the amino acid sequence of a protein (e.g. tyrosine-based 
sorting signal YXX /NPXY or LL-(di-leucine)-motif or they can be 
postranslationally appended to the proteins in a regulated manner (e.g. ubiquitination, 
phosphorylation) (Bonifacino and Traub 2003, Traub 2009). 
 
   17 
Ubiquitin is a 76 amino acid protein that becomes conjugated to the proteins through 
the sequential action of three enzymes: ubiquitin-activating enzyme (E1), ubiquitin 
conjugating enzyme (E2) and ubiquitin ligase (E3). The ubiquitin attachment to a 
target peptide results in generation of an isopeptide bond between the C-terminus of 
ubiquitin and lysine residues in substrates (Weissman 2001). Substrates can be 
modified either with monoubiquitin or with a polyubiquitin chain that is an array of 
ubiquitin moieties linked through lysines present in ubiquitin itself (Hicke 2001). 
 
It is now well-established that different types of ubiquitin conjugates are involved in 
the regulation of different cellular processes. Monoubiquitination is implicated in the 
endocytosis of plasma membrane-associated proteins and sorting of these proteins to 
the MVB and subsequently to the lysosomes. In contrast, polyubiquitin chains have a 
well-characterized role in targeting proteins for degradation by the 26S proteosome 
(Hicke 2001). Ubiquitin signals can be removed and trimmed by various cellular 
deubiquitinating enzymes (Weissman 2001), suggesting that ubiquitination is a 
crucial regulatory element in cells. 
 
Biogenesis of MVBs is extensively studied in yeast (Babst et al. 1997, Babst et al. 
1998, Bilodeau et al. 2002, Odorizzi et al. 1998, Piper et al. 1995, Raymond et al. 
1992) and great deal of current understanding of this cellular pathway originates from 
these studies (Katzmann et al. 2002). Yeast cells rely on a single pathway in MVB 
formation which occurs at the late endosomal compartment when the limiting 
membrane of this organelle invaginates and buds into its lumen. This gives a 
characteristic morphology of numerous intralumenal vesicles within a larger 
membrane-enclosed endosome. Mammalian cells have been described to contain 
more than one kind of MVB pathway, one similar to that of yeast, and at least a two 
of pathways that involve different kinds of membrane lipid derivatives such as 
lysobisphosphatidic acid (LBPA) or ceramide (Hurley et al. 2010, Matsuo et al. 2004, 
Trajkovic et al. 2008). 
 
Cargoes destined to the intraluminal vesicles of MVBs, such as internalized surface 
receptors seems to be selected on the basis of monoubiquitin signal on their lysine 
moieties, although alternative sorting signals may exist (Katzmann et al. 2001, 
Reggiori and Pelham 2001, Urbanowski and Piper 2001). The vesicle formation and 
budding towards the lumen of MVB is mediated by a complex set of proteins called 
ESCRTs (Endosomal Sorting Complexes Required for Transport). Three distinct 
ESCRT-complexes have been described, termed ESCRT-I, II and III (Babst et al. 
2002a, Babst et al. 2002b, Bache et al. 2003, Katzmann et al. 2001, Williams and 
Urbe 2007).  
 
ESCRT-complex initiation, sometimes referred to as ESCRT-0 (Hurley and Hanson 
2010) consists of two different proteins, hepatocyte growth factor-regulated tyrosine 
kinase substrate (HRS) and signal transducing adaptor molecule and it is essential for 
initial recognition and clustering of ubiquitinated cargo at the endosomal membrane 
(Wollert and Hurley 2010). HRS is recruited to the endosomal membrane through the 
binding to the endosome-enriched lipid phosphatidylinositol-3-phosphate (PI(3)P) 
(Raiborg et al. 2001). In addition to cargo selection, HRS also to recruits flat clathrin 
coats into the ESCRT-initiation complex as well as it is responsible for the 
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recruitment of downstream ESCRT-complexes to the site of MVB formation (Bache 
et al. 2003, Katzmann et al. 2003, Raiborg et al. 2002, Sachse et al. 2002). The 
function of clathrin in ESCRT-assembly is to stabilize HRS-complex to distinct 
microdomains at the MVB limiting membrane (Raiborg et al. 2006, Wollert and 
Hurley 2010). 
 
ESCRT-I consists of Tsg101 (tumour susceptibility gene 101, also known as VPS23), 
VPS28, VPS37 (VPS stands for Vacuolar Protein Sorting) (Babst et al. 2000, Bishop 
and Woodman 2001, Katzmann et al. 2001) and possibly also protein called Mvb12 
(Curtiss et al. 2007, Oestreich et al. 2007). Tsg101 binds HRS, ubiquitin and ESCRT-
associated protein ALIX (also known as AIP1) (Bache et al. 2003, Katzmann et al. 
2001, Matsuo et al. 2004) and it functions in cargo recognition at the MVB limiting 
membrane. The role of ALIX/AIP1 is probably to regulate MVB biogenesis and 
inward budding through a conical lipid LBPA present at the endosomal membranes 
of mammalian cells (Matsuo et al. 2004). In addition to MVB budding, ALIX/AIP1 
has linked to other cellular processes involving membrane fusion and fission, such as 
apoptosis, endocytosis and cytokinesis (Chatellard-Causse et al. 2002, Morita et al. 
2007, Odorizzi 2006). 
 
ESCRT-II is a heterotetramer consisting of one copy of each VPS22 and VPS36 and 
two molecules of VPS25 (Babst et al. 2002b). This complex has been shown to bind 
both ubiquitin and PI(3)P (Slagsvold et al. 2005, Teo et al. 2006). At least in yeast, it 
also recruits the ESCRT-III complex to the MVB limiting membrane (Babst et al. 
2002a). The interaction between ESCRT-II and -III in mammalian context may not 
be strictly required, as ESCRT-II independent degradation of cellular receptors has 
been reported (Bowers et al. 2006). Indeed, it has been suggested that ALIX/AIP1 or 
some yet unknown factor may provide an alternative link between ESCRT-I and 
ESCRT-III (Langelier et al. 2006, Williams and Urbe 2007). 
 
The last multisubunit complex to be recruited to the site of MVB biogenesis is an 
ESCRT-III complex that consists of at least 10 CHMP-proteins (Charged 
Multivesicular body Proteins) (Babst et al. 2002a, Martin-Serrano et al. 2003, Morita 
and Sundquist 2004). ESCRT-III makes multiple contacts with other MVB sorting 
pathway components and related proteins, such as ESCRT-II, ALIX/AIP1 and 
deubiquitinating enzyme AMSH (Agromayor and Martin-Serrano 2006, Katoh et al. 
2003, Martin-Serrano et al. 2003, McCullough et al. 2006, Teo et al. 2004). A recent 
in vitro reconstitution of MVB biogenesis has provided new insight of the precise 
role of ESCRT-complexes. It was suggested that ESCRT-I and ESCRT-II localize at 
the neck of the MVB-bud and together confine ESCRT-0 stabilized cargo in the 
inward budding regions as well as to recruit ESCRT-III for to carry out the final 
scission reaction in order to release the budding vesicle into the lumen of a MVB 
(Wollert and Hurley 2010). 
 
Given their crucial role in MVB biogenesis, ESCRT-complexes and clathrin coat are 
removed from the limiting membrane of the MVB just prior the inwards budding has 
completed (Babst et al. 1998, Sachse et al. 2004).The dissociation of at least ESCRT-
III components from the membrane is catalysed by VPS4, an ATPase (Lata et al. 
2008, Wollert et al. 2009) while there is no direct evidence of earlier ESCRT-
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components of being substrates for VPS4. These may instead require for other factors 
such as Did2, Vta1and VPS60 for their disassembly from the limiting membrane of 
an MVB (Nickerson et al. 2010). Abolishment of VPS4 function as well as that of 
Did2 and Vta1 and VPS60 in mammalian cells produces enlarged endosomal 
compartments (called class E phenotype in yeast) and alters the size of internal 
vesicles in MVBs (Fujita et al. 2003, Nickerson et al. 2010). 
 
 
Fig. 3. A schematic drawing depicting the ESCRT-mediated cargo selection at 
the MVB limiting membrane (simplified from Williams and Urbe 2007) 
 
1.2.3 The main three endocytic pathways dissected 
 
Endocytosis occurs in most mammalian cell types and it can be categorized at least 
into three major pathways as mentioned before: (i) the chlathrin-mediated endocytic 
pathway (CME), to multiple distinct (ii) clathrin-independent endocytic routes (CIE) 
and (iii) macropinocytosis/phagocytosis-driven entry pathways. Given that 
endocytosis is in most parts a constitutive process intended to fulfil the nutritional 
requirements of the cell and regulate multiple signalling events, many intracellular 
pathogens have adapted to use endocytosis to gain access into the host cells. For 
instance, in the view of viruses, indeed a majority of them are dependent on 
endocytic processes for their entry to the cells (Ghigo 2010, Marsh and Helenius 
2006). Hijacking of endocytic vesicles provide a convenient means for the incoming 
viruses to reach their replicative compartments without a need of confronting cellular 
obstacles such as cortical actin or cytosolic sensors of pathogen associated molecular 
patterns. Furthermore, by entering cells by endocytosis, no viral components are left 
at the plasma membrane for the detection by the host immune surveillance (Marsh 
and Helenius 2006). 
 
 
Clathrin-mediated endocytosis (CME) 
 
The best characterized endocytic process, the receptor-mediated endocytosis, 
involves the internalization of receptors and their ligands by clathrin coated pits. 
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CME follows the general scheme of the coat-assisted endocytic process, i.e. 
nucleation of the pit and assembly of the coat at the confined regions of the plasma 
membrane, cargo sequestering to the pit and subsequent membrane deformation, 
scission of the vesicle into the cell interior, uncoating the basket-like clathrin lattice 
and finally the fusion of the vesicle with the acceptor compartment (Mousavi et al. 
2004, Traub 2009). 
 
The clathrin coated pit is indeed a multi-component endocytic unit that in addition to 
clathrin and sequestered cargo proteins is composed of several different adaptor 
proteins and assisting factors, such as regulators of the adaptors (Maldonado-Baez 
and Wendland 2006). The assembly unit of clathrin itself, called a triskelion, is a 
three-legged structure consisting of three heavy and light chains (Kirchhausen and 
Harrison 1981). Clathrin triskelions can form structures of variable curvature, 
allowing these protein scaffoldings engulf cargoes of different sizes and shapes 
(Fotin et al. 2004). According to the current view, the role of the clathrin coat is 
likely to fix and stabilize the budding vesicle (Ford et al. 2002, Nossal 2001) rather 
than induce membrane deformation as it was suggested earlier (Maldonado-Baez and 
Wendland 2006). 
 
Clathrin itself is unable to bind to either phospholipids or integral membrane protein 
components. Therefore, recruitment of vesicle cargo occurs through intermediary 
proteins known as nucleators, scaffolds and adaptors (Henne et al. 2010). The 
function of these proteins is to initiate the pit formation, determine the selective 
inclusion of membrane anchored proteins into the vesicles, form an interface between 
the clathrin coat, incorporated cargo proteins and accompanying membrane bilayer as 
well as participate in membrane deformation (Johannes and Mayor 2010, Traub and 
Wendland 2010). 
 
The most abundant and best studied adaptor protein (AP) found in clathrin coated pits 
originating from the plasma membrane is AP-2. This heterotetrameric protein 
complex, by using separate domains, can simultaneously bind to membranes through 
interaction with phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), to the sorting 
signals in the cytosolic tails of cargoes, to clathrin itself as well as to many other 
clathrin-associated sorting proteins (CLASPs), such as AP180/CALM, Eps15, epsin 
and Dab2 (Collins et al. 2002, Honing et al. 2005, Maldonado-Baez and Wendland 
2006, Mishra et al. 2002, Owen et al. 2004, Rohde et al. 2002, Traub 2009, Traub 
and Wendland 2010). Over 20 different binding partners have been described for AP-
2 (Owen et al. 2004), thus it has been speculated that AP-2 functions as a central 
scaffold organizer in clathrin coated pits (Traub and Wendland 2010). Given the 
central role of AP-2, the coats can still be formed with diminished levels of AP-2 
(Motley et al. 2003), suggesting that other adaptors may substitute the function of 
AP-2 in a redundant manner (Traub 2003)or alternatively, remaining AP-2 levels are 
enough to direct the pit formation without being itself involved in cargo sorting 
(Motley et al. 2006). 
 
In addition of AP-2, AP-1 has been found to be enriched in clathrin coated vesicles. 
These vesicles however are found in the trans-Golgi network (TGN) and endosomes 
while AP-2 is found on vesicles originating from the plasma membrane. Two 
   21 
additional adaptor complexes have been also characterized, namely AP-3 and AP-4. 
Both of these adaptors are found on TGN/endosomal membranes, with AP-3 merely 
localizing on tubular endosomal compartment (Peden et al. 2004) and AP-4 on TGN. 
AP-3 and AP-4 appear to function independently of clathrin, suggesting that internal 
membranes may harbour an alternative scaffolding protein other than clathrin 
(Robinson 2004). 
 
Vesicle fission of a newly formed clathrin coated pit is mediated by dynamin, a 
GTPase that self-assembles into collar-like structures around the neck region that 
connects the invaginated clathrin coated vesicle and the donor membrane 
(Ramachandran 2010). The exact molecular mechanism of dynamin-mediated vesicle 
scission remains to be resolved, but several models have been suggested. Classically, 
dynamin has been viewed as a mechano-chemical enzyme where GTP-hydrolysis 
induces a conformational change that provides the mechanical force needed for the 
vesicle release (Chen et al. 2004, Stowell et al. 1999). A more recent study has 
challenged this classical view by showing that conformational change on dynamin 
collar is not sufficient for vesicle scission and suggests that other factors are required 
in order to execute the vesicle fission (Ramachandran and Schmid 2008). According 
to another model, interaction of dynamin with the plasma membrane (PI(4,5)P2) and 
conformational change in dynamin helices upon GTP-hydrolysis together drive the 
local increase of membrane PI(4,5)P2 density and clustering that leads to PI(4,5)P2 
phase separation from the bulk membrane and to the spontaneous vesicle release 
(Bethoney et al. 2009, Liu et al. 2006, Liu et al. 2009). The third model proposes that 
dynamin is just a classical GTPase that in biologically active GTP-form regulates the 
downstream interactions of the effector molecules at the vesicle neck that are 
required for vesicle fission (Merrifield et al. 2005, Ramachandran and Schmid 2008). 
Dynamin has been shown to have multiple interacting partners, such as sorting nexin-
9, syndapin, amphiphysin and endophilin that have been suggested to mold and 
stabilize membrane curvature and link actin cytoskeleton to the endocytic events 
(Johannes and Mayor 2010, Ramachandran 2010). 
 
Clathrin-independent carriers 
 
In comparison to the clathrin-mediated endocytic pathway, alternative clathrin-
independent internalization routes have remained relatively poorly understood. 
Accumulating data suggest that CIE can be categorized into two major pathways 
according to the dependence of the internalization mode on dynamin (Mayor and 
Pagano 2007). However, both of these two pathways consist of several 
morphologically distinct carriers that are each regulated by different proteins such as 
coat protein caveolin or different small GTPases (Gong et al. 2008, Howes et al. 
2010, Mayor and Pagano 2007). 
 
Of dynamin-dependent internalization pathways the caveolae-mediated endocytosis 
refers to the internalization of material via flask-shaped plasma membrane 
invaginations which are associated with structural coat proteins caveolin-1 and -2 
(Parton and Simons 2007). Caveolins are integral membrane proteins that associate 
with lipid bilayers enriched in cholesterol and sphingolipids (Ortegren et al. 2004). 
Recent data have demonstrated that another set of proteins called cavins associate 
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with caveolin coats in a tissue specific manner (Bastiani et al. 2009). Cavins have 
been implicated in stabilizing the caveolin scaffolds at the site of bud formation, 
promote membrane curvature and regulate caveolae budding to the cytoplasm 
(Hansen et al. 2009, Hill et al. 2008, McMahon et al. 2009). Similar to CME, 
dynamin is required for the fission of a caveola from the donor membrane (Oh et al. 
1998), but in contrast to other coated vesicular carriers, caveolae retain their coats 
associated with the vesicle membrane after the release of the vesicle into the cell 
interior (Pelkmans et al. 2004, Tagawa et al. 2005). Caveolae bring their contents into 
early endosomal compartment in the Rab5-dependent manner from where coat units 
can be recycled back to the plasma membrane or destined for degradation via 
MVB/late endosomal pathway (Gong et al. 2008, Hayer et al. 2010, Parton and 
Simons 2007). Many types of cargo can be carried by caveolae, such as lipids, 
proteins and lipid-anchored proteins, but the definite role of these carriers has still 
remained obscure as same cargo molecules can be also internalized by a caveolin-
independent manner (Mayor and Pagano 2007, Parton and Simons 2007). 
 
The second clathrin-independent internalization pathway that relies on dynamin for 
endocytic vesicle scission is regulated by small GTPase RhoA. The knowledge of 
this pathway is very limited, but it has been shown at least to mediate the constitutive 
internalization of lipid raft resident interleukin-2-receptor (Lamaze et al. 2001). It has 
been implicated that actin dynamics may be crucial for this pathway, since RhoA is a 
known regulator of actin fibers (Mayor and Pagano 2007). 
 
Rho-family member GTPase CDC42 and Arf-family member Arf6 have been 
identified as regulators for dynamin-independent CIE-pathways (Mayor and Pagano 
2007, Naslavsky et al. 2004, Sabharanjak et al. 2002). Among other cargoes such as 
fluid-phase uptake, both of these pathways mediate internalization of GPI-anchored 
proteins and are therefore commonly referred to as CLIC/GEEC-pathways (Clathrin-
Independent Carrier/GPI-Enriched Endosomal Compartment) (Gong et al. 2008, 
Mayor and Pagano 2007). CDC42-mediated uptake is dependent on cholesterol and 
actin dynamics (Chadda et al. 2007) and forms long tubular invaginations at the site 
of carrier formation at the plasma membrane (Kirkham et al. 2005, Sabharanjak et al. 
2002). It is not clear at the moment whether Arf6-regulated pathway is distinct of 
CDC42-pathway since these two pathways seem to share common features. It has 
been speculated that these two internalization mechanisms may be different 
variations of the same uptake modes or alternatively, it may as well be possible that 
CLIC/GEEC-pathway used is dependent on the cell type (Kalia et al. 2006, Mayor 
and Pagano 2007, Naslavsky et al. 2004). 
 
Macropinocytic and phagocytic entry routes 
 
Macropinocytosis refers to a process used by cells to internalize large amounts of 
fluid, solutes and membranes. Although macropinocytosis can occur constitutively in 
some tumor cell lines and immature dendritic cells (Norbury 2006), external 
stimulation usually by growth factors or other mitogenic signals, such as phorbol 
esters causes the actin-driven formation of membrane protrusions that fuse with the 
plasma membrane forming large endocytic vesicles known as macropinosomes 
(Ghigo 2010).  Three types of membrane ruffles have been described in 
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macropinocytosis (i) planar lamellipodia-like membrane folds, (ii) cup-shaped 
circular ruffles and (iii) large balloon-like blebbings of the plasma membrane 
(Mercer and Helenius 2009). Macropinosomes are irregular in size and shape, have 
no discernible coat and do not concentrate receptor molecules or specific particulate 
cargo (Johannes and Lamaze 2002, Mercer and Helenius 2009). 
 
The induction of macropinocytic activity leads to the activation of a complex 
signaling cascade that is initiated by receptor tyrosine kinase activated Ras 
superfamily GTPases. Ras in turn activate another set of small GTPases, such as 
Rac1, Rab5 and Arf6 as well as various kinases, including Pak1 and protein kinase C 
(Liberali et al. 2008, Swanson 2008). These all together activate the effectors of actin 
polymerization that subsequently leads to the actin remodeling and ruffle formation 
(Mercer and Helenius 2009). Other factors implicated in regulation of membrane 
ruffling include Na
+
/H
+
-exchangers and membrane cholesterol as inhibition of cation 
exchanger by amiloride or depletion of membrane cholesterol block the induction of 
membrane ruffling (Grimmer et al. 2002, West et al. 1989). 
 
Final steps in macropinosome formation include membrane ruffle extension, cup 
formation and macropinosome closure (Swanson 2008). Internalized 
macropinosomes can either fuse with lysosomes (e.g. in macrophages) or recycle 
back to the cell surface release their contents to the extracellular space. The final fate 
of macropinosomes seems to be induction as well as cell type-dependent (Ghigo 
2010, Mercer and Helenius 2009). 
 
Besides growth factor induced activation of macropinocytic pathway, a variety of 
particles, such as viruses and apoptotic cells can induce macropinocytosis in many 
cell types and can be internalized together with ingested fluid. A growing evidence 
suggest that many viruses, including both enveloped and non-enveloped viruses enter 
into the cells via macropinocytosis (Karjalainen et al. 2008, Marechal et al. 2001, 
Mercer and Helenius 2008, Mercer and Helenius 2009). Intriguingly, it has been 
demonstrated that enveloped viruses can mimic apoptotic bodies by modifying the 
lipid contents of their envelopes in order to facilitate their entry into the host cells by 
inducing phosphatidylserine-mediated macropinocytosis (Hoffmann et al. 2001, 
Mercer and Helenius 2008, Mercer and Helenius 2009). Other functions assigned to 
macropinocytic pathway include the aforementioned uptake of apoptotic remnants, 
uptake of nutrients from the cell exterior, enhancement of cell motility, antigen 
presentation and immune surveillance as well as regulation of activated signaling 
cascades (Amyere et al. 2002, Ghigo 2010, Norbury 2006). 
 
Phagocytosis refers to the uptake of large particles by professional phagocytes such 
as macrophages and dendritic cells. In contrast to macropinosomes which carry cargo 
and fluid in an unspecific manner, phagocytosis do not involve massive fluid uptake 
and is strictly dependent of receptor mediated recognition of the particles to be 
internalized. Phagocytosis is actin-driven uptake mechanism and relies on dynamin in 
phagosome fission. Phagocytic cargo, such as bacteria and fungi is degraded by 
endo-lysosomal pathway (Ghigo 2010, Haas 2007, Mercer and Helenius 2009). 
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1.3 HOST AND VIRUS INTERACTIONS IN THE ASSEMBLY AND 
BUDDING OF HIV-1 
1.3.1 Pr55gag and assembly  
 
The major structural protein of HIV-1, Pr55
gag
 can assemble and bud from cells in the 
absence of any other viral factors (Gheysen et al. 1989), implicating that this 
precursor protein has an intrinsic property to multimerize into spherical particles at 
the host cell membranes. In numerous mutational studies three distinct domains of 
Pr55
gag
 have been mapped to be essential for successful particle production. M-
domain, that is located at the N-terminal part of p17 (MA) mediates the membrane 
association of Pr55
gag
 while I-domain at the C-terminus of p24 (CA) is required for 
efficient Pr55
gag
 multimerization. Lastly, L-domain, also referred to as a late domain 
is located within the p6-protein and is essential for release of the viral particles from 
the host cell membrane (Parent et al. 1995). 
 
M-domain and myristic switch are critical for the membrane binding of Pr55
gag
 
 
The M-domain of Pr55
gag
 consists of a bipartite membrane-binding signal composed 
of N-terminally attached myristic acid moiety and a stretch of basic amino acids (17-
31) located at the N-terminus of the matrix domain (Zhou et al. 1994). The covalently 
attached 14-carbon saturated fatty acid myristate is a crucial determinant for 
membrane association of Gag and thus also for particle production (Bryant and 
Ratner 1990, Gottlinger et al. 1989, Pal et al. 1990, Spearman et al. 1994). The role 
of myristic acid is regulated by a myristic switch mechanism which implies that 
myristic acid first adopts a sequestered conformation within the matrix domain. Upon 
encountering an appropriate stimulus at the host cell membranes it becomes exposed 
and is inserted into the bilayer (Ono and Freed 1999, Spearman et al. 1997, Zhou and 
Resh 1996). Recent studies have identified multiple triggers for myristic switch, 
including Pr55
gag
 multimerization and membrane-associated phosphoinositodes 
(Saad et al. 2006, Shkriabai et al. 2006, Tang et al. 2004). 
 
The acyl modification at the N-terminus of the matrix domain alone does not provide 
sufficient hydrophobic energy for stable membrane association (McLaughlin and 
Aderem 1995). Therefore, it has been proposed that basic residues within the N-
terminal part of MA are also required for efficient membrane association of Pr55
gag
. 
These positively charged amino acids are expected to strengthen the membrane 
associations via ionic interactions with acidic phospholipids present at the 
cytoplasmic leaflet of the plasma membrane (Hill et al. 1996, Zhou et al. 1994). 
Furthermore, residues in near vicinity of myristoylation signal as well as several 
downstream sequences of M-domain have been shown to confer in membrane 
affinity of Pr55
gag
 (Ono and Freed 1999). 
 
In addition to role of M-domain in membrane binding, sequences within p17 (MA) 
region have been implicated in targeting of virus assembly. Some amino acid 
substitutions in MA seem to redirect assembly from the plasma membrane to the 
internal membranes (Freed et al. 1994, Hermida-Matsumoto and Resh 2000, Ono et 
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al. 2000, Yuan et al. 1993) suggesting that amino acids conferring membrane 
specificity lies within the matrix domain. Several reports claim that large deletions on 
MA have no significant impact on particle production (Accola et al. 2000, Borsetti et 
al. 1998, Lee and Linial 1994, Reil et al. 1998) implying that HIV-1 Gag could 
harbour membrane association determinants also in domains other than MA. Indeed, 
one study has shown that substitution mutations in a very C-terminal part of CA led 
to impairment in particle production because these mutants had a lowered affinity to 
the membranes (Liang et al. 2003). Furthermore, the sequences within interaction 
domain on NC and the major homology region (MHR) at the C-terminal part of CA 
have been suggested to contribute in membrane affinity (Ebbets-Reed et al. 1996, 
Sandefur et al. 1998). 
 
I-domain mediates the oligomerization of Pr55
gag
 
 
Following targeting to the site of assembly, the membrane-associated Pr55
gag
 
oligomerizes into an immature core and concomitantly induces membrane curvature 
and formation of a membrane bud. Extensive mutational analyses have revealed that 
C-terminal CA (residues 282-363) with adjoining p2 spacer peptide and N-terminal 
NC-domains are required for efficient Gag multimerization and VLP production 
(Accola et al. 1998, Accola et al. 2000, Borsetti et al. 1998, Ono et al. 2000, Sandefur 
et al. 2000). 
 
The C-terminal part of CA contains a region that is important for assembly and is 
called the major homology region. This region consists of a stretch of amino acids 
that show considerable sequence homology among lentiviral CA-proteins. 
Substitutions or deletions in residues within or immediate upstream of MHR severely 
impair particle formation (Borsetti et al. 1998, Mammano et al. 1994), implicating 
that MHR is an evolutionally conserved subdomain that is essential for Gag-Gag 
interactions. In addition, to MHR the N-terminal part of NC-domain is also involved 
in Gag multimerization (Ono et al. 2000, Sandefur et al. 2000). This domain is called 
the interaction domain (I-domain) and it minimally consists of seven first N-terminal 
amino acids of the p7 (NC)-domain. Two basic arginine residues within the I-domain 
are essential for its function, suggesting that I-domain contributes to electrostatic 
interactions, most likely with RNA. The sequences downstream of minimal I-
domain, including two zinc finger structures have been shown to enhance I-domain 
function (Sandefur et al. 2000), further implicating that RNA based interactions 
promote Gag-Gag interactions (Cimarelli et al. 2000).  
 
Taken together, assembly is predominantly driven by protein-protein interactions 
established by the C-terminal region of CA within the Pr55
gag
 polyprotein. These 
initial interactions are enhanced upon stabilization of oligomers by membrane 
association through the N-terminal MA-domain. The formation of Gag oligomers at 
the membranes directed with these domains may create new functional surfaces that 
further increase affinity of Gag-multimers to membranes (Ebbets-Reed et al. 1996, 
Provitera et al. 2001, Sandefur et al. 1998, Sandefur et al. 2000). In addition, to 
protein-protein interactions assembly intermediates are stabilized by binding to RNA 
which has been speculated to function as a structural scaffold for assembling particles 
(Jouvenet et al. 2009b, Muriaux et al. 2001, Sandefur et al. 2000). 
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p6-late domain (L) function  
 
The last stage of budding requires a final pinching off-step to release the assembled 
virus particle from the host cell membrane. This step is mediated by the p6 domain at 
C-terminal part of precursor Gag protein which contains conserved PTAP-motif also 
called late domain. Disruption of this motif results in a distinct phenotype where 
nascent immature particles remain attached to the plasma membrane via a 
membraneous tether resulting in defect in particle release and accumulation of virus 
particles at a near vicinity of the host cell membrane (Demirov et al. 2002b, Freed 
2002). The late phenotype of PTAP-mutations seems to be dependent on cell type 
and experimental conditions used (Morikawa 2003). For instance, while p6-domain 
mutations impaired virus release in adherent cell lines (e.g. HeLa) and primary 
macrophages, the mutations had only minor effects on particle release in T-cells lines 
and primary T-cells (Demirov et al. 2002b). In addition, expression of Gag alone in 
high level of expression systems seems to overcome the late domain defect compared 
to systems where the full length virus is used (Gheysen et al. 1989). 
 
In addition to HIV-1, late domains have been also identified in Gag proteins of other 
retroviruses (Bouamr et al. 2003, Gottwein et al. 2003) as well as in unrelated 
enveloped viruses, such as Ebola virus (Licata et al. 2003). Viral late domains have 
been found to be functionally interchangeable between different viruses and they can 
exert their activity when positioned at an unnatural location within Gag or provided 
in trans (Martin-Serrano et al. 2001, Parent et al. 1995). This functional and 
positional flexibility suggests that late domains are not structural elements of particle 
assembly and are thus not involved in direct Gag-Gag interactions. Accumulating 
evidence instead implies that viral late domains function as docking sites for cellular 
factors that assist in viral egress through the cellular membrane (Freed 2002). 
 
1.3.2 Pr55gag trafficking in the cells 
 
As other myristoylated proteins, Pr55
gag
 is expected to be synthesized on soluble 
ribosomes in the cytoplasm. It has been however remained unclear how does Pr55
gag
 
reach its final destination at the cellular membranes. Pr55
gag
 can be actively 
transported to the site of assembly or alternatively the initial intracellular trafficking 
can occur by passive diffusion. The involvement of actin cytoskeleton, microtubules 
and vesicular transport pathways in Pr55
gag
 intracellular trafficking have been 
suggested (Martinez et al. 2008, Rey et al. 1996), but the evidence has been 
conflicting since no apparent co-localization of Pr55
gag
 with actin or tubulin has been 
detected (Perrin-Tricaud et al. 1999, Poole et al. 2005). Furthermore, the disruption 
of microtubules or late endosomal trafficking by pharmacological agents seem not to 
interfere Pr55
gag
 localization to the site of assembly at the plasma membrane 
suggesting that these cellular pathways do not mediate the initial targeting of the 
newly synthesized Pr55
gag
 in the cells (Jouvenet et al. 2006). One intriguing 
mechanism for Pr55
gag
 localization to the site of assembly would be the targeting of 
Pr55
gag
 encoding mRNA to the near vicinity of the assembly site. The localized 
synthesis would thus alleviate the need of specialized transport machinery for Pr55
gag
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targeting to the plasma membrane. In addition, full length mRNAs specifically 
transported to the site of assembly would also conveniently serve as genomes for 
assembling virus particles. Recent evidence indeed suggests that Pr55
gag
 trafficking to 
the site of assembly may be regulated already at the level of mRNA transport (Sherer 
et al. 2009), since Pr55
gag
 encoded from transcripts mutated at RRE-sequence failed 
to assemble into extracellular particles and associate with the plasma membrane (Jin 
et al. 2009).  
 
In order to build an immature virus particle, multiple Gag monomers must interact to 
form a lattice that ultimately becomes the doughnut-shaped shell of the complete, but 
immature virus particle. The identification of sequential assembly intermediates 
suggests that assembly of HIV-1 virus particles follows an ordered series of events 
and requires several host components, such as ATP and HP68 (Dooher and Lingappa 
2004, Morikawa et al. 2000, Tritel and Resh 2001, Zimmerman et al. 2002). The 
traditional view of assembly however suggests that monomeric Gag is first 
transported to the plasma membrane where it becomes directly recruited into a 
developing particle. According to an alternative view, some level of multimerization 
may occur already in the cytoplasm and these cytosolic oligomers are then targeted to 
the site of assembly at the plasma membrane (Adamson and Jones 2004). There is 
some evidence to support the latter model of the assembly since small oligomeric 
Gag complexes (e.g. trimers) have been detected in the cytoplasm (Morikawa et al. 
1998, Nermut et al. 2003, Spearman et al. 1997) as well as existence of larger 
discrete oligomeric structures have been described (Lee et al. 1999, Morikawa et al. 
2000). It is however unclear whether these oligomeric Gag structures represent true 
assembly intermediates as the majority of newly synthesized cytosolic complexes 
have been shown to be rapidly degraded while only a minority reaches the plasma 
membrane (Nermut et al. 2003, Tritel and Resh 2001). However, the membrane 
association of these putative cytosolic assembly intermediates seems to be the trigger 
for further assembly to higher molecular weight assemblies and eventually 
incorporation of these complexes into particles (Lee et al. 1999, Lingappa et al. 1997, 
Morikawa et al. 2000, Tritel and Resh 2001). Although the precise steps in early 
assembly are still unclear, the evidence so far implicates a mixed assembly model in 
which small Gag assemblies form already in the cytosol and these are then rapidly 
relocated to the membranes where the higher order oligomerization is expected to 
proceed. 
 
Two recent high resolution microscopy studies observing virus assembly in living 
cells have shed new light on the dynamics of Gag recruitment to the nascent virus 
particles. These reports show that Gag forms discrete clusters at the plasma 
membrane which are precursors for single virus particles suggesting that no large 
assembly platforms are required for successive virus production. Particle nucleation 
is driven by oligomerization of Gag recently attached to the membrane and 
subsequent incorporation of Gag molecules into growing virus particles occurs 
directly from the cytosolic pool of newly synthesized Gag (Ivanchenko et al. 2009, 
Jouvenet et al. 2008). No evidence was found to support the transport of 
preassembled multimeric Gag complexes to the plasma membrane (Ivanchenko et al. 
2009). The overall assembly process of Gag core complex was found to be rapid, 
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while the egress of the nascent particle through the plasma membrane and completion 
of the budding event was speculated to be rate limiting (Ivanchenko et al. 2009). 
 
Targeting to the assembly site 
 
The identity of the cellular membrane which provides the site for particle assembly 
has been highly controversial in recent years and the debate seems still be ongoing. 
Initially, it was taken as a proof that Pr55
gag
 assembles at the plasma membrane of an 
infected host cell but this view has been challenged by numerous studies 
demonstrating considerable amounts of Pr55
gag 
or mature virus particles in late 
endosomal compartment (Nydegger et al. 2003, Pelchen-Matthews et al. 2003, 
Raposo et al. 2002, Sherer et al. 2003). These findings suggested that Pr55
gag
 is first 
targeted to the limiting membrane of late endosomes/MVBs and virions are formed 
by budding into the lumen of this compartment. Virion release to the extracellular 
milieu was thought to occur via an exosome-based secretory pathway when 
endosomes fused with the plasma membrane (Chertova et al. 2006, Gould et al. 2003, 
Nguyen et al. 2003). This endosomal assembly model was further supported by 
finding that ESCRT-machinery which normally operates at the limiting membrane of 
an MVB was essential for successful budding (Morita and Sundquist 2004).  
Although the intracellular accumulation of Pr55
gag
 and virus particles was most 
prominent in macrophages (Jouve et al. 2007, Kramer et al. 2005, Pelchen-Matthews 
et al. 2003, Raposo et al. 2002) accumulation of Pr55
gag
 was also obseved in other 
cell types, such as T-cells and epithelial cell lines suggesting that HIV-1 assembly 
universally initiated at the endosomal compartment (Grigorov et al. 2006, Nydegger 
et al. 2003, Perlman and Resh 2006, Sherer et al. 2003). 
 
Opposing studies however suggested that assembly of HIV-1 occurs at the plasma 
membrane (Finzi et al. 2007, Gomez and Hope 2006, Jouvenet et al. 2006, Jouvenet 
et al. 2008, Neil et al. 2006, Rudner et al. 2005). Biochemical analyses revealed that 
newly synthesized Pr55
gag
 is specifically targeted to the plasma membrane (Finzi et 
al. 2007, Jouvenet et al. 2006, Neil et al. 2006). An appearance of Pr55
gag
 or virions 
later in endosomes is due to endocytosis of the plasma membrane-associated 
assembly intermediates or fully formed particles. Furthermore, when using 
fluorescently labeled Pr55
gag
 derivatives it was also concluded that soon after 
synthesis Gag molecules appeared at specific areas at the plasma membrane and 
assembled there for individual virions (Gomez and Hope 2006, Jouvenet et al. 2008, 
Rudner et al. 2005). Interestingly, these results were also soon extrapolated to include 
macrophages as it was shown by using a membrane-impermeant dye that apparent 
intracellular compartments were actually connected to the plasma membrane by 
narrow memraneous channels (Deneka et al. 2007, Welsch et al. 2007). Recently 
however, the specificity of this staining method has been questioned (Benaroch et al. 
2010).  
 
To further complicate this apparently contradictory data of the primary assembly site 
of HIV-1 virus particles it has been proposed that in macrophages Pr55
gag
 assembles 
both at the plasma membrane and in an internal compartment as no obvious 
internalization of the plasma membrane associated Pr55
gag
 was observed (Gousset et 
al. 2008). On the other hand, T-cells were reported to harbour domains of endosomal 
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origin at the plasma membrane which served as specific budding sites for both 
cellular exosomes and HIV-1(Booth et al. 2006). Recently, it was also shown that the 
late endosomal compartment in T -cells can support for productive virus particle 
production (Joshi et al. 2009). Taken together, highly controversial data have been 
obtained so far from studies exploring the the membrane targeting of HIV-1. 
Differential data most likely reflect the different settings and method used during 
experimentation and the interpretation of the data. Alternatively, as HIV-1 can infect 
multiple cell types, the virus may have evolved to exploit different cellular pathways 
for ensuring efficient particle production. The choice of assembly pathway in a given 
experimental setting may be determined for instance by the temporal availability of 
cellular factors. 
 
Membrane selection 
 
Despite of ongoing controversy about exact assembly site of HIV-1, the initial data 
suggested that assembly takes place at the plasma membrane of an infected cell. As 
plasma membrane represents only a minor fraction of total cellular membranes and 
Pr55
gag
 potentially encounters a variety of intracellular membranes before arriving at 
the plasma membrane it has been long intriguing what is the basis of Pr55
gag
 being 
specifically localized at the plasma membrane for assembly. Initial clues what is 
conferring to this specificity came from in vitro studies showing that authentic 
assembly of VLPs required the presence of mammalian cell lysates in the assembly 
reaction (Campbell and Rein 1999). Further studies by the same group implicated 
that inositol phosphate derivatives present in the cell lysates were responsible for 
correcting the aberrant assembly phenotype observed in the absence of these lipid 
species (Campbell et al. 2001). More light was shed on the membrane specificity 
when it was reported that targeting of Pr55
gag
 to the plasma membrane is regulated by 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2), an inositol derivative primarily 
resident in the cytoplasmic leaflet of the plasma membrane (McLaughlin and Murray 
2005, Ono et al. 2004). 
 
Recent studies have provided knowledge over more detailed mechanism behind the 
specificity of the plasma membrane targeting. (PI(4,5)P2) has been shown to bind 
directly the basic residues of the MA-domain, trigger the exposure of myristic acid 
and serving as an membrane anchor for Pr55
gag
 via its unsaturated 2’ acyl chain and 
inducing membrane curvature to facilitate budding (Chukkapalli et al. 2008, Saad et 
al. 2008, Shkriabai et al. 2006). Consistent with these data, (PI(4,5)P2) is enriched in 
viral particles and this enrichment is dependent on the presence of globular MA-
domain in the Pr55
gag
 polyprotein (Chan et al. 2008). As myristic switch and 
membrane binding affinity of MA-domain have been reported to increase upon 
trimerization of MA (Tang et al. 2004), it has been suggested that in addition to 
protein-lipid interactions also protein-protein interactions in the context of growing 
Pr55
gag
 shell at the inner leaflet of the cell surface may confer to membrane 
specificity of HIV-1 assembly. Furthermore, the interaction of MA-domain with 
RNA has been recently implicated in protecting Pr55
gag
 from promiscuous 
localization at the internal membranes. RNA was found to bind basic amino acids at 
the MA-domain and PI(4,5)P2 containing liposomes could outcompete RNA from 
interacting with MA. This data together suggest that there are multiple overlapping 
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mechanisms ensuring that Pr55
gag
 localizes to the correct membrane domain for 
assembly (Alfadhli et al. 2009, Chukkapalli et al. 2010). 
 
1.3.3 HIV-1 assembly and lipid rafts 
 
In many reports it has been suggested that assembly and budding of HIV-1 is 
critically dependent on lipid rafts (Graham et al. 2003, Lindwasser and Resh 2001, 
Nguyen and Hildreth 2000, Ono and Freed 2001, Rousso et al. 2000, Zheng et al. 
2001). Rafts have been speculated to provide a platform for assembly, by allowing a 
selective enrichment of the viral proteins in discrete domains at the plasma 
membrane. This hypothesis has been encouraged by confocal microscopy studies, 
which have shown that Pr55
gag
 localizes to the discrete, punctate regions beneath the 
plasma membrane of infected cells (Hermida-Matsumoto and Resh 2000, Sandefur et 
al. 1998). The punctate appearance of Pr55
gag
 localization suggests that there are 
cellular factors present at distinct locations at the cell periphery and these factors may 
contribute to the virus assembly. 
 
The strongest evidence that HIV-1 may assemble in lipid rafts has become from 
studies where Pr55
gag
 was found to associate with detergent resistant membranes 
(Lindwasser and Resh 2001, Nguyen and Hildreth 2000, Ono and Freed 2001). Also, 
HIV-1 spike protein, Env, was found to associate in detergent resistant membranes 
and this property was found to be dependent on Env palmitoylation (Rousso et al. 
2000). Further evidence of possible budding of HIV-1 from rafts has become from 
lipid analysis of virus particles, where it was found that virion envelope possesses a 
lipid profile similar to that of rafts with a marked enrichment in sphingolipids and 
cholesterol compared to the plasma membrane of the host cells (Aloia et al. 1993, 
Brugger et al. 2006). Accordingly, removal of cholesterol, an essential component of 
lipid rafts, renders virions non-infectious (Campbell et al. 2004, Graham et al. 2003, 
Ono and Freed 2001, Zheng et al. 2001) further supporting the role of rafts in HIV-1 
assembly. In a recent report it was shown that Env associates with distinct membrane 
patches that exclude other viral spike proteins expressed in same cells. Only one kind 
of spike protein containing VLPs were produced from co-transfected cells suggesting 
that a virion buds from an individual lipid raft that harbours only one kind of 
glycoproteins (Leung et al. 2008). 
 
However, despite extensive studies of HIV-1 budding from lipid rafts, the evidence 
of HIV-1 being a genuine raft-associated virus mostly remains circumstantial. For 
instance, it was concluded that HIV-1 particles bud from raft domains because raft-
associated GPI-anchored proteins (CD59 and Thy-1) as well as GM1 were 
incorporated into virions while non-raft associated CD45, a tyrosine phosphatase, 
was excluded from virus particles (Nguyen and Hildreth 2000). This piece of data 
may reflect of HIV-1 being associated with rafts, but exclusion of CD45 from HIV-1 
virions can as well be due to steric hindrance between long cytoplasmic tail of CD45 
and assembling Gag, rather than its non-raft localization in the site of assembly. 
Accordingly, incorporation of raft-associated components to virus particles may be a 
consequence of the fact that at the site of assembly the host components are rather 
indiscriminately included into particles along the Gag precursor (Chertova et al. 
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2006, Hammarstedt and Garoff 2004). Due to this rather sloppy assembly process, 
neither incorporation of raft-associated proteins into virions nor exclusion of non-
raft-associated proteins cannot taken as a proof for HIV-1 utilizing raft membranes as 
assembly platforms.  
 
Gradient centrifugation analyses after cold Triton X-100 extraction from several 
groups have shown that HIV Gag seems to associate with detergent resistant 
membranes at least for some extent but the interpretation of these results lack critical 
evaluation of the identity of the buoyant Gag complexes (Ding et al. 2003, 
Lindwasser and Resh 2001, Nguyen and Hildreth 2000, Ono and Freed 2001). In two 
of aforementioned studies HIV Gag was found to associate with detergent resistant 
membranes denser than classical lipid rafts and a term of barges instead of rafts was 
coined to these heavier structures (Lindwasser and Resh 2001). The electron 
microscopy analysis of these floating Pr55
gag
 complexes revealed that these high 
density structures represent merely multimerized Pr55
gag
 containing sheets formed by 
detergent extraction rather than cores assembling at lipid rafts (Ding et al. 2003). 
These studies clearly point out that one clear obstacle in obtaining reliable and 
consistent data seems to be a lack of standardized conditions used in detergent 
extraction studies. For instance the usage of dissimilar flotation gradients in parallel 
studies is one source of incoherent data and has kept creating ground for shady 
conclusions. 
 
The analyses of VLPs have also spoken on the behalf of the assembly of HIV at lipid 
rafts based on comparison of virion envelope to that of detergent resistant membranes 
(Aloia et al. 1993, Brugger et al. 2006). Both have been found to be enriched with 
cholesterol and sphingolipids and this have been taken as a proof of HIV budding 
from lipid rafts. However, in these studies the composition of the virion envelope has 
been compared to the isolated total membranes which include both the plasma 
membrane and internal membranes. The presence of internal membranes in this 
fraction obscures the analysis of the actual lipid composition at the site of virus 
budding at the plasma membrane and therefore it is questionable whether these data 
provide solid evidence on HIV utilizing rafts for assembly.  
 
In recent report plasma membranes of infected cells were isolated by using cationic 
silica beads that can give rise to relatively pure plasma membrane fraction (Chan et 
al. 2008, Spector et al. 1998). When this fraction was compared to the viral envelope 
it was found that the composition of the two membranes was strikingly similar except 
the enrichment of phosphoinositol phosphates at the viral membrane. In this 
particular study the authors did not find any evidence of HIV budding from lipid raft-
like membranes. 
 
In many reports it has been shown that virus production ceases or viral infectivity is 
lost upon treatment of virus producing cells or virions by cholesterol depleting agents 
such as -methyl-cyclodextrin. These data have also led to the conclusion that virus 
egress occurs through raft domains (Campbell et al. 2004, Graham et al. 2003, Liao 
et al. 2003, Ono and Freed 2001, Zheng et al. 2001). However, the loss of infectivity 
may as well reflect the defect in viral entry upon cholesterol depletion or inactivation 
of viral particles rather than direct problems in egress. On the other hand, it has been 
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shown that Pr55
gag
 binding to the membranes is less efficient in the absence of 
membrane cholesterol explaining the reduced virus production from cholesterol 
depleted cells (Ono et al. 2007). Furthermore, cholesterol depletion is known to cause 
global effects such as loss of plasma membrane (PI(4,5)P2) and reorganisation of 
cellular actin (Kwik et al. 2003), so the perturbation of virus production may also be 
an indirect consequence caused by cholesterol level modulating drugs rather than 
unbeatably proving the importance of lipid rafts in HIV assembly. 
 
Taken together, the issue of HIV utilizing lipid rafts for its egress from the host cells 
is still controversial. Many reports show evidence on the behalf of the importance of 
lipid rafts in HIV assembly and budding, but the lack of consistent methodology in 
studying raft association apparently complicates the interpretation of the data.  
 
1.3.4 Host cell factors that mediate the late stages of virus budding 
 
To date, it is well established that HIV-1 Gag late domain PTAP as well as a 
downstream sequence LYPXnL (that resembles the late domain of EIAV) recruit a 
vast array of cellular proteins that are needed for effective release of viral particles 
(Morita and Sundquist 2004, von Schwedler et al. 2003). These proteins, termed 
ESCRT or class E Vps proteins are normally found to act at the site of MVB 
formation. The idea that retroviruses may utilize MVB-associated budding machinery 
for their escape from the host cells is supported by a fact that both reactions include 
an analogous budding mode, that is, away from the cytoplasm (Pornillos et al. 2002). 
Numerous studies have now linked cellular MVB formation machinery and retrovirus 
budding (Morita and Sundquist 2004). 
 
HIV-1 PTAP-domain specifically binds a cellular protein Tsg101 (Demirov et al. 
2002a, Garrus et al. 2001, Martin-Serrano et al. 2001, VerPlank et al. 2001) which is 
a part of a multiprotein complex ESCRT-I (Katzmann et al. 2001). HIV-1 Pr55
gag
 
mimics a cellular protein HRS that normally is a binding partner of Tsg101 (Pornillos 
et al. 2003). Pr55
gag
 recruits Tsg101 to the site of budding by interacting with the 
UEV-domain of Tsg101. The recruitment of Tsg101 to the membrane is a first step in 
formation of an away from cytosol budding complex. The role of Tsg101 is then to 
recruit Vps28 and Vps37 which then together form an ESCRT-I complex. Analogous 
to events in MVB formation, the next complex recruited to the site of budding is 
ESCRT-II which is composed of another set of Vps proteins (Babst et al. 2002b). The 
third and the final complex to be recruited at the site of a bud is called ESCRT-III 
(Babst et al. 2002a). The components of this complex (the CHMP proteins) co-
assemble into a lattice once recruited to the endosomal membrane (von Schwedler et 
al. 2003). 
 
After ESCRT-III associated proteins have performed their function in formation of an 
away-from-cytosol budding, the AAA-type ATPase Vps4 catalyses the dissociation 
of the protein complex in an ATP-dependent manner. Class E Vps proteins are 
released from the membrane and recycled back to the cytoplasm for further rounds of 
membrane sorting (Babst et al. 1998, Babst et al. 2002a). The studies with mutant 
Vps4 ATPase have indicated that non-functional Vps4 induces a late-like phenotype 
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in HIV-1 transfected cells, i.e. budding viral particles remain tethered to each other 
on the cell surface (Garrus et al. 2001, von Schwedler et al. 2003). Of note however, 
in Vps4 mutant expressing cells the budding seems to proceed somewhat further than 
in cells transfected with HIV-construct lacking the L-domain (von Schwedler et al. 
2003), suggesting that ESCRT-complexes are important either directly or indirectly 
in inducing membrane curvature and in formation a membrane stalk. 
 
 
Fig. 4. ESCRT-recruitment by HIV-1 p6-late domain.  
The ESCRT-II complex is omitted as its role in HIV-1 release has been 
questioned (Langelier et al. 2006). Simplified from Pornillos et al. 2007). 
 
The role of downstream sequence LYPXnL has been shown to bind a protein called 
ALIX/AIP1 (Munshi et al. 2007, Strack et al. 2003). ALIX/AIP1 in turn binds 
Tsg101/ESCRT-I and CHMP4/ESCRT-III suggesting that ALIX/AIP1 may 
functionally link different ESCRT-complexes on the limiting membrane of MVB 
(Odorizzi et al. 2003, von Schwedler et al. 2003). Recent data shows that ALIX/AIP1 
has also a binding site on NC-domain of HIV-1 Pr55
gag
, perhaps providing alternative 
links between Pr55
gag
 and ESCRT-machinery (Popov et al. 2008, Popova et al. 2010). 
 
ALIX/AIP1 has been shown to be a crucial facilitator of virus particle release in the 
context of retroviruses that rely only on single, LYPXnL-type late domain, such as 
EIAV (Fisher et al. 2007, Martin-Serrano et al. 2003). The role of ALIX/AIP1 in 
HIV-1 budding, which mainly rely on interaction of PTAP-motif with Tsg101was 
shown to be auxiliary rather than indispensable if PTAP-motif was functional (Fisher 
et al. 2007, Fujii et al. 2009). Another study suggested that the role of ALIX/AIP1 is 
to recruit Nedd4-1 ubiquitin ligase through LYPXnL-motif to facilitate HIV-1 release 
in PTAP/ESCRT-independent manner (Sette et al. 2010). This alternative pathway 
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could provide a means to ensure an effective particle release for instance in cell types 
where the availability of Tsg101 is limiting (Usami et al. 2008). 
 
1.3.5 Endocytic pathway in retrovirus assembly 
 
The first clues that the host cell endocytic process may be involved in the late stages 
of retrovirus cycle become evident from a study where it was shown that EIAV late 
domain (YPDL) interacted with an adaptor protein complex AP-2 (Puffer et al. 
1998). The functional relevance for this interaction was not determined, but the host 
cell endocytic membrane trafficking was for the first time connected to the late 
domain function of viral Gag. 
 
The components of the endocytic machinery have also been shown to interact with 
HIV-1 Gag and play a role in the intracellular trafficking of Pr55
gag
. Clathrin adaptor 
protein AP-2 was shown to bind Pr55
gag
 through a putative YXX  -motif at MA-CA 
junction (Batonick et al. 2005), while AP-1 and AP-3 have binding sites within the 
MA-domain (Camus et al. 2007, Dong et al. 2005). Depletion of AP-1 or AP-3 from 
the virus producing cells was shown to reduce particle release while disruption of 
Gag-AP-2 binding site surprisingly had and opposing effect. EM data suggested that 
AP-1 and AP-3 could function upstream of ESCRT-complexes as depletion of these 
adaptor proteins did not induce late phenotype but diminished the formation of 
budding profiles at the cell surface (Camus et al. 2007, Dong et al. 2005). 
Furthermore, these studies suggested that AP-1 and AP-3 are probably involved in 
sequential steps of the same pathway since they inhibited virion release to the similar 
extent and could not functionally compensate each other. AP-1 was shown to interact 
with Tsg101 and Nedd4-1 implicating that AP-1 may facilitate virus release by 
recruiting ESCRT-machinery to the site of virus assembly (Camus et al. 2007). 
However, the precise role of these adaptor proteins in Pr55
gag
 trafficking remains 
obscure since AP-1 and AP-3 normally mediate cargo selection and incorporation 
into transport vesicles at intracellular compartments (Ihrke et al. 2004, Peden et al. 
2004, Reusch et al. 2002). Based on current data it is difficult to establish why an 
effective particle release is dependent on these mediators because they do not 
normally operate at the site of HIV-1 budding at the plasma membrane. On the other 
hand the dependence of virus release on AP-1 and AP-3 may speak on the behalf of 
Pr55
gag
 routing through intracellular membranes prior to assembly at the plasma 
membrane (Grigorov et al. 2006, Perlman and Resh 2006). 
 
As mentioned above, the interaction of Pr55
gag
 with AP-2 had negative effect on 
HIV-1 virus release (Batonick et al. 2005). The normal function of AP-2 is to sort 
cargo to clathrin coated pits at the plasma membrane (Traub 2003) and apparently 
AP-2 directs Pr55
gag
 to the endocytosis via binding YXX -recognition signal at MA-
CA junction (Batonick et al. 2005). It was speculated that AP-2-mediated endocytosis 
may prevent excess budding from the plasma membrane which could be hazardous 
for producer cells or alternatively, endocytosis of the plasma membrane-bound Gag 
has a yet unidentified functional role in the productive infectious cycle (Batonick et 
al. 2005). 
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1.3.6 Pr55gag ubiquitination 
 
The implications of the potential role of ubiquitin in the HIV-1 assembly came 
from a study showing that virus particles contained free ubiquitin and a small 
percentage of Pr55
gag
 was monoubiquitinated at p6-domain (Ott et al. 1998). More 
evidence suggesting the role of ubiquitination in HIV-1 budding was obtained when 
it was shown that proteosome inhibitors, by abolishing the cellular pool of free 
ubiquitin (Mimnaugh et al. 1997) interfered with the particle release and produced a 
phenotype reminiscent of a late domain defective virus (Patnaik et al. 2000, 
Schubert et al. 2000, Strack et al. 2000). Furthermore, overexpression of ubiquitin 
variants mutated in residues important for ubiquitin function was shown to inhibit 
HIV-1 particle release (Strack et al. 2002). 
 
Later studies indicated that Pr55
gag
 can be monoubiquitinated, in addition to p6-
domain in all domains including MA, CA and NC and that PTAP- and LYPXnL-
sequences in p6 were not required for Pr55
gag
 ubiquitination (Gottwein and 
Krausslich 2005). Further studies implicated that lysine residues downstream CA-
domain were important for budding, as cumulative mutations of these residues 
delayed virus release kinetics suggesting that Pr55
gag
 ubiquitination was 
functionally involved in transient protein interaction network at the budding site 
(Gottwein et al. 2006). Despite of evidence above, it is not still clear whether 
Pr55
gag
 ubiquitination is required for efficient release or whether ubiquitination of 
transacting factors contribute to ubiquitin-dependent particle release (Zhadina et al. 
2007). 
 
1.3.7 Role of ubiquitin ligases in HIV-1 budding 
 
It is now well established that PPXY-type late domains recruit Nedd4-like ubiquitin 
ligases to link viral late domain and ESCRT-machinery (Martin-Serrano et al. 
2005), whereas LYPXnL-motifs recruit ALIX/AIP1 to promote virus release 
(Fisher et al. 2007, Strack et al. 2003). As HIV-1 lacks PPXY-late motif, and 
mainly rely on PTAP-Tsg101 interaction in recruiting ESCRT-machinery to 
complete budding (Garrus et al. 2001, VerPlank et al. 2001) the role of ubiquitin 
ligases in HIV-1 budding have remained relatively scarce. Interestingly however, 
Nedd4-type ubiquitin ligases can rescue budding of HIV-1 in case of defective 
PTAP- and LYPXnL-motifs (Chung et al. 2008, Usami et al. 2008).  
 
Two studies have implicated that two distinct ubiquitin ligases, namely Tsg101-
associated ligase and Mahoqunin (Amit et al. 2004, Kim et al. 2007) may regulate 
the activity and stability of Tsg101 instead of that of Pr55
gag
 and mediate capability 
of Tsg101 to recruit ESCRT-I components to the site of budding (Martin-Serrano 
2007). Furthermore, a TGN-associated E3-ubiquitin ligase POSH has been shown 
to be essential for targeting Pr55
gag
 to the plasma membrane and virus release 
(Alroy et al. 2005) suggesting that ubiquitination of Pr55
gag
 or other cellular 
substrates may regulate productive assembly at multiple levels. In accordance with 
this, a recent report suggested that ALIX/AIP1 is a substrate for POSH and 
ubiquitination of ALIX/AIP1by POSH may play an auxiliary role in facilitating 
HIV-1 release (Votteler et al. 2009). 
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1.3.8 Tetraspanins 
Tetraspanins comprise a large group (33 members) of membrane proteins with four 
membrane spanning domains. Tetraspanins share little sequence homology, but are 
conserved in secondary and tertiary structures. They are present in high copy 
numbers in every cell type although the repertoire varies from a cell type to another 
(Hemler 2005). Tetraspanins, with their ability to associate with themselves and 
other receptor molecules are implicated to act as membrane organizers forming 
functional units called tetraspanin-enriched microdomains (TEMs) at cellular 
membranes. These domains have been assigned to increasing number of cellular 
functions such as cell adhesion, fusion and motility, intracellular signaling, actin 
organization as well as regulation of immune cell functions (Hemler 2005, Yanez-
Mo et al. 2009). TEM are also exploited by various pathogens for their cellular 
entry, for instance HIV, hepatitis C virus (HCV), human papilloma virus (HPV) 
and Plasmodium (Gordon-Alonso et al. 2006, Harris et al. 2008, Silvie et al. 2006, 
Spoden et al. 2008). 
 
The role of TEMs in assembly, budding and cell-to-cell spread of HIV-1 has been 
lately under intense investigation. Tetraspanins CD9, CD53, CD63, CD81 and 
CD82 have been found to form TEMs at the plasma membrane of various cell types 
and HIV-1 structural proteins along with ESCRT-I components were shown to co-
localize to these discrete domains. At least some of these tetraspanins are also 
incorporated into virions also suggesting that TEMs are gateway for HIV-1 egress 
(Booth et al. 2006, Deneka et al. 2007, Nydegger et al. 2006). Furthermore, 
tetraspanins CD63 and CD81 were shown to be recruited to the specific, actin-
dependent, Env-induced structures called virological synapses (VS) (Jolly et al. 
2004, Jolly and Sattentau 2007) implicating in their role in cell-to-cell transmission 
of the virus. In addition, it has been suggested that CD81 in T-cells and CD63 in 
macrophages are of particular importance in organizing assembly platform for HIV-
1 as downmodulation of these molecules impairs the particle production by several 
fold (Chen et al. 2008, Grigorov et al. 2009) In contrast, however, some studies 
have rendered tetraspanins dispensable for budding (Krementsov et al. 2009, Ruiz-
Mateos et al. 2008).  
 
Some evidence suggest that rather than serving as assembly facilitators or budding 
co-factors, tetraspanins actually negatively regulate cell-to-cell transmission and at 
least when overexpressed, reduce particle infectivity (Krementsov et al. 2009). In 
accordance with the latter observation, knockdown of tetraspanins in virus 
producing cells failed to increase cell-free infectivity (Ruiz-Mateos et al. 2008, Sato 
et al. 2008). In contrast though, opposing conclusions were drawn from knockdown 
studies of CD81 (Grigorov et al. 2009). Evidently, some studies speak on behalf of 
tetraspanins and TEMs owing an importance in the late steps of HIV-1 replication 
cycle, while critical data suggests merely a restrictive function for these membrane 
domains. Clearly more studies are required to resolve these apparent controversies. 
 
1.3.9 Actin cytoskeleton and assembly 
 
The role of actin and cytoskeletal components in virus release has been relatively 
poorly studied. It have been known for years that both actin and various actin 
binding proteins are found inside the virus particles and that actin-associated with 
the NC-domain of HIV-1 (Ott et al. 2000, Wilk et al. 1999). Also, virus release is 
impaired upon application of actin modulating agents, such as cytochalasin D or 
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latrunculin B (Sasaki et al. 1995). These studies however omit the fact that 
pharmacological agents may have global effects on the cellular functions. In 
principle though, actin could have either positive role in promoting the formation of 
a budding structure or negative, acting as a barrier for an assembling virion (Fackler 
and Krausslich 2006). Studies exploiting microscopic techniques have shown that 
HIV-1 remodels actin cytoskeleton of the host. Particularly, actin bundles were 
seen to assemble at the beginning of the virus budding process and while these 
disappeared immediately after a nascent virion left the host cell (Carlson et al. 
2010, Gladnikoff et al. 2009). Although actin dynamics may not be critical for 
budding, this conceptually shows that retroviruses can rely on actin-driven 
mechanism when releasing particles. 
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2 AIMS OF THIS THESIS 
 
 
1. To critically evaluate the possible role of lipid rafts in HIV-1 assembly  
                  and budding. 
 
2. To identify viral and cellular factors involved in HIV-1 Pr55gag assembly. 
 
 
3. To probe for possible mechanism of endocytosis involved in Vpu- 
           independent uptake of Pr55
gag
 -complexes. 
 
   39 
3 MATERIALS AND METHODS 
 
3.1 SEMLIKI FOREST VIRUS (SFV) EXPRESSION SYSTEM OF HIV-1 
GAG  
 
For studies investigating the association of HIV-1 Gag with lipid rafts we used 
Semliki forest virus (SFV)-driven expression of Pr55
gag
 (Liljestrom and Garoff 
1991). Briefly, SFV structural genes have been replaced with the coding region of 
Pr55
gag
 fused with the capsid (C)-protein of SFV. SFV-C region works as a 
translational enhancer which ensures high production of the gene of interest. The 
recombinant SFV particles were produced by co-electroporation of Baby Hamster 
Kidney 21fibroblast cells with in vitro transcribed RNA from the expression plasmid 
encoding C/HIV-Pr55
gag
 and containing the SFV RNA packaging signal and with 
helper RNA. The helper RNA provides the SFV structural proteins but lacks the 
packaging signal. Recombinant SFV particles, capable for a single-round infection 
were made carrying the sequence of C/HIV-Pr55
gag
. C-region of the translated fusion 
protein is cleaved by an autoprotease activity contained in the C-region (Aliperti and 
Schlesinger 1978). The recombinant SFV particles were used for expression of HIV-
1 (strain BH10) Pr55
gag
 in Jurkat T-cells. Also, control proteins CD55, Tr2  
(Suomalainen and Garoff 1994) and influenza NP (Zhao et al. 1998) were expressed 
in Jurkat T-cells by using SFV-expression system. 
 
3.2 CYTOMEGALOVIRUS (CMV) PROMOTER-DRIVEN EXPRESSION 
OF HIV-1 GAG 
 
To obtain more sustained level of Pr55
gag
 expression, nuclear cytomegalovirus 
(CMV) promoter-driven gene expression was used. pCMV-HIVgag was transfected 
to 293T-cells by Ca2PO4-precipitation technique. 
 
3.3 METABOLIC LABELING OF JURKAT-CELLS WITH 35S-
METHIONINE 
 
Recombinant SFV-infected Jurkat-cells were starved in methionine-free minimum 
essential medium for 30 min and subsequently metabolically labeled in methionine-
free modified Eagle’s medium containing 100 Ci 35S-methionine per ml for 15 min 
and chased for various times in RPMI-BSA medium containing 10-fold excess of 
cold methionine (0-180 min). 
 
3.4 CELLULAR FRACTIONATION FOR ANALYSIS OF PR55GAG RAFT 
ASSOCIATION 
 
(i) Total cell lysates. 
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Pulse-chased Jurkat cells were taken up into lysis buffer (10 mM Tris-HCl, pH 7,4, 
150mM NaCl, 1 mM EDTA, 1% Triton X-100, protease inhibitor coctail) and lysed 
at 0 C for 30 min. Lysate was mixed with 56% iodixanol (Optiprep) and applied to 
the iodixanol flotation gradient (see Fig.5). 
 
(ii) Total membrane fraction from crude cell homogenates. 
Pulse-chased Jurkat cells were taken up into homogenization buffer at cold (10 mM 
Tris-HCl, pH 7.4, 1 mM EDTA, protease inhibitor coctail) and homogenized with a 
tight-fitting Dounce homogenizer. Immediately after homogenization NaCl was 
added to 150 mM and homogenate was mixed with 100% Nycodenz to give final 
60% Nycodenz concentration. The sample was overlaid with 50% Nycodenz and a 
layer of homogenization buffer supplied with 150 mM NaCl. The gradient was 
centrifuged in an SW50.1 rotor at 63 000 x g for 45 min at +4 C. The total membrane 
fraction at the buffer/50% Nycodenz interphase was collected, solubilized with 1% 
Triton X-100 for 30 min either at 0 C or at +37 C and applied to the iodixanol 
flotation gradient. 
 
(iii) Total membrane fraction from post-nuclear supernatants. 
Pulse-chased Jurkat cells were homogenized (in buffer containing 25 mM Hepes-
KOH pH 7.4, 0.25 M sucrose, 4 mM MgCl2 and protease inhibitor coctail) by using a 
tight-fitting Dounce homogenizer. The crude cell homogenates were centrifuged at 
1400 x g for 4 min at +4 C to pellet nuclei and cellular debris. The post nuclear 
supernatant (PNS) was fractionated on the Nycodenz step gradient described above to 
separate membranes from cytosolic material. 
 
The total membrane fraction from buffer/50% Nycodenz interphase was mixed with 
1% Triton X-100 and after 30 min of incubation either at 0 C or +37 C the extracted 
membranes were analyzed on iodixanol flotation gradients. In the case of Brij98 
extraction, the total membranes were mixed with 0.5% Brij98 and incubated for 5 
min at +37 C. The extract was applied to a slightly modified density gradient in order 
to get a more precise separation of detergent resistant membranes from other floating 
complexes (see Fig. 5b). 
 
3.5 PURIFICATION OF VLPS FORTHE ANALYSIS OF PR55GAG RAFT 
ASSOCIATION 
 
Recombinant SFV-infected Jurkat cells were metabolically labeled with 
35
S-
methionine for 3 h. Culture media were collected and cellular debris was removed by 
centrifugation at 200 x g for 4 min. VLPs were purified from the culture media by a 
two consecutive gradient centrifugations. The culture supernatant was first applied 
onto a linear 5-20% iodixanol gradient (Hammarstedt et al. 2000) and centrifuged in 
an SW40 rotor at 160 000 x g for 1 h at cold. VLP-containing fractions were pooled 
and mixed with dense iodixanol (56%). This was overlaid by layers of 27%, 20% and 
5% iodixanol respectively. After centrifugation in a SW41 rotor at 77 000 x g for 14 
h at +4 C VLPs were collected from the 20%/27% iodixanol interphase, extracted 
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with Triton X-100 or Brij98 under conditions described above and analyzed on 
iodixanol flotation gradients. 
 
3.6 IODIXANOL FLOTATION GRADIENTS 
 
The figure below depicts the compositions of Optiprep-gradients used to assess the 
possible association of Pr55
gag
, virus-like particles (VLPs) and control proteins with 
raft-like membranes. Gradients were centrifuged in an SW41 rotor at 77 000 X g for 
14 h at +4 C. One-milliliter fractions were collected from the top and equal aliquots 
of each fraction were analyzed by SDS-PAGE. Radioactivity in Pr55
gag
, NP or Tr 2-
bands were analyzed by using BAS-III phosphoimager system. The amount of 
protein in each fraction was expressed as a percentage of the total (the sum of all 
fractions). SFV1-CD55 infected cells were prepared 5 h post infection and proteins in 
gradient fractions were precipitated with 10% trichloroacetic acid and analyzed by 
SDS-PAGE followed by Western blotting with anti-CD55 antibody. Endogenous Lck 
was analyzed from gradient fractions by Western blotting with anti-Lck antibody. 
 
 
 
 
Fig. 5a) Triton X-100 gradient b) Brij98 gradient 
 
3.7 ANALYSIS OF 32P-ORTHOPHOSPHATE AND 35S-METHIONINE 
LABELED VLPS 
 
Jurkat T-cells were prelabeled with 
32
P-orthophosphate for 40 h (Hammarstedt et al. 
2000) and infected with SFV-C/HIVgag. Four hours post infection cells were 
metabolically labeled with 
35
S-methionine and VLPs were collected for 3 h and 
purified as before. Culture medium from SFV-C/NP-infected Jurkat cells was 
prepared in similar way and used as a control to estimate the contamination of VLP 
fraction by cell-shedded microvesicles. Triton X-100 or Brij98-extracted VLPs and 
NP control were fractionated on iodixanol flotation gradients as described above, 
except the centrifugation used was significantly shorter (4,5 h). Buoyant Pr55
gag
 
complexes were collected from 30%/40%-iodixanol interphase (or the 25% zone in 
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the case of Brij98 extraction), diluted with homogenization buffer and pelleted by 
centrifugation in a SW41 rotor at 160 000 x g for 1h at +4 C. The pelleted Pr55
gag
 
complexes and non-extracted VLPs were taken up into 3% SDS and analyzed on 
20% SDS-polyacrylamide gels. The 
32
P-signal was determined by BAS-III 
phosphoimager system. 
35
S-methionine label in extracted and non-extracted VLP 
samples was used to ensure that equal amounts of Pr55
gag
 complexes were loaded on 
20% gels for phospholipid analysis.  
 
3.8 PRODUCTION AND ANALYSIS OF 3H-CHOLESTEROL LABELED 
VLPS 
 
Jurkat T-cells were infected with SFV-C/HIVgag or /NP for 30 min. The virus 
inoculum was removed and cells were metabolically labeled with 
3
H-cholesterol (10 
Ci/ml) for 4 h in RPMI-BSA medium. The radioactive cholesterol was removed and 
VLPs were collected for 3 h. VLPs were harvested from the culture medium by a 
two-step procedure as before. VLPs collected from the second purification gradient 
were diluted and pelleted by a 2-h centrifugation at 173 000 x g in an SW50.1 rotor 
(+4 C). Pellets were solubilized with Triton X-100 or Brij98 in small volume under 
conditions used before and extracts were analyzed on short iodixanol flotation 
gradients. These consisted of iodixanol solutions similar to described before, but the 
volumes were significantly smaller. The gradients were centrifuged in TLS-55 rotor 
at 166 000 x g for 4h at 4 C. Fractions were collected from the top and analyzed by 
scintillation counting. The counts from the NP control were substracted from the 
Pr55
gag
 VLP values and the amount of 
3
H-cholesterol radioactivity in different 
fractions was expressed as a percentage of the total. 
 
3.9 CONFOCAL FLUORESCENCE MICROSCOPY 
 
Subconfluent 293T-cells seeded onto glass coverslips were transfected with 3 g of 
pCMV-HIVgag. After 20-22 h, cells were placed on ice and incubated for 20 min 
with fluorescein isothiocyanate-conjugated cholera toxin B subunit (10 mg/ml). After 
extensive washes cells were fixed with 4% formaldehyde (unpatched cells) or 
incubated on ice in PBS containing anti cholera toxin antibodies for 30 min and 
subsequently transferred to 37 C for 30 min for patching. Cells were fixed with 4% 
formaldehyde, permeabilized with 0,3% Triton X-100 and stained with mouse anti-
Pr55
gag
 antibodies (EF-7 or 38:9, gifts from J. Hinkula) and tetramethyl rhodamine 
isocyanate-conjugated anti-mouse IgG. Preparations were mounted and analyzed 
with Carl Zeiss LSM 510 confocal system by using lasers with a wavelength of 488 
nm and 514-543 nm. 
 
3.10 PROVIRAL PLASMID CONSTRUCTS AND PRODUCTION OF VSV-G 
PSEUDOTYPED VLPS  
 
In studies addressing the membrane targeting of the newly synthesized Pr55
gag
 we 
turned into expression of Pr55
gag
 and Gag/Pol from the proviral genomes. The viral 
proteins expressed from the context of virus genome mimic more closely the natural 
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infection than does the expression of single viral proteins from the expression 
constructs. For safety reasons certain areas were deleted from the proviral genomes in 
order to minimize the theoretical possibility of recombination events that could lead 
to production of a virus capable of productive infection during the course of the 
experiment. Table 2 summarizes the proviral plasmid constructs used in this study. 
 
Proviral plasmid 
construct Phenotype Gag-expression profile 
      
pHXB2D vpu-, vpr-, nef- 
Processed (MA, CA, NC, p6, 
p1, p2) 
pHXB2D-Gag vpu-, vpr-, nef-, pol- Precursor Pr55gag 
pHXB2D-GagHA vpu-, vpr-, nef-, pol- 
Pr55gag with C-terminal HA-
tag 
pHXB2D-Gagflag vpu-, vpr-, nef-, pol- 
Pr55gag with C-terminal flag-
tag 
pHXB2D-
( Vpu/ Env/ Nef) vpu-, vpr-, nef-, env- 
Processed (MA, CA, NC, p6, 
p1, p2) 
pNL4-3(Gag) pol- Precursor Pr55gag 
pNL4-3(Gag/ Vpu) pol-, vpu- Precursor Pr55gag 
pNL4-3(Gag p6/ Vpu) pol-, vpu-, gag/p6- 
Precursor Pr55gag w/o p6-
domain 
pNL4-3( Env/ Nef) env-, nef- 
Processed (MA, CA, NC, p6, 
p1, p2) 
 
Table 2. The proviral constructs and the phenotype of lentiviral vectors. 
 
Vesicular stomatitis virus (VSV) G-protein pseudotyped infectious lentivirus vectors 
carrying modified HIV-1 genomes were produced by co-transfecting pCMV R8.91 
and pMD2.VSV-G (gifts from D. Trono) together with a plasmid directing the 
synthesis of a recombinant HIV-1 genome into 293T cells by a Ca2PO4 precipitation 
method. Next day the transfection medium was changed to fresh culture medium and 
viruses were harvested 24 h later. HeLa H1-cells were infected with these virus 
stocks (~1-5 PFU/cell) for ~24 h. 
 
3.11 SUBCELLULAR FRACTIONATIONS BY SILICA COATING 
 
VSV-G-pseudotyped lentivirus vector-infected, metabolically labeled (
35
S-
methionine, 50 Ci for 30 min) and chased HeLa H1-cells were detached from 
culture plates by a 2-min incubation in PBS- 0.02% EDTA at 37 C. Suspension cell 
were coated at +4 C with 1% cationic silica beads in coating buffer (20 mM MES, 
150 mM NaCl, pH 6.66-6.68). Coated cells were treated with 1 mg/ml sodium 
polyacrylic acid to give the net negative charge to coated plasma membranes. Cells 
were taken up into homogenization buffer (25 mM Hepes-KOH, 150 mM NaCl, 2 
mM MgCl2, protease inhibitor cocktail, 2,5 mg/ml heparin) and homogenized with a 
tight-fitting Dounce homogenizer. 
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The crude cell homogenates were mixed with 100% Nycodenz solution to give a 
final 60% Nycodenz concentration. The sample was placed on cushion of 70% 
Nycodenz and overlaid with 50% Nycodenz and 25 mM Hepes-150 mM NaCl-1 mM 
EDTA-solutions. The gradient was centrifuged in an SW55 Ti rotor at 63 000 x g for 
45 min at +4 C. 
 
 
 
Fig.6. A schematic drawing of silica coating procedure. 
 
The pelleted plasma membrane fraction was resuspended in hot 0.5% SDS-0.5M 
NaCl-buffer, boiled for 5 min and silica beads were removed from the sample by a 
brief centrifugation (1 min) full speed in a tabletop Eppendorf centrifuge. The 
internal membrane fraction from the buffer/50% Nycodenz interphase was collected, 
diluted fivefold with 25 mM Hepes-150 mM NaCl-1 mM EDTA-buffer and 
membranes were pelleted by centrifugation at 100 000 x g for 1 h at +4 C. The 
membrane pellet was solubilized as described above for the plasma membrane. Both 
resuspensed membrane fractions were diluted with a 10-fold excess of lysis buffer 
(1% Triton X-100, 25 mM Hepes, 150 mM NaCl, 1 mM EDTA, protease inhibitor 
cocktail) and Pr55
gag
 proteins were immunoprecipitated from the lysates with mouse 
anti-HIV-1 CA-antibodies. HA-tagged Pr55
gag
 was immunoprecipitated by using 
rabbit polyclonal anti-HA and FLAG-tagged Pr55
gag
 by using mouse monoclonal 
anti-FLAG-antibody. 
 
3.12 BIOTINYLATION OF CELL SURFACE PROTEINS 
 
HeLa H1-cells were brought into suspension by a brief treatment with PBS-0.02% 
EDTA at 37 C and incubated in PBS containing 0.5 mg/ml of EZ-Link Sulfo-NHS-
SS-biotin for 30 min at 0 C. The sample was quenched with 50 mM NH4Cl, coated 
with 1% silica beads and fractionated as described above. Biotin-tagged proteins at 
the plasma membrane and the internal membrane fractions were visualized by dot 
blots using streptavidin-peroxidase polymer. 
 
3.13 CONTROLS FOR SUBCELLULAR FRACTIONATION 
 
Biotinylated transferrin proteins (15 g/ml) bound to HeLa H1 cells by incubation at 
0 C or internalized at 37 C for 20 min in a serum-free medium were used as markers 
for the plasma membrane and recycling endosomes respectively. In the case of 
internalized transferrin cells were incubated in buffer (pH 4,5) containing 25 mM 
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citric acid, 24 mM trisodiumcitrate, 280 mM sucrose and 10 M deferoxamine 
mesylate for 2 min to remove the cell surface-bound transferrin prior to silica coating 
and fractionation. Transferrin proteins in the plasma membrane and internal 
membrane fractions were visualized by Western blotting with streptavidin-peroxidase 
polymer. 
 
The amount of endoplasmic reticulum (ER) marker protein calnexin and the late 
endosome/lysosome marker protein Lamp-1 in the plasma membrane and internal 
membrane fractions were determined by Western blotting with rabbit polyclonal anti-
calnexin and goat polyclonal anti-lamp-1, respectively. 
 
3.14 ELECTRON MICROSCOPY 
 
HeLa H1-cells infected with recombinant lentiviral vectors were fixed at 24 h post 
infection. Fixed samples were first stained with 1% osmium tetroxide, followed by 
staining with 0.5% alcoholic uranyl acetate, dehydration in ethanol and embedding in 
Agar 100 resin. Sections (60 nm) were cut on an LKB-microtome and imaged by 
electron microscopy. 
 
3.15 FILIPIN AND AMILORIDE TREATMENTS 
 
Testing of cholesterol-dependence of Pr55
gag
 endocytosis HeLa H1-cells were treated 
with filipin complex (3 g/ml). Filipin was added to the chase medium either at the 
beginning of the chase or after 30 min of the chase and continued for further 180 min.  
 
To test whether Pr55
gag
 occurred by macropinocytosis-like activity, 100 M 
amiloride, a potent inhibitor of induced macropinocytosis, was added to the chase 
medium. To measure macropinocytosis, cells were preincubated in minimum 
essential medium containing 0.2% BSA (MEM-BSA) for 30 min and then shifted to 
MEM-BSA containing 1 mg/ml of lysine fixable fluorescein isothiocyanate-
conjucated dextran for 10 min. After washing cells were further incubated at MEM-
BSA for 5 min. To strip the plasma membrane-associated dextran cells were placed 
on ice and incubated for 5 min in buffer (pH 5.5) containing 100 mM sodium acetate 
and 50 mM NaCl. Cells were detached from culture plates by incubation in PBS-
0.02% EDTA on ice for 20 min, fixed with 2% paraformaldehyde and analyzed by a 
fluorescence-activated cell sorter. 
 
3.16 VLP RESCUE FROM VPU  -VIRUS INFECTED HELA H1 CELLS 
 
Infected HeLa H1-cells were metabolically labeled with 
35
S-methionine and VLPs 
were collected for 180-240 min. Culture supernatants were filtered to remove the 
cellular debris, layered onto 20% sucrose cushion and centrifuged at 100 000 x g for 
1 h. These pellets representing constitutively released extracellular particles were 
analyzed by SDS-PAGE. 
 
 46 
To analyze the amount of VLPs tethered at the cell surface cells were incubated with 
trypsin (0.5 mg/ml) for 10 min at 37 C. Reaction was stopped by adding culture 
medium containing 7% fetal bovine serum. Cells were pelleted and culture 
supernatants were filtered and released VLPs were pelleted through a sucrose layer as 
described for constitutively released VLPs. 
 
3.17 RNA-INTERFERENCE 
Short interfering RNAs (siRNA) against Tsg101 or scrambled sequence control 
siRNA were transfected to HeLa H1-cells by using Oligofectamine. 20 pmol siRNA 
was used for each 10 cm plate (Garrus et al. 2001). Mock cells were treated with 
transfection reagent alone. After an overnight incubation cells were infected with 
recombinant lentivirus vectors and analysis of Pr55
gag
 was carried out 24 h post 
infection. The cellular Tsg101 levels were monitored by Western blotting using anti-
Tsg101 antibody. Intracellular actin level was used to control the specificity of 
Tsg101 siRNAs. 
 
Clathrin heavy chain (CHC) knockdown was achieved by using siRNAs against 
CHC. 10 cm HeLa H1 plates were transfected by using 40 pmol siRNA (Hinrichsen 
et al. 2003) and siLentFect according to manufacturer’s instructions. Mock cells were 
treated with siLentFect alone. About 22 h post transfection cells were infected with 
recombinant lentivirus vectors and analyzed 24 h post infection. Intracellular level of 
CHC was determined by Western blotting with polyclonal goat anti-CHC antibody. 
The polyclonal anti-glyceraldehyde-3-phosphate dehydrogenase antibody was used 
as a control. 
 
To analyze the effect of CHC knockdown on Pr55
gag
 endocytosis siRNA treated and 
infected HeLa H1 cells were incubated on ice for 30 min in PBS containing 0.2% 
bovine serum albumin and 500 ng/ml human biotin-tagged transferrin. After removal 
of unbound transferrin, cells were shifted to MEM-BSA and incubated at +37 C for 
0-15 min to allow the internalization of cell-associated transferrin. Cells were then 
shifted back on ice and treated with an acid wash (0.2 M Na-citrate pH 4.5, 0.5 M 
NaCl) and rinsed extensively. Cell surface-bound transferrin was removed by a 
trypsin treatment and the reaction was stopped by inactivating trypsin by culture 
medium containing 7% fetal bovine serum. Cells were homogenized and PNS was 
prepared. The amount of trypsin-resistant biotinylated transferrin in PNS was 
analyzed by Western blotting using streptavidin-peroxidase polymer. 
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4 RESULTS 
 
4.1 HIV-1 ASSEMBLY AND LIPID RAFTS: PR55GAG ASSOCIATES WITH 
MEMBRANE DOMAINS THAT ARE LARGELY RESISTANT TO 
BRIJ98 BUT SENSITIVE TO TRITON X-100 (PAPER I) 
 
4.1.1 Sample preparation strongly affects the outcome of flotation 
pattern after Triton X-100 extraction 
 
Jurkat T-cells were infected with recombinant SFV-C -particles carrying HIV-1 
Pr55
gag
 coding region. High level of Pr55
gag
 synthesis was obtained when using SFV-
driven expression system (data not shown). Cells were metabolically labelled with 
35
S-methionine and chased for various times. Cell homogenates were either directly 
solubilized with Triton X-100 or fractionated prior to the detergent treatment. 
Solubilized cell extracts were loaded on iodixanol gradients. During 
ultracentrifugation the detergent resistant membrane domains floated to a light-
density fraction while detergent soluble material stayed in the loading zone. 
 
In the first experiments a crude cell homogenate was used as a starting material for 
detergent extraction at cold. Our control for a raft associated protein, GPI-anchored 
CD55 (Solomon et al. 1998) efficiently floated to fraction 1 (5%/30% interphase) on 
an iodixanol density gradient as expected. In contrast to raft-resident CD55, only a 
minority of HIV-1 Gag was found in fraction 1 and the most of the protein floated to 
30%/40% iodixanol interphase (fractions 5 and 6) instead. Less than a half of the 
total amount of Gag was found in the soluble pool (fractions 9 to 12), this fraction 
most likely presenting cytosolic, non-membrane associated Gag or detergent soluble 
Gag of membranous origin. 
 
In parallel to HIV-1 Gag and raft-associated CD55, various other control proteins 
were tested for their flotation phenotype. Influenza virus nucleoprotein (NP), 
primarily a nucleus-associated protein and the cytosolic nucleocapsid protein C of 
SFV both floated to the 30%/40% iodixanol interphase after Triton X-100 extraction. 
Likewise, a non-raft membrane transferrin receptor (TR2 ) ended up to the 
30%/40% iodixanol interphase as well. In order to obtain an insight into the flotation 
behaviour of an analogously membrane-associated protein as Pr55
gag
, the distribution 
of an endogenously expressed Scr family kinase Lck on iodixanol gradient was 
analyzed. Lck was mainly detergent soluble as had been previously reported (Hawash 
et al. 2002), but a fraction of this protein also concentrated at the 30%/40% iodixanol 
interphase as well as some Lck was also found in fraction 1. 
 
The results from above suggested, that many different types of proteins from the 
crude cell homogenates tended to float to the 30%/40% iodixanol interphase and 
therefore it was difficult to assess whether this flotation phenotype correlated with 
Pr55
gag
 being a raft-associated protein. Furthermore, an extreme viscosity of SDS-
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solubilized fraction 5 and 6 samples implicated that chromatin contained in the crude 
cell homogenates might have ended up to this region of the gradient during the 
ultracentrifugation. The unspecific trapping of Pr55
gag
 or other marker proteins to the 
nuclear remnants may therefore explain the observed flotation phenotype of the 
proteins studied. In order to circumvent this potential source of artifacts, in next 
experiments an extra step was added to the extraction protocol. 
 
Recombinant SFV-infected Jurkat cells were treated as before but total membranes 
from these crude cell homogenates were first isolated by a Nycodenz flotation 
gradient. The total membrane fraction contained both the plasma membrane and 
intracellular membranes.  
 
When using total membranes as a starting material for the extraction, raft-associated 
CD55 still floated to fraction 1, suggesting that total membrane isolation by a 
Nycodenz gradient had no adverse effect on detergent extraction assay. Some of 
CD55 though remained in the bottom of the gradient this phenomenon most likely 
reflects the transient nature of lipid rafts or limited temporal association of raft 
proteins in these structures. The flotation phenotype of non-raft protein TR 2 
remained largely unchanged compared to previous set of experiments, except the 
buoyant complexes now shifted from fraction 6 to fraction 5. In the case of Lck, the 
relative amount of the protein in the middle densities clearly reduced and the buoyant 
complexes shifted now from fraction 5 to fraction 6. We could not offer an 
explanation for these minor shifts occurring in this assay. 
 
The analysis of influenza NP suggested that the modified extraction scheme was still 
prone to artifacts caused by unspecified nuclear material. As NP is a nucleus-resident 
protein our analysis clearly indicated that chormatinous material still contaminated 
our total membrane fraction as about 64% of intracellular NP co-fractionated with the 
total membranes in a Nycodenz gradient. After Triton X-100 solubilisation at cold 
and a run in an iodixanol gradient most of the membrane-associated NP floated to 
fractions 2 to 5 as did a small amount of co-purified cytosolic nucleocapsid protein 
(C) of SFV. When total membranes from NP expressing cells were solubilised at 
37 C, in conditions that should lead to the complete solubilisation of Triton X-100-
resistant membranes, NP was nearly exclusively found at the bottom of the density 
gradient. As it can be argued that floating NP-complexes could be associated with 
detergent resistant microdomains, we still favour the explanation of these less dense 
complexes originate from unspecific floating of chromatin-associated material to the 
intermediate densities. 
 
The analysis of HIV-1 Pr55
gag
 by fractionation scheme above yielded both light 
density and intermediate density complexes. When the total membranes from Pr55
gag
 
expressing cells were solubilised at physiological temperatures prior to the iodixanol 
density gradient, membrane-associated Gag was now equally distributed to the 
soluble pool and at the 30%/40% iodixanol interphase. According to these results, it 
would have been conceivable to suggest that newly synthesized Pr55
gag
 is at least 
partially associated with Triton X-100-resistant lipid rafts. But when the flotation 
profiles of NP and Pr55
gag
 were compared, a strikingly similar pattern of the 
behaviour upon Triton X-100 solubilisation at +37 C was observed, i.e. low density 
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complexes shifted to the soluble pool upon the extraction procedure. As both proteins 
are nucleic acid binding proteins these results led to a mere conclusion that these 
heterogeneous Triton X-100 insoluble (at 0 C) light density complexes most likely 
still represented structures that associated with unspecified nuclear remnants rather 
than represented Triton X-100-resistant lipid rafts. 
 
In order to reduce potential artifacts caused by chromatin in our samples we further 
modified the flotation scheme. Infected Jurkat cells were taken up into a hypotonic 
homogenization buffer supplemented with Mg
2+
, which promotes the integrity of the 
nuclear envelope. Prior to isolating the total membranes by a flotation gradient, the 
nuclei were removed from the crude lysate by a brief centrifugation. Post nuclear 
supernatant was then applied to the Nycodenz gradient and the total membrane 
fraction was then analyzed after Triton X-100 solubilisation on an iodixanol step 
gradient as before. When using PNS as a starting material for Triton X-100 
extraction, the influenza NP did not co-purify with the cellular membranes 
suggesting nuclear remnants were now qualitatively removed. 
 
At 0 min chase point Pr55
gag
 complexes were partially concentrated at the 
intermediate densities, while some of the protein scattered over fractions 9 to 12. 
After 2 hours chase the soluble pool had disappeared with Pr55
gag
 now exclusively 
concentrating at fractions 5 and 6. This shift most likely reflected the increased 
affinity of newly synthesized Pr55
gag
 to the membranes due to multimerization of 
Pr55
gag
 precursors (Lindwasser and Resh 2001, Ono and Freed 2001). Detergent 
extraction of these complexes at +37 C did not yield any changes in buoyant density. 
The analysis of Triton X-100-extracted extracellular VLPs yielded same buoyant 
complexes that ended up to the 30%/40% iodixanol interphase. This flotation profile 
of VLPs remained unchanged even if Triton X-100 treatment was performed at the 
physiological temperature. These results strongly suggested that Pr55
gag
 does not 
necessarily localise to the Triton X-100 insoluble lipid rafts during the assembly. 
 
4.1.2 Virus-like particles are largely devoid of raft-like membranes 
 
As the results from above suggested that Pr55
gag
 may not be a raft-associated protein 
we decided to further assess the nature of Pr55
gag
 complexes floating to 30%-40% 
iodixanol interphase. If these complexes were genuine Triton X-100-resistant lipid 
rafts then the lipid composition of these floating complexes should resemble those of 
naturally found in raft microdomains, i.e. they should be enriched in cholesterol and 
sphingomyelin. As VLP preparations can be obtained relatively free of contaminating 
cellular material it was a rational choice to use VLPs as a starting material for 
isolating floating Pr55
gag
 complexes.  
 
To assess the cholesterol content of these complexes we labelled SFV/C-HIVgag 
infected Jurkat cells with 
3
H-cholesterol and 
35
S-methionine.VLPs were recovered 
from the culture media by a two-step gradient centrifugation. Triton X-100 
solubilised VLPs were run in an iodixanol gradient and the distribution of 
3
H-
cholesterol and Pr55
gag
 in gradient fractions was analyzed. Our analysis showed that 
Pr55
gag
 signal was mainly found at the 30%/40% iodixanol interphase as before, 
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while the signal produced by 
3
H-cholesterol was almost exclusively distributed to the 
bottom of the gradient representing the Triton X-100 soluble pool. This data clearly 
indicated that flotation of Pr55
gag
 is not due to these complexes being physically 
associated with the membrane cholesterol. 
 
To determine whether membrane phospholipids (including sphingomyelin) instead of 
cholesterol are retained on the virion envelope upon Triton X-100 extraction and 
could explain the flotating phenotype of Pr55
gag
 complexes. We labelled SFV-
C/HIVgag infected Jurkat cells with both 
35
S-methionine and 
32
P-orthophosphate. 
VLPs were purified as described earlier and analyzed on iodixanol step gradient. The 
material was recovered from the 30%/40% iodixanol interphase and concentrated by 
pelletation. SDS-PAGE analysis of Triton X-100-extracted and non-triton-treated 
sample indicated that Triton X-100-extracted VLPs are largely devoid of 
phospholipids. After careful analysis of possible contamination by microvesicles of 
cellular origin and substraction of background values we estimated that only at 
maximum of 12-17% of virion-associated phospholipids remained attached to 
buoyant Pr55
gag
 complexes after Triton X-100 treatment. These data together 
suggested that conventional Triton X-100 extraction at cold readily solubilized the 
bulk phospholipids and cholesterol from the envelope of the VLPs thus leaving the 
explanation for observed intermediate buoyancy unresolved at this point. 
 
4.1.3 Confocal fluorescence microscopy reveals the co-localization of 
Pr55gag with raft-like domains 
 
The data from previous experiments suggested that Pr55
gag
 does not associate with 
Triton X-100-resistant lipid rafts. This does not however by any means exclude the 
possibility of Pr55
gag
 being associated with membrane microdomains other than 
classical Triton X-100-resistant lipid rafts as it is well established that cellular 
membrane do contain raft domains that are Triton X-100 sensitive (Hao et al. 2001, 
Pike et al. 2005, Roper et al. 2000, Schuck et al. 2003). To further study the possible 
association of Pr55
gag
 with lipid rafts we probed the raft association of Pr55
gag
 by 
confocal fluorescence microscopy. Individual raft domains are smaller than 
resolution of a light microscopy as such, but they can be induced to form larger 
patches by antibody cross-linking of raft-resident proteins. 
 
GM1, a lipid raft associated glycolipid was chosen for antibody cross-linking since 
this ganglioside has also been reported to be incorporated into HIV-1 envelopes 
(Nguyen and Hildreth 2000). 293T-cells transfected with CMV-HIVgag were 
incubated with fluorescein isothiocyanate-conjugated cholera toxin B-subunit which 
specifically binds to GM1. Patching of lipid rafts were induced by an antibody 
against the toxin. Pr55
gag
 was visualized with an antibody against unprocessed 
HIVgag and tetramethyl rhodamine isocyanate-conjugated secondary antibody. 
 
The confocal image analysis showed that Pr55
gag
 seems to co-localize with GM1-
positive membrane patches. This apparent co-localization does not necessarily reflect 
the association of Pr55
gag
 with Triton X-100-resistant microdomains, since in this 
experimental setting the formation of raft patches was artificially induced.  
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4.1.4 Pr55gag associates with Brij98-resistant but Triton X-100 
sensitive membrane domains 
 
To obtain further insight whether Pr55
gag
 localizes to rafts distinct from the Triton X-
100 sensitive lipid microdomains we tested the solubility of the newly synthesized 
Pr55
gag
 with various detergents. Pr55
gag
 was found to be partially resistant for several 
non-ionic detergents of Brij-series as well as for CHAPS and Lubrol. We decided to 
focus on Brij98 as lipid rafts can be recovered with this detergent under physiological 
conditions (+ 37 C) (Drevot et al. 2002). In order to maximize the resolution capacity 
of the iodixanol gradient we slightly modified the final step of the assay. Instead of 
using 40%-30%-5% iodixanol solutions in the gradient, we added layers of 25% and 
20% iodixanol while omitting the 40% solution. 
 
The analysis of the newly synthesized Pr55
gag
 indicated that at 0 min chase point 
Pr55
gag
 is partially sensitive to Brij98 extraction but localizes to the Brij98-resistant 
microdomains in a time-dependent manner. This phenomenon most likely reflected 
the multimerisation of Pr55
gag
 molecules at the plane of membranes since a mutant 
lacking domains required for multimerisation ( NC) (Burniston et al. 1999, Sandefur 
et al. 1998) did not associate with Brij98-resistant domains even after a longer chase 
(120 min) but remained in the Brij98 soluble pool. 
 
We next tested whether these floating Brij98-resistant complexes could be precursors 
for extracellular VLPs. Gradient-purified, 
35
S-methionine labelled VLPs were 
extracted with Brij98 for 5 min at + 37 C and run on modified iodixanol gradients 
(described above). SDS-PAGE analysis of the gradient fractions showed that Brij98 
solubilised VLPs readily ended up to the overlapping region at fractions 3-6 where 
did intracellular Pr55
gag
 complexes float on a similar gradient. This data strongly 
suggested that Brij98-resistant membrane domains could represent precursors for 
extracellular VLPs and therefore function as assembly platforms for HIV-1 Pr55
gag
. 
 
To further assess the nature of Brij98-resistant complexes the cholesterol content of 
these floating membrane domains was analyzed. SFV/C-HIVgag infected Jurkat cells 
were labelled with 
35
S-methionine and 
3
H-cholesterol and VLPs were collected and 
purified as before. After Brij98 extraction VLPs were run on a shortened iodixanol 
gradient and fractions were analyzed by SDS-PAGE for 
35
S-methionine signal and by 
scintillation counting for 
3
H-cholesterol, respectively. The gradient analysis indicated 
that majority of the signal for Pr55
gag
 and for cholesterol peaked at the 20%/30% 
iodixanol interphase suggesting that Brij98 extraction did retain majority of the 
envelope cholesterol on these floating complexes.  
 
Analogously, the extractability of envelope phospholipids on floating Brij98-treated 
VLPs was assessed. SVF/C-HIVgag infected Jurkat cells were labelled by 
32
P-
orthophosphate and 
35
S-methionine. VLPs were collected and purified from cellular 
contaminants as before and extracted with Brij98. Influenza NP-expressing Jurkat 
cells were used as controls for the microvesicular contamination of the VLP fraction. 
SDS-PAGE analysis of Brij98-extracted VLPs indicated that approximately a half of 
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the phospholipids remained attached to the floating Pr55
gag
 complexes suggesting 
that virion envelope is largely resistant to Brij98 extraction. 
 
In conclusion, our data suggested that Pr55
gag
 may associate with lipid domains that 
are largely resistant to Brij98 extraction but sensitive for Triton X-100. These Brij98-
resistant domains could possibly serve as platforms for the Pr55
gag
 assembly. Further 
studies are required in order to characterise these membrane domains and evaluate 
their biological relevance.  
 
4.2 VPU AND TSG101 REGULATE INTRACELLULAR TARGETING OF 
THE HIV-1 CORE PROTEIN PRECURSOR PR55GAG (PAPER II) 
 
4.2.1 Experimental approach 
 
In order to distinguish whether Pr55
gag
 assembles at the plasma membrane or at the 
internal membranes we employed a method of silica coating to assess the distribution 
of the newly synthesized Pr55
gag
 between these two membrane compartments. In this 
method, prior to homogenization and subcellular fractionation HeLa H1-cells were 
coated with cationic silica beads that give the plasma membrane increased density 
compared to the internal membranes (Spector et al. 1998). During centrifugation on a 
Nycodenz step gradient the less dense internal membranes float to the top of the 
gradient while the plasma membrane fraction is found in the pellet. Amounts of the  
newly synthesized Pr55
gag
 in the internal membrane fraction (I) and in the PM-
fraction (PM) were assessed by immunoprecipitation and by SDS-PAGE analysis of 
these fractions. Our control experiments with both the plasma membrane-associated 
proteins and proteins resident in the intracellular compartment indicated that coating 
of HeLa H1-cells with cationic silica beads enabled an efficient separation of the 
plasma membrane from the internal membranes. 
 
4.2.2 Newly synthesized Pr55gag is first targeted to the plasma 
membrane in Hela H1-cells 
 
HeLa H1-cells were infected with VSV-G pseudotyped lentiviral vectors carrying 
modified HIV-1 proviral genomes and cells were metabolically labelled with 
35
S-
methionine followed by a chase of various lengths. After employing the silica coating 
and subsequent analysis, our initial experiments revealed that in HeLa H1-cells 
Pr55
gag
 can accumulate either at the plasma membrane or at the internal membranes 
so this cell line was ideal for distinguishing at which membranes the newly 
synthesized Pr55
gag
 is first targeted.  
 
Our analysis indicated that after a short period of chase (e.g. 5 min) Pr55
gag
 
accumulated at the plasma membrane with essentially no labelled Pr55
gag
 in the 
internal membrane fraction. After a longer chase (e.g. 60 min or 180 min) we 
observed a slight shift of newly synthesized Pr55
gag
 to the internal membranes, but 
still the majority of the protein was present at the plasma membrane. An efficient 
VLP production was observed (pNL4-3/Gag) already after 2 h of chase, determined 
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by appearance of labelled Pr55
gag
 in the culture medium. Furthermore, in an EM 
analysis numerous budding profiles were observed at the plasma membrane of pNL4-
3/Gag infected cells while the internal membranes were essentially devoid of these 
profiles. These data together suggested that when expressed from the pNL4-3-
proviral construct, the newly synthesized Pr55
gag
 is exclusively targeted to the plasma 
membrane and is subsequently incorporated into VLPs that bud from the plasma 
membrane.  
 
4.2.3 Vpu regulates the intracellular localization of Pr55gag 
 
In the next experiments we tested whether Pr55
gag
 had an intrinsic affinity to the 
plasma membrane or whether other viral proteins had a role in directing Pr55
gag
 
assembly to the cell surface in HeLa H1-cells. After having deleted various genes 
from the original proviral Gag-expressing construct, we found out that deletion of the 
vpu gene caused a dramatic change in the intracellular localization of the newly 
synthesized Pr55
gag
.  
 
After a period of a short chase the vast majority of labelled Pr55
gag
 was found at the 
plasma membrane as before, but during a longer chase Pr55
gag
 was shifted to the 
intracellular membranes. Upon deletion of vpu, the VLP release was also severely 
affected since the amount of virions found in the culture medium dropped 
significantly (~18-fold). Similar results were obtained in the context of Gag/Pol co-
expression. 
 
When cells infected with Vpu-deleted proviral construct were analyzed by the EM, a 
dual distribution of the budding profiles was observed. In addition to budding profiles 
present at the plasma membrane, an endosome-like intracellular compartment loaded 
with VLP-sized vesicles was detected. Furthermore, occasionally clear budding 
profiles at intracellular locations were recorded, although they were far more rare 
than those observed at the plasma membrane.  
 
This data strongly suggested that Vpu regulates the intracellular localization of 
Pr55
gag
. Deletion of this viral accessory protein retargets Pr55
gag
 from the plasma 
membrane to the intracellular compartments by endocytosis with a concomitant 
decrease in release of extracellular VLPs. 
 
Interestingly, when Pr55
gag
 was fused to carboxyterminal HA-tag, no redistribution of 
Pr55
gag
/HA to the internal membranes was observed in the absence of Vpu, 
suggesting that C-terminus of Pr55
gag
 is mechanistically important for correct 
trafficking of Pr55
gag
 in the cells. In striking contrast, C-terminal FLAG-tag fused to 
Pr55
gag
 had no similar effect. 
 
4.2.4 Host protein Tsg101 is required for endocytosis of Pr55gag 
 
It is well documented that PTAP-motif in p6 -domain of Pr55
gag
 binds to a host factor 
Tsg101 and this interaction is indispensable for the productive release of HIV-1 viral 
particles from the cell surface (Garrus et al. 2001, Martin-Serrano et al. 2001, 
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VerPlank et al. 2001, von Schwedler et al. 2003). To test whether Tsg101 is involved 
in the endocytosis of Pr55
gag
/ Vpu a siRNA-mediated downregulation of Tsg101 
was employed (Elbashir et al. 2001, Garrus et al. 2001). 
 
In cells expressing reduced levels of Tsg101, the uptake of newly synthesized Pr55
gag
 
construct was also reduced compared to control cells transfected with scrambled 
sequence siRNA. This implicated that endocytic uptake of Pr55
gag
 is mediated by 
Tsg101. As Tsg101 is a part of ESCRT-machinery (Katzmann et al. 2001) this data 
further implied that the endosomal sorting complex may be involved in the 
endocytosis of Pr55
gag
 from the plasma membrane. 
 
According to some speculations the siRNA-mediated knockdown of proteins is not 
necessarily as specific for their targets as have been thought before since this method 
has been shown to induce alterations in the levels of non-related proteins and also 
potentially activate interferon-mediated antiviral pathways (Persengiev et al. 2004, 
Scacheri et al. 2004, Sledz et al. 2003). Therefore, to assure that inhibition of Pr55
gag
 
endocytosis caused by Tsg101 knockdown was not due to potential off-target effect 
produced by siRNAs, the p6-domain of Pr55
gag
 was deleted. This deletion abolished 
the Tsg101 interaction site in Pr55
gag
. Our results indicated that when Pr55
gag
 was 
truncated just prior to p6 coding sequence and the proviral construct did not express 
Vpu, the majority of the newly synthesized Pr55
gag
/ p6 remained at the plasma 
membrane. This data confirm that Tsg101/p6-interaction is required for Pr55
gag
 
endocytosis in the context of Vpu-negative virus in HeLa H1-cells. 
 
4.3 THE VPU-REGULATED ENDOCYTOSIS OF HIV-1 GAG IS 
CLATHRIN-INDEPENDENT (PAPER III) 
 
As in previous work we reported that the newly synthesized, plasma membrane-
associated Pr55
gag
 is endocytosed in the absence of viral accessory protein Vpu we 
here further investigate the endocytic phenotype of HIV-1 Gag in HeLa H1-cells. 
 
4.3.1 The Vpu-regulated endocytosis of HIV-1 Gag is independent of 
clathrin but clathrin knockout leads to a slight assembly defect 
in the context of Gag/Pol coexpression  
 
RNAi-mediated knockdown of clathrin heavy chain (CHC) was used to probe 
whether the endocytosis of Pr55
Gag
 is clathrin-mediated. HeLa H1-cells were treated 
with CHC-siRNAs prior to infection with Pr55
gag/ΔVpu and clathrin-mediated 
endocytosis was probed by measuring the uptake of biotin-tagged transferrin. Our 
results indicated that clathrin-mediated endocytosis was severely compromised in 
CHC-siRNA-treated cells but knockdown of CHC did not inhibit the uptake of the 
plasma membrane-associated newly synthesized Pr55
gag
. This suggested that 
endocytosis of Pr55
gag
 is clathrin-independent. In the case of Gag/Pol co-expression, 
a partial retention of processed Pr55
gag
 (i.e. CA) at the plasma membrane fraction was 
observed in CHC-knockdown cells. This finding implicated that a subpopulation of 
virions may be internalized in a clathrin-dependent manner (Neil et al. 2006) or 
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alternatively, CHC-knockdown had an interfering impact on the late stages of virus 
assembly in Gag/Pol-expressing cells.  
 
To distinguish between these two alternatives, the production of VLPs from Pr55
gag
 
and Gag/Pol-expressing cells was analyzed both in the context of normal levels of 
CHC and in CHC-siRNA-treated cells. It was suggested first by others (Neil et al. 
2006) that in the absence of Vpu HIV-1 Gag may be endocytosed from the plasma 
membrane as fully formed virions and membrane-bound particles can be released by 
a brief protease treatment. According to this finding we analyzed both virions 
produced directly to the culture medium and those that were released by a trypsin 
treatment. Our results showed that virtually no particles were produced to the culture 
medium from Pr55
gag/ΔVpu-expressing cells, but equal amounts of virions had 
remained tethered on the surface of both control and CHC-siRNA-treated cells and 
these could be released by a protease treatment. In the case of Gag/Pol-expressing 
cells the amount of tethered virions remained about three times lower in CHC-
knockdown cells in repeated experiments albeit there was no difference in the levels 
of protein expression or membrane-associated Gag. This suggested that CHC-
knockdown produced a moderate late assembly defect, by an unidentified mechanism 
in Gag/Pol-expressing HeLa H1-cells.  
 
4.3.2 The Vpu-regulated Pr55gag endocytosis is independent of 
macropinocytosis-like activity 
 
Previous results suggested that Pr55
gag
 internalization was independent of clathrin-
mediated endocytosis, so it was tested whether macropinocytosis played a role in 
Pr55
gag
 uptake. The flow cytometric analysis measuring the uptake of fluorescein-
conjugated dextran into both noninfected and Pr55
gag
 or Gag/Pol-expressing HeLa 
H1-cells showed that the basal level of macropinocytosis activity was low and virus 
infection did not upregulate this activity. The effect of amiloride, an inhibitor of 
induced macropinocytosis on Pr55
gag
 endocytosis was tested in the absence of Vpu. 
Amiloride failed to block the shift of the newly synthesized Pr55
gag
 to the internal 
membranes indicating that uptake of Pr55
gag
 unlikely occurred by a 
macropinocytosis-like activity.  
 
4.3.3 Interfering with plasma membrane cholesterol reduces uptake 
of cell surface-associated Pr55gag 
 
The possible dependence of Pr55
gag
 endocytosis on cholesterol was tested by filipin, 
an antibiotic commonly used to disrupt cholesterol-dependent raft-like microdomains 
at the cell surface. Filipin treatment reduced the amount of Pr55
gag
 at internal 
membranes when added at the beginning of the chase suggesting that endocytic 
uptake of Pr55
gag
 in ΔVpu background could occur by a cholesterol-dependent 
mechanism. However, the effect of filipin on Pr55
gag
 internalization was less 
pronounced if it was added after 30 min of chase when the maximal membrane 
insertion of newly synthesized Pr55
gag
 has already been achieved. 
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Since cholesterol is required for efficient membrane binding and higher-order 
multimerization of Pr55
gag 
(Ono et al. 2007), the observed effect could be due to an 
inability of plasma membrane-associated Gag proteins to efficiently multimerize in 
the presence of filipin. To probe this possibility the impact of filipin in the context of 
Gag/Pol co-expression was tested, since the processing of Pr55
gag 
offers a convenient 
indirect marker for efficient multimerization of Gag (Kaplan et al. 1994). Filipin was 
added to Gag/Pol-expressing cells after 30 min of chase and the chase was continued 
for further 180 min. 
  
These analyses indicated that filipin-treated cells contained significant amounts of the 
plasma membrane-associated, unprocessed Pr55
gag 
even after a long chase suggesting 
that filipin affected the proper higher-order multimerization of Pr55
gag
. In other 
words, filipin most likely reduced the overall virus assembly, since the processing of 
Pr55
gag 
was impaired in Gag/Pol-expressing cells. This led us to conclude that Pr55
gag
 
endocytosis is only indirectly dependent on membrane cholesterol as cholesterol 
sequestration interferes with a step upstream of Pr55
gag
 endocytosis. 
 
4.3.4 Pr55gag trafficking is dependent on cell confluency 
 
Our results have convincingly indicated that the newly synthesized Pr55
gag
 is initially 
targeted to the plasma membrane of an infected cell and endocytosed unless the viral 
accessory protein Vpu is present. These data have been produced by using confluent 
HeLa H1-cultures. Interestingly, when subconfluent cultures (cell density ~30-40%) 
were used for the corresponding experimentation it was found that in the absence of 
Vpu the newly synthesized Pr55
gag
 was targeted both to the plasma membrane and to 
the internal membranes and during the chase there was only a minor shift of the 
initially plasma membrane associated Pr55
gag
 to the internal compartment. This 
suggested that the targeting of Pr55
gag
 in subconfluent cells could occur in a random 
manner or the uptake in these cells could be more rapid than in confluent cells. To 
test between these two hypotheses the subconfluent cultures were infected with 
Pr55
gag
/HA, a tagged variant that we have previously shown to remain at the plasma 
membrane even in the absence of Vpu. Our results indicated that Pr55
gag
/HA in 
subconfluent cells was targeted almost exclusively to the plasma membrane and 
remained there even after a long chase as in confluent cells. Taken together, these 
data implicated that cell confluency can have an impact on the intracellular targeting 
of Pr55
gag
 when the protein is expressed in the absence of Vpu. 
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5 DISCUSSION 
 
In the first paper (paper I) we have critically evaluated whether the detergent 
extraction followed by an iodixanol step-gradient is a suitable method for separation 
of raft membranes from non-raft membranes and whether this method provides solid 
evidence to conclude that HIV-1 assembles at these specific Triton X-100-resistant 
lipid raft domains. Our results strongly indicate that detergent extraction yields highly 
variable results depending on the starting material used for the extraction protocol. 
We also show that VLPs emerging from cells do not possess raft-like membranes 
around them suggesting that classical cholesterol and sphingolipid rafts are not 
necessarily assembly platforms for extracellular HIV particles. We imply that Pr55
gag
 
associates with Brij98-resistant membrane structures instead of classical, Triton X-
100-resistant raft membranes. 
 
5.1 CONSIDERATIONS OVER EXPERIMENTAL APPROACHES TO 
ANALYZE DETERGENT RESISTANT MEMBRANES 
 
Lipid raft hypothesis has received over the past years much attention and is no doubt 
appealing as such, but the correlation between detergent extraction and cholesterol 
depletion data and membrane domain formation in living cells needs apparently some 
further consideration. Although cell membranes clearly are not only homogenous 
mixture of lipids and proteins providing cells just a boundary against the outer world, 
almost all aspects defining rafts, such as their size, composition, variation in 
composition, life-time and biological relevance have remained controversial (Pike 
2006). One apparent reason for this is that lipid rafts are too small to be seen with 
light microscopy and all other conventional methods to study rafts, like detergent 
extraction at cold, cholesterol depletion or domain patching with antibodies are more 
or less perturbing for the cells (Hao et al. 2001, Harder et al. 1998, Kwik et al. 2003) 
and do not necessarily provide any information of the existence of rafts in natural 
settings (Lai 2003, Munro 2003).  
 
Cholesterol- and sphingolipid-enriched domains are expected to be resistant to Triton 
X-100 at +4 C and they can be separated from detergent soluble bulk membranes by 
means of density gradients (Brown and Rose 1992). This traditional method to define 
and analyze detergent resistant microdomains has however evoked a great deal of 
criticism since temperature and detergents interfere with normal cellular dynamics 
and organization and therefore these extracts do not reflect the real state and 
functions of living cells (Hao et al. 2001, Kwik et al. 2003, Lichtenberg et al. 2005, 
Pike et al. 2005). In addition, non-standardized extraction procedures, gradient 
conditions and experimentation with synthetic membranes have further generated 
confusion over the existence and relevance of detergent resistant membranes 
(Hancock 2006). On the other hand, it has been suggested that lipid-independent 
protein-protein interactions alone can create distinct domains at the plasma 
membrane and these interactions in turn determine which molecules are retained in or 
excluded from certain microdomain assemblies (Douglass and Vale 2005). 
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Our data is consistent with the considerations over the relevance of the detergent-
extracted membrane fractions. We clearly show that the classical detergent treatment 
with Triton X-100 at cold followed by a density gradient centrifugation gives highly 
variable results depending on which cellular fraction is used as a starting material for 
extraction. We have identified cellular chromatin as a possible source of artifacts. 
Cellular chromatin is sticky and thus may give a flotation phenotype for unspecific, 
non-raft-associated cellular components, such as nucleic acid binding proteins easily 
leading to misinterpreted conclusion about raft association of a given protein. Works 
by others have pointed out another plausible source of artifacts such as actin 
cytoskeleton which has differential solubility depending on detergent concentration 
used (Babiychuk and Draeger 2006). 
 
What is creating further confusion in the field of detergent resistant microdomains or 
lipid rafts, is the usage of different kinds of detergents for the membrane extraction. 
Detergents are a vast group of chemical compounds with different properties 
including their differential capacity to solubilise physiological membranes (Pike et al. 
2005, Schuck et al. 2003). Alongside Triton X-100, the Brij-series of detergents and 
for instance Lubrol WX, can be used for membrane extraction (Drevot et al. 2002, 
Roper et al. 2000, Yanez-Mo et al. 2009). Each of these, according to their 
solubilisation capacity produces different flotation patterns of membrane lipids and 
proteins in density gradients (Pike et al. 2005, Schuck et al. 2003). It have however 
remained to be determined, whether these different types of detergent resistant 
membranes are distinct or at least relevant functional entities in the living cells. 
 
Cholesterol is essential for the structural integrity of lipid rafts and cholesterol 
depletion is a widely used method in studying these domains as they are dispersed 
upon extraction. Cholesterol is typically depleted from the cells by inhibitors of 
synthesis (statins) in combination with cholesterol-free culture medium or by 
extracting it from the membranes with methyl-β-cyclodextrin (Hao et al. 2001). The 
cholesterol extraction method is however also prone to misinterpretations. 
Cholesterol depletion has been shown to alter drastically the composition of the 
plasma membrane by inducing domain segregation, decreasing the diffusion rate of 
both raft and non-raft proteins, alter the bilayer permeability and affecting the 
endocytic pathways (Goodwin et al. 2005, Hao et al. 2001, Hao et al. 2004, 
Kenworthy et al. 2004, Subtil et al. 1999). Furthermore, cholesterol depletion has 
been shown to affect the phosphoinositode content of the membrane and reorganize 
cellular actin (Kwik et al. 2003). Cholesterol depletion has vast adverse global effect 
on the cell biology. In other words, cholesterol depletion makes cells sick and 
therefore it is questionable whether this method is suitable for drawing definitive 
conclusions of the existence or functions of cholesterol and sphingolipid-enriched 
membrane domains. 
 
5.2 HIV-1 ASSEMBLY AND LIPID RAFTS 
 
The assembly and budding of HIV-1 have been linked to the raft domains 
biochemically by non-ionic detergent extractions and fractionations of these extracts 
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on different kinds of density gradients (Lindwasser and Resh 2001, Nguyen and 
Hildreth 2000, Ono and Freed 2001) or by simple pelletation of cell extracts (Rousso 
et al. 2000). Further evidence for raft association of HIV-1 has been gained from 
confocal microscopy studies where the co-localization of viral proteins with raft 
markers has been examined (Nguyen and Hildreth 2000). 
 
To evaluate the possible role of detergent resistant microdomains in HIV-1 assembly, 
our first approach was a classical detergent extraction assay with Triton X-100 
followed by a density gradient. Our results first suggested that Pr55
gag
 associates with 
a heterogenous group of light and intermediate density membranes implicating that 
Pr55
gag
 may be a raft-associated protein as reported by others (Lindwasser and Resh 
2001, Nguyen and Hildreth 2000, Ono and Freed 2001, Zheng et al. 2001). However, 
our control proteins that are not associated with lipid rafts surprisingly also floated to 
the intermediate density fractions. This prompted us to believe that buoyant Pr55
gag
 
complexes were not true detergent resistant membrane-associated complexes but 
structures most likely representing post-lysis artifacts. Moreover, Triton X-100 
extraction at physiological temperatures did not resolve these buoyant Pr55
gag
 
complexes further suggesting that these structures were not genuine lipid rafts. After 
modifications made in membrane isolation protocol that quantitatively removed the 
artificial floating we could conclude, that newly synthesized Pr55
gag
 associates with 
membranes with intermediate density in a time-dependent manner, but these do not 
represent genuine Triton X-100-resistant lipid rafts because of their increased density 
and inability to float through 30% iodixanol.  
 
Consistent with our results these intermediate density complexes have been also 
observed by other groups (Ding et al. 2003, Lindwasser and Resh 2001). The former 
concluded that multimerization of Gag promotes its localization to barges, which are 
described to be more dense raft domains than classical light density Triton X-resistant 
lipid rafts. Remarkably though, even when Pr55
gag
 was found to float to these 
intermediate density fractions instead of light ones, this floatation phenotype was 
interpreted to as a raft association, nevertheless of a special kind, but without any 
further analysis of these floating barges. Given that intermediate density flotation 
phenotype is obtained also for membranes largely devoid of cholesterol and 
sphingomyelin, i.e. essential raft components, we disagree with the interpretation of 
barges possessing raft-like properties. The latter study was in agreement with us as 
they clearly interpreted these intermediate density complexes to be distinct of lipid 
rafts based on flotation analyses, cholesterol extraction studies and electron 
microscopy data. 
 
Two other major studies implicating that rafts are important for HIV-1 assembly 
(Nguyen and Hildreth 2000, Ono and Freed 2001) cannot be directly compared with 
our results, as in flotation assays different types of density gradients were employed. 
In the former study it was reported that 
3
H-myristic acid-labelled intracellular Pr55
gag
 
is associated with light density Triton X-100-resistant structures in cold cell lysates. 
However, the density gradient used in this study did not have dense enough 
separating layer (38% sucrose corresponds to ~30% iodixanol) that could be capable 
of separating intermediate buoyant complexes from light density Triton X-100-
resistant membranes. In addition, Gag complexes floating through 38% sucrose were 
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not further characterized and the buoyant phenotype was directly interpreted as 
Pr55
gag
 being a raft-associated protein. 
 
In the report of Ono and Freed (Ono and Freed 2001) it was shown that about half of 
the membrane-associated Pr55
gag
 is found at detergent resistant fractions and 
association of newly synthesized Pr55
gag
 with this subset of membranes occurs after 
the initial targeting of Pr55
gag
 to the membranes. On the basis of the flotation 
phenotype of Pr55
gag
 they concluded that rafts play a critical role in HIV assembly 
and release. Unfortunately though, the density gradient used in this study was not 
apparently capable of separating complexes possessing light and intermediate 
densities since the gradient consisted of only a relatively dense separating layer made 
of 65% sucrose solution. The use of such a dense separation layer leads to an 
apparent flotation of both intermediate density as well as light density complexes to 
the top fractions of the gradient and therefore these results cannot be used to validate 
the association of Pr55
gag
 with lipid rafts. 
 
However, this study (Ono and Freed 2001) is consistent with our results in regard to 
the kinetic studies where they show that maturation of membrane-bound complexes 
takes place during the chase. Our results also indicated that initially Triton X-100 
soluble Pr55
gag
 becomes associated with intermediate density membranes over time 
(paper I). Furthermore, their results are also in agreement with ours in respect that 
Pr55
gag
 domains present affect the degree of Pr55
gag
 complexes that remain attached 
to detergent resistant membranes. Our preliminary data analysing truncated Gag 
variants showed that Pr55
gag
 lacking NC-domain and sequences downstream does not 
associate with membranes possessing intermediate density, but remains soluble even 
after longer periods of chase (unpublished results), most likely due to their 
incapability to form higher order oligomers (Burniston et al. 1999). 
 
To gain further insight whether Pr55
gag
 associates with lipid rafts, we turned into 
confocal microscopy. Inherently rafts are too small to be visualized by light 
microscopy, but raft domains can be cross-linked by antibodies against raft 
components in order to coalesce them into larger visible patches. Our data showed 
that significant amount of Pr55
gag
 indeed colocalized with GM1-choleratoxin B 
subunit cross-linked raft domains. According to our data from detergent extraction 
experiments, these domains are apparently sensitive to Triton X-100. On the other 
hand, one can speculate that artificially patched raft domains do not exist in the native 
membranes, so to my opinion it is questionable whether this data bring about 
anything conclusive upon putative association of Pr55
gag
 with rafts. Furthermore, 
apparent colocalization in general does not have to mean direct association of the 
components under study, so based on our confocal images it is still highly speculative 
whether Pr55
gag
 is raft-resident or not. 
 
The fluorescent microscopy studies by others (Nguyen and Hildreth 2000) have 
shown that HIV-1 viral proteins colocalize with raft markers such as GM1 and Thy-1 
but no colocalization is observed with a raft-excluded protein CD45. Furthermore, 
when Jurkat cells were loaded with raft-specific and non-raft partitioning fluorescent 
lipid analogs it was shown that HIV-1 proteins colocalize preferentially with raft-
specific lipid analog, but not with fluid phase associating analog. Interestingly, the 
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staining pattern of HIV-1 in chronically infected Jurkat cells seemed to concentrate to 
discrete regions at one side of the cells, to the uropods, rising a possibility that these 
subcellular structures may in itself contain factors that lead to this particular virus 
protein distribution and the primary cause for such distribution lies far away from 
lipid raft-induced phenomena. 
 
One method to assess whether lipid rafts play a role in HIV-1 assembly and budding 
is apparently the analysis of VLP lipid composition as the viral envelope is derived 
from the actual budding site. Furthermore, VLPs can be easily purified from the most 
contaminants of cellular origin hence providing a relatively uniform material for 
analyses. 
 
Our data suggested that VLPs do not possess raft-like membranes around them as 
they exclusively ended up on intermediate density fractions on iodixanol density 
gradients and the extraction at physiological temperatures did not change this 
flotation pattern. In accordance with this, the cholesterol and phospholipid analysis of 
Triton X-100-extracted VLPs showed that these buoyant complexes are largely 
devoid of cholesterol and sphingolipids further confirming that lipid rafts are not an 
inherent component of extracellular virions. Consistent with our findings it was also 
confirmed by others that Triton X-100-extracted VLPs floated to the intermediate 
densities (Ding et al. 2003, Lindwasser and Resh 2001), resembling the flotation 
phenotype of intracellular Pr55
gag
. Lindwasser and Resh interpreted these buoyant 
complexes as Triton X-resistant rafts containing oligomeric Pr55
gag
, but no lipid 
analysis whatsoever was performed to confirm the raft-like nature of these floating 
objects. 
 
The direct analyses of virion lipids have also spoken on behalf of HIV-1 budding 
from raft domains. The virion envelope has been shown to be enriched in cholesterol 
and sphingomyelin, the main constituents of lipid rafts suggesting that HIV egress 
occurs through special membrane domains (Aloia et al. 1993, Brugger et al. 2006). A 
recent study however suggested that overall lipid content of virions matched closely 
to that of the plasma membrane except with enrichment in cholesterol, ceramide and 
phosphoinositodes. These authors did not find any evidence of HIV budding from the 
rafts with unusual lipid composition (Chan et al. 2008). This is in line with our results 
as our data did not either support the conclusion of Pr55
gag
 being associated with lipid 
rafts. 
 
5.3 BRIJ98-RESISTANT MICRODOMAINS 
 
It is well established that not all rafts are resistant to Triton X-100 (Drevot et al. 
2002, Roper et al. 2000) and different detergents vary in their capacity to solubilise 
biological membranes (Pike et al. 2005, Schuck et al. 2003). To assess whether 
Pr55
gag
 associates membrane rafts other than classical Triton X-100 rafts we tested 
the sensitivity of membrane-bound Pr55
gag
 to various other detergents. Our analysis 
suggested that Pr55
gag
 is partially resistant to many other detergents, such as 
members of Brij-series. We decided to focus on polyoxyethylene ether Brij98, as 
this detergent detects rafts at physiological temperatures (Drevot et al. 2002) and 
thus may provide more relevant information of lipid microdomain behaviour on the 
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native membranes than extraction at cold with Triton X-100. We also slightly 
modified the density gradient in order to achieve more accurate separation of the 
detergent resistant membranes from soluble complexes.  
 
Our results indicated that at the steady state Pr55
gag
 is largely resistant to Brij98 
extraction at physiological temperatures. We implicate that these buoyant 
complexes are most likely precursors for the assembling particles as newly 
synthesized Pr55
gag
 accumulate to these membrane domains in a time-dependent 
manner and recovered extracellular particles also exhibit comparable buoyant 
density when analyzed on density gradients. Our analysis of Brij98-extracted VLPs 
suggested that cholesterol and phospholipids are quantitatively retained on the 
particles upon detergent treatment.These data all together suggest that instead of 
usurping Triton X-100-resistant lipid rafts for assembly, Pr55
gag
 may egress through 
Brij98-resistant membrane microdomains. Our data is consistent with a work 
showing that infectious wild-type HIV-1 particles contains Brij98 rafts but only 
minimal amounts of Triton X-100 rafts (Campbell et al. 2004). 
 
The membrane microdomains owing resistance to other detergents than Triton X-
100 are less characterized entities in the raft field. We are here first to implicate, 
based on careful analysis of detergent extracted buoyant complexes that HIV-1 may 
associate with lipid domains other than classical Triton X-100-resistant lipid rafts. 
We strongly emphasize that anything that owns a floating phenotype on a density 
gradient cannot directly taken as a proof of HIV-1 Gag being associated with lipid 
rafts as suggested previously (Lindwasser and Resh 2001, Nguyen and Hildreth 
2000, Ono and Freed 2001).  
 
It is worth discussion what is, indeed, the biological relevance of lipid 
microdomains. At least classical Triton X-100-resistant lipid rafts have been 
assigned to many cellular functions such as signal transduction, formation of 
immunological synapse upon B- and T-cell activation and clathrin-independent 
endocytosis (Kirkham et al. 2005, Simons and Toomre 2000, Sohn et al. 2008, Zech 
et al. 2009), but also serious concerns have been raised on this issue (Lai 2003, 
Munro 2003). One should consider critically what is the biological ”gain” of such a 
compartmentalization in living biological systems; are these domains true 
composites of membranes directing certain cellular functions or are they just by-
products induced by protein-protein or physically preferred protein-lipid 
interactions (Lingwood and Simons 2010).  
 
Whatever is the case, the assignment of Brij98-resistant lipid domains in the 
assembly of Pr55
gag
 provided a fresh insight in the raft field. These membrane 
domains seem to exist at physiological temperatures rendering them at least 
conceptually more relevant in the biological sense than lipid domains that can be 
scored only when extracted at low temperatures. On the other hand, extractability at 
cold does not necessarily render Triton X-100-resistant non-existent in the native 
membranes as rapid cooling of a biological system is known to slow down free 
diffusion on the membranes and preserve cellular structures. Clearly more studies 
are needed in order to elucidate whether the Brij98-rafts possess any relevance on 
native cellular functions or in the context of HIV-1 assembly.  
 
New advanced microscopy-based techniques have been applied to study lipid rafts in 
the context of living cells (Simons and Gerl 2010). Some of these methods, such as 
total internal reflection fluorescence microscopy have also been used in order to 
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visualize the assembly of HIV-1 at the cell membrane (Ivanchenko et al. 2009, 
Jouvenet et al. 2008). In these studies virus particles have been seen to assemble at 
discrete punctate areas at the plasma membrane. Whether these discrete clusters 
reflect the assembly of HIV-1 in specialized microdomains, such as Brij98-resistant 
rafts remains to be elucidated. 
 
According to another view, interaction of Gag with phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) at the plasma membrane could promote the membrane 
reorganization and formation of lipid rafts. Upon Gag binding and insertion of Gag 
N-terminal saturated myristic acid into the cytoplasmic leaflet of the plasma 
membrane the unsaturated acyl chain of PI(4,5)P2 flips out from the membrane. This 
exchange has been speculated to cluster saturated lipids at the site of virus assembly 
and promote raft formation (Simons and Gerl 2010, Waheed and Freed 2009). In this 
case though, HIV-1 assembly merely drives the formation of certain 
microenvironment rather than targeting itself into the pre-existing lipid rafts for the 
assembly. Moreover, the composition and functional relevance of these virus-driven 
nanoclusters remain to be assessed. 
 
5.4 TARGETING OF PR55GAG 
 
In this work (paper II) we have analyzed the targeting of newly synthesized Pr55
gag
 
to the site of assembly in HeLa H1-cells by pulse-chase studies and subcellular 
fractionations. Our results suggested that Pr55
gag
 first arrives at the plasma 
membrane of an infected cell and is subsequently direceted either to the 
extracellular space as virions or alternatively endocytosed. We were first to show 
that Vpu, a viral accessory protein is an essential regulator of the intracellular 
trafficking of Pr55
gag
. Furthermore, we found that integrity of p6-domain of Pr55
gag
 
and endogenous Tsg101 are required for the endocytic uptake of Pr55
gag
. 
 
The intracellular targeting of Pr55
gag
 has been under vigorous study during past 
years. Electron microscopy and fluorescent microscopy studies initially suggested 
that in T-cells and laboratory adapted model cell lines such as HeLa, Cos-1 and 
293T Pr55
gag
 predominantly assembles at the plasma membrane of the infected 
cells and that the plasma membrane was also the site of production of progeny 
virions (Hermida-Matsumoto and Resh 2000, Ono et al. 2004). In compelling 
studies however, Pr55
gag
 and virus particles have been found both at the plasma 
membrane and in internal, endosome-like compartments (Grigorov et al. 2006, 
Nydegger et al. 2003, Sherer et al. 2003).  
 
There are basically three options how Pr55
gag
 can achieve its stady state localization 
both at the plasma membrane and at the internal membranes: (i) Pr55
gag
 is initially 
targeted to the plasma membrane and endosomal localization could be achieved via 
endocytosis of the cell surface-associated protein, (ii) Pr55
gag
 is first inserted into 
endosomal membranes and is then either retained in these compartments or 
transported further to the plasma membrane, or (iii), Pr55
gag
 promiscuously 
associates simultaneously with both type of membranes. To distinguish between 
these three possibilities, we employed pulse-chase studies combined to subcellular 
fractionations to follow the targeting of newly synthesized Pr55
gag
 in HeLa H1-
cells. 
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Subcellular fractionation was carried out by using silica coating of the plasma 
membrane by cationic colloidal silica beads. In this method, the outerface of the 
plasma membrane is covered by silica beads and the plasma membrane fraction can 
be separated from the internal membranes in a discontinuous density gradient based 
on increased density of the bead-coated plasma membrane (Spector et al. 1998). 
Our results suggested that an efficient separation of the plasma membrane from 
internal membranes in HeLa H1-cells can be achieved by using this method. 
However, our observations suggested that this method can be employed only with 
cell types with a rigid cytoskeleton (data not shown) as cells with less firm 
cytoskeleton, which is typical for suspension cells, (e.g. Jurkat T-cells) tended to 
disrupt during the coating procedure leading to binding of silica beads to internal 
membranes as well. Similarly, we found that we could not test the involvement of 
cytoskeleton on Pr55
gag
 endocytosis (paper III) as pharmagological agents 
disrupting cytoskeletal fibers also rendered cells unsuitable for silica coating. In 
contrast to our observations, others have successfully used silica coating for 
suspension cells as well (Chan et al. 2008). This discrepancy may be explained by 
Jurkat T-cells being extraordinary sensitive to plasma membrane modifying silica 
beads or experimental differences employed in these studies. 
 
5.5 VPU REGULATES THE ENDOCYTOSIS OF PR55GAG 
 
Our pulse-chase analyses of newly synthesized Pr55
gag
 revealed that Pr55
gag
 is first 
targeted to the plasma membrane in HeLa H1-cells and remains at the cell surface 
when coexpressed with the viral accessory protein Vpu. In contrast, in the absence 
of Vpu the cell surface-associated Pr55
gag
 was endocytosed from the plasma 
membrane and considerably less extracellular virions were released from these cells 
(data not shown). This study was the first to show that Vpu regulates the 
intracellular trafficking of Pr55
gag
 by preventing the endocytosis of the protein from 
the cell surface. Similar results were suggested soon by others (Neil et al. 2006). 
Several studies are also in line with our results showing that in established model 
cell lines Pr55
gag
 primarily localizes at the plasma membrane (Finzi et al. 2007, 
Gomez and Hope 2006, Jouvenet et al. 2006, Jouvenet et al. 2008). 
 
Targeting of newly synthesized Pr55
gag
 to the plasma membrane in HeLa-cells was 
observed also in study using tetracysteine tagged Gag-molecules (Rudner et al. 
2005) while this study failed to show the dependence of Pr55
gag
 trafficking on Vpu. 
These contrary results may be due to the fusion tags inserted into Pr55
gag
 as our 
data also indicated that carboxyterminal tag may interfere with Pr55
gag
 endocytosis 
in the absence of Vpu. This observation raises a general concern when using tagged 
proteins. Fusion tags are extremely common method in studying the localization 
and functions of proteins because of facilitated detection with commercially 
available antibodies, but as shown by us, unexpected consequences may occur 
when using these tagged variants leading easily to false conclusions.  
 
5.6 TSG101 IS INVOLVED IN THE ENDOCYTOSIS OF PR55GAG 
 
Our results further show that a host cell protein Tsg101 is required for the 
endocytosis of Pr55
gag
 in the absence of Vpu. Tsg101 binds to the late PTAP-
domain of Pr55
gag
 and recruits ESCRT-machinery to the site of budding (Martin-
Serrano et al. 2001, Morita and Sundquist 2004). Cellular levels of Tsg101 were 
downmodulated by siRNAs designed to be specific for Tsg101. As a control, 
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siRNAs with scrambled sequence was used. Despite of control siRNA, RNA 
interference may sometimes cause unexpected off-target effects or induce 
activation of antiviral state which grossly modulates the gene expression of the cell 
(Scacheri et al. 2004, Sledz et al. 2003). To ensure that Tsg101-PTAP interaction 
was indeed essential for Pr55
gag
 endocytosis and was not due to the adverse effects 
caused by RNAi, we deleted the whole p6-domain from our proviral construct. As 
expected, the newly synthesized Pr55
gag
/ p6 was targeted to the plasma membrane 
and even in the absence of Vpu, remained there. These data confirmed that Tsg101 
interaction with Pr55
gag
 is required for the endocytic uptake of the plasma 
membrane-associated HIV-1 Gag. Given that interaction of Pr55
gag
 p6-domain with 
Tsg101 and ESCRT-machinery is expected to facilitate the release of virus particles 
from the cell surface it was in slightly unexpected that Tsg101 also regulated the 
uptake of Pr55
gag
 in the absence of Vpu. We could speculate that Tsg101 may have 
yet-undefined functional roles early in HIV-1 assembly other than so far 
recognized. As suggested by others (Neil et al. 2006) the role of Tsg101 in Pr55
gag
 
endocytosis most likely included the requirement of completed budding process 
with a disclosure of the membrane stalk prior to endocytosis. 
 
5.7 PR55GAG IS ENDOCYTOSED AS VIRIONS 
 
In our original discussion (paper II) we speculated that in the absence of Vpu, the 
over time accumulating internal Pr55
gag
 signal was due to endocytosis of the plasma 
membrane-associated Pr55
gag
 rather than originating from extracellular particles 
taken up by endocytosis. We thought that was a case since very little Pr55
gag
 signal 
was detected at the internal membranes when Pr55
gag
 was expressed in the presence 
of Vpu and in the context where approximately 18-fold more VLPs were released 
(data not shown). Furthermore, when exploring the data from electron micrographs, 
in the absence of Vpu we could detect occasional budding structures at MVB-like 
compartments and the steady state analysis of Gag/Pol -expressing cells by Western 
blotting revealed the presence of Pr55
gag
 processing intermediates at the internal 
membrane fraction. 
 
In the work of others (Neil et al. 2006) and confirmed also later by us (paper III) it 
was conclusively shown that in the absence of Vpu, fully formed VLPs can be 
stripped from the surface of infected cells by a protease treatment suggesting that 
nascent virions remained captured at the cell surface by a protein-mediated manner. 
In the light of this newer data we would re-discuss that accumulating internal 
Pr55
gag
 signal in the absence of Vpu expression is due to these tethered VLPs 
endocytosed from the cell surface. The processing intermediates observed in the 
internal membrane fraction and few budding structures seen in MVB-like 
compartment most likely arose from endocytosis of plasma membrane regions 
containing incomplete buds. Furthermore, we cannot exclude the possibility that 
internally scored MVB-resembling structures were not true endosomes since deep 
membrane invaginations containing tethered particles can sometimes be difficult to 
distinguish from the genuine internal compartments (Deneka et al. 2007, Welsch et 
al. 2007). Retrospectively speaking, the fact that Pr55
gag
 is internalized as fully 
formed virions would also explain why HA-tagged variant of Pr55gag was retained 
at the plasma membrane in the absence of Vpu. This engineered protein is defective 
in forming virus particles and as completed budding is required for the subsequent 
endocytosis in the absence of Vpu, it is now obvious that Pr55
gag
 with C-terminal 
HA-tag was not internalized in our experiments. 
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To date, the ultimate fate of endocytosed particles have remained unclear. As our 
subcellular fractionation method did not separate different intracellular 
compartments from each other we could not conclude to which compartment 
endocytosed particles were directed. Our fluorescence microscopy analysis (data 
not shown) indicated that internalized Pr55
gag
-signal gave a vesicular staining 
pattern but did not extensively co-localize with early or late endosomal markers or 
recycling endosomal compartment. 
 
This paper was first to assign Vpu to the intracellular trafficking of Pr55
gag
 and is 
therefore a precursor for expanded understanding behind the old observations of 
Vpu being an enhancer of particle release (Klimkait et al. 1990). Data published 
during the past couple of years have gone far beyond from our initial observations 
and revealed more of the molecular mechanism behind the action of Vpu. Vpu have 
been shown to counteract a host restriction factor CD317, also known as tetherin. In 
the absence of Vpu, nascent viral particles remain attached at the host cell surface 
via an anchor formed by tetherin and are subsequently endocytosed instead of 
released as extracellular virions (Neil et al. 2006, Neil et al. 2007). It has been 
speculated that Vpu may counteract tetherin by blocking the insertion of the 
tetherin N-terminal transmembrane domain into virion envelopes (McNatt et al. 
2009, Perez-Caballero et al. 2009) and relocating tetherin from the plasma 
membrane to the intracellular compartments in order to sequester it away from the 
site of productive particle assembly (Dube et al. 2009, Dube et al. 2010, 
Habermann et al. 2010, Van Damme et al. 2008). However, the analyses of virus 
particles (Fitzpatrick et al. 2010, Habermann et al. 2010) have shown that tetherin is 
incorporated into virions even in the presence of Vpu implicating that mechanisms 
other than suggested above may contribute to the activity of Vpu. Interestingly, 
nascent virus particles could also be released from Vpu expressing cells by protease 
treatment (Karetnikov and Suomalainen 2010) further implicating that Vpu action 
is not yet conclusively studied. 
 
5.8 PR55GAG ENDOCYTOSIS IS CLATHRIN-INDEPENDENT 
 
As the viral accessory protein Vpu was found to be an important regulator of 
Pr55
gag
 endocytosis, in this work (paper III) we further assessed the endocytosis 
phenotype of Pr55
gag
 in the absence of Vpu. Mammalian cells harbor several 
endocytic routes of which the three major uptake modes are clathrin-mediated 
endocytosis, macropinocytosis and cholesterol-dependent (lipid raft-mediated) 
uptake. We used inhibitors of these three uptake modes to probe the mechanism of 
Pr55
gag
 endocytosis. 
 
We used RNAi-mediated knockdown of clathrin heavy chain (CHC) to determine 
whether the endocytosis of Pr55
gag
 occurred by a clathrin-dependent mechanism. 
SiRNA against CHC efficiently inhibited the endocytosis of transferrin, but did not 
block the uptake of Pr55
gag
 in the absence of Vpu. This suggested that endocytosis 
of Pr55
gag
 is not directed by clathrin-mediated endocytosis. However, in case of 
Gag/Pol coexpression, we observed a minor inhibition in uptake of processed 
Pr55
gag
. This prompted us to furher investigate whether a subpopulation of Gag is 
indeed internalized via clathrin-mediated endocytosis or whether the RNAi against 
CHC had an effect on assembly. To distinguish between these possibilities, we 
analyzed VLP production from Pr55
gag
 and Gag/Pol-expressing cells. Our results 
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indicated that CHC-knockdown did not intefere with particle production from 
Pr55
gag
 expressing cells, but did significantly reduce the amount of VLPs rescued 
by protease-treatment from Gag/Pol-expressing cells. This suggested that overall 
assembly in the Gag/Pol-expressing cells is somehow perturbed when CHC-level is 
downmodulated.  
 
Our conclusion that Pr55
gag
 endocytosis is clathrin-independent is in concordace 
with studies showing that inhibition of clathrin-mediated endocytosis by 
chloropromazine did not block Gag endocytosis (Finzi et al. 2007). In contrast, 
when using dominant negative forms of regulators of clathrin-mediated 
endocytosis, such as dynamin, EPS15 or Rab5a, a clear inhibition in Pr55
gag
 
endocytosis was observed (Jouvenet et al. 2006, Neil et al. 2006). This discrepancy 
may be due to different experimental approaches or different cells used. In these 
studies C-terminally tagged Pr55
gag
 variants were used instead of our proviral 
expression of wild type Pr55
gag
 and furthermore, it is recognized also in other 
studies that expression of dominant negative proteins may yield different results 
than depletion of endogenous proteins by RNAi (Martin-Serrano et al. 2001, Ward 
et al. 2005). Also, it is possible although not likely that in our study the remaining 
CHC-levels in cells could be still enough to carry out clathrin-mediated endocytosis 
required for Pr55
gag
 uptake as RNAi at best only reduces the amount of targeted 
protein but do not eliminate it completely. The applicability of RNAi in studies of 
coated-pits has been generally questionned because of short half life of these pits 
and redundancy of coated-pit proteins (Sorkin 2004). 
 
It would be intriquing to test whether results from above studies would be more 
uniform if for instance dynamin was targeted by a small-molecule inhibitor 
dynasore, that blocks the GTPase activity of the protein (Macia et al. 2006) and 
have been shown to diminish HIV-1 particle endocytosis from the cell surface 
(Miyauchi et al. 2009). Despite of certain drawbacks of dynasore studies, such as 
batch-dependent variation, that approach may be more specific to block clathrin-
mediated endocytosis than either RNAi or usage of dominant negative mutants as 
both are prone to off-target effects and can induce unexpected global changes in 
cells. Likewise, new small-molecule inhibitors called pitstops that regulate coated 
pit dynamics (von Kleist et al. 2011) would be worth trying in addressing the role 
of clathrin-mediated endocytosis in Pr55
gag
 uptake.  
 
In the scope of this thesis it remained unresolved why CHC-knockdown reduced 
virus assembly in the context of Gag/Pol co-expression. Most likely the assembly 
defect occurred at very late step in the assembly process as Pr55
gag
 processing had 
already started. A careful inspection of the Western blot comparing the 
internalization of processed Pr55
gag
 in mock-treated and CHC-knockdown cells 
might suggest that there is actually a processing defect in question as in CHC-
knockdown cells more higher molecular weight complex (p25) seems to remain at 
the plasma membrane fraction than in mock cells.This analysis is however very 
speculative. It seems like only fully processed Pr55
gag
 (p24) could have been 
endcytosed, being in concordace of VLPs taken ups as fully formed virions (Neil et 
al. 2006). 
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5.9 PR55GAG ENDOCYTOSIS OCCURS INDEPENDENTLY OF 
MACROPINOCYTOSIS 
 
We next tested whether the endocytosis of Pr55
gag
 could occur through 
macropinocytosis like activity. As HeLa-cells are a type of epithelial cells, 
macropinocytosis is not a constitutive process in this cell type and if Pr55
gag
 uptake 
occurred by this process the viral infection would need to stimulate this uptake 
mechanism. When the uptake of fluorescein-conjugated dextran into HeLa H1-cells 
was measured by flow cytometry the low levels of macropinocytosis-like activity 
was observed in both infected and uninfected cells, indicating that infection itself 
did not induce any gross changes in macropinocytosis. The effect of amiloride, a 
potent inhibitor of an induced macropinocytosis was tested (Meier et al. 2002, West 
et al. 1989). Our analysis indicated that amiloride did not block the shift of newly 
synthesized Pr55
gag
 from the plasma membrane to the internal membranes 
suggesting that Pr55
gag
 endocytosis did not occur by a macropinocytosis-like 
activity. Unfortunately we could not confirm this result by for instance disrupting 
the actin fibers which are essential for the macropinocytic ruffle formation by 
pharmacological agents such as latrunculin B because actin disrupted cells were too 
fragile for silica coating. 
 
5.10 THE EFFECT OF MEMBRANE CHOLESTEROL ON PR55GAG 
ENDOCYTOSIS IS INDIRECT 
 
The possible dependence of Pr55
gag
 endocytosis on cholesterol was probed with 
filipin, an antibiotic used to disrupt lipid raft domains on the cell surfce. Our results 
indicated that cholesterol sequestration by filipin reduced the amount of Pr55
gag
 at 
internal membranes when added in the beginning of the chase, but the effect was 
less pronounced if the drug was applied at the time point where the membrane 
insertion of the newly synthesized Pr55
gag
 was maximal (Tritel and Resh 2001). As 
cholesterol is required for the efficient membrane binding and higher-order 
oligomerization of HIV-1 Gag (Ono et al. 2007) and as Pr55
gag
 is most likely 
endocytosed as a fully assembled virion (Neil et al. 2006) we reasoned that the 
observed effect of filipin could be due to the inability of plasma membrane-bound 
Pr55
gag
 to multimerize in the presence of filipin. As processing of Pr55
gag
 is a 
convenient marker for the multimerization of Pr55
gag
, we tested the effect of filipin 
on Gag endocytosis in the context of Gag/Pol co-expression. Our results indicated 
that Pr55
gag
 processing is largely inhibited in the presence of filipin suggesting a 
defect in Pr55
gag
 multimerization. However, there was not significant difference in 
the intracellular distribution of the capsid protein in filipin treated or in mock 
treated cells indicating that Gag endocytosis occurred in a cholesterol-independent 
fashion. This is also consistent with the assumption that Gag is endocytosed as 
assembled virions (Neil et al. 2006) since only processed Gag was found in the 
internal membrane fraction. Our data implicates that membrane cholesterol is 
required for efficient assembly, but once assembled, the endocytosis of the virions 
does not require intact cholesterol or in other words, the endocytosis of virions is 
not occurring in a lipid raft-mediated manner. 
 
To date it has been remained to be elucidated by which mechanism Gag 
internalization is taking palce in the absence of Vpu. As we did not find any direct 
evidence of uptake proceeding by the three most common modes of endocytosis, 
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this most likely suggests that endocytosis of Gag occurs by a yet-undefined or less 
studied internalization pathway (Gong et al. 2008). It also remains to be determined 
what is the fundamental function of removing the membrane-tethered virions from 
the cell surface. One could speculate that tethered virions at the plasma membrane 
may promote some kind of a scavenging activity to maintain the membrane 
homeostasis and organized membrane trafficking or alternatively, virions can be 
just endocytosed by a default pathway. 
 
Our results also demonstrate that in the absence of Vpu the cell confluency can 
have an impact on the targeting phenotype of Pr55
gag
 as shown also before (Deora 
and Ratner 2001). Our results indicated that in subconfluent cells the newly 
synthesized Pr55
gag
 simultaneously appeared both at the plasma membrane and at 
the internal membranes while in confluent cell cultures Pr55
gag
 is first detected 
exclusively at the plasma membrane. What is the basis for this more promiscuous 
membrane association in subconfluent cells is currently unresolved. One could 
argue that membrane trafficking is highly accelerated in rapidly growing cells 
instead of being compromised somehow when cells are subconfluent. This 
interpretation is consistent with our data showing that a tagged Pr55
gag
 variant that 
is not internalized was targeted directly to the plasma membrane also in 
subconfluent cells showing no apparent association with internal membrane 
fraction.  
 
It should be noted that our results have been obtained by using a laboratory-adapted 
model cell line, and these results may not be directly applicable to the natural target 
cells of HIV-1. This work has however brought up the fact that anything that 
interferes with proper assembly would most likely also interfere with Pr55
gag
 
intracellular trafficking and endocytosis in the absence of Vpu. We also imply that 
membrane trafficking events are highly dynamic in nature and when studying HIV-
1 localization by using cell culture applications, it should be kept in mind that even 
slight modifications in assay conditions, expression systems and cell types may 
easily yield variable data that could explain different outcomes produced by some 
other laboratories. 
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6 CONCLUDING REMARKS 
 
This thesis, which consists of three original publications covers two different entities. 
First (paper I) we have analyzed the possible lipid raft association of HIV-1 structural 
precursor protein Pr55
gag
. It has been widely accepted in the literature that HIV-1 
assembles at lipid domains that are resistant for Triton X-100 extraction at cold. Our 
data however strongly suggests that during virus assembly, Pr55
gag
 associates with 
lipid domains other than classical Triton X-100-resistant lipid rafts. We show here 
that Triton X-100 extraction actually produces highly variable floating complexes 
depending on the starting material used for detergent extraction and that floating 
phenotype alone cannot be taken as a proof of a protein being associated with lipid 
rafts. Our data further implicates that Pr55
gag 
associates with lipid domains that are 
resistant for Brij98 extraction at physiological temperatures and these lipid 
microdomains may serve as assembly platforms for Pr55
gag
. 
 
In the second part of this thesis (paper II and III) we discuss about the assembly site 
of HIV-1 Pr55
gag
. There has been an intense debate over the issue whether the 
assembly takes place initially at the plasma membrane of an infected cell or at the 
endosomal compartment. Our results from the kinetic analyses and subcellular 
fractionations show clearly that in HeLa H1-cells the newly synthesized Pr55
gag
 first 
arrives exclusively at the plasma membrane and is subsequently either released as 
extracellular virus like particles or endocytosed. We were first to show that HIV-1 
accessory protein Vpu and the cellular protein Tsg101 both regulate the endocytosis 
of the plasma membrane-associated Pr55
gag
. We then probed for the mechanism by 
which the plasma membrane-associated Pr55
gag
 is internalized in the context of Vpu-
negative virus. Our results implicated that neither clathrin-mediated endocytosis nor 
macropinocytosis is involved in Pr55
gag
 uptake. Membrane cholesterol sequestration 
had an effect on Pr55
gag
 endocytosis, but only if employed prior to the extensive 
multimerization of newly synthesized Pr55
gag
 at the plasma membrane suggesting 
that cholesterol-dependent uptake is most likely only indirectly involved in Pr55
gag
 
internalization. We, therefore, conclude that factors that interfere with Pr55
gag
 
assembly also have an effect on subsequent Pr55
gag
 endocytosis. 
 
Taken together, the original publications in this thesis have provided valuable new 
insight concerning the assembly attributes of HIV-1 and the host cell components 
related to the assembly process. 
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The assembly and budding of human immunodeﬁciency virus type 1 (HIV-1) at the plasma membrane are
directed by the viral core protein Pr55gag. We have analyzed whether Pr55gag has intrinsic afﬁnity for sphin-
golipid- and cholesterol-enriched raft microdomains at the plasma membrane. Pr55gag has previously been
reported to associate with Triton X-100-resistant rafts, since both intracellular membranes and virus-like
Pr55gag particles (VLPs) yield buoyant Pr55gag complexes upon Triton X-100 extraction at cold temperatures,
a phenotype that is usually considered to indicate association of a protein with rafts. However, we show here
that the buoyant density of Triton X-100-treated Pr55gag complexes cannot be taken as a proof for raft
association of Pr55gag, since lipid analyses of Triton X-100-treated VLPs demonstrated that the detergent
readily solubilizes the bulk of membrane lipids from Pr55gag. However, Pr55gag might nevertheless be a
raft-associated protein, since confocal ﬂuorescence microscopy indicated that coalescence of GM1-positive
rafts at the cell surface led to copatching of membrane-bound Pr55gag. Furthermore, extraction of intracellular
membranes or VLPs with Brij98 yielded buoyant Pr55gag complexes of low density. Lipid analyses of Brij98-
treated VLPs suggested that a large fraction of the envelope cholesterol and phospholipids was resistant to
Brij98. Collectively, these results suggest that Pr55gag localizes to membrane microdomains that are largely
resistant to Brij98 but sensitive to Triton X-100, and these membrane domains provide the platform for
assembly and budding of Pr55gag VLPs.
The plasma membrane is partially composed of ordered
domains, called “rafts,” which are enriched in sphingolipids
and cholesterol and contain a speciﬁc set of proteins (5, 43).
Rafts are resistant to extraction with nonionic detergents at
low temperatures, and thus rafts and raft-associated proteins
can be separated from detergent-solubilized material by frac-
tionation of cell lysates on density gradients (6). The plasma
membrane apparently contains different types of rafts, which
exhibit differential sensitivities to different detergents (11, 41).
The best-characterized rafts are Triton X-100-resistant rafts,
which have been implicated in playing a critical role in numer-
ous cellular processes (28, 43, 45). Triton X-100-resistant rafts
have also been proposed to provide a platform for assembly
and budding of several different enveloped viruses (38, 53, 55).
One of these viruses is human immunodeﬁciency virus type 1
(HIV-1) (32, 35, 36, 42). Assembly and budding of HIV-1
occur at the plasma membrane and are directed by the viral
core protein precursor Gag (Pr55gag), since Pr55gag expressed
in the absence of other viral components induces formation of
enveloped virus-like particles (VLPs) (18, 30). Pr55gag associ-
ates with the cytoplasmic leaﬂet of the plasma membrane via
an amino-terminal dual motif that consists of a covalent my-
ristic acid modiﬁcation and a cluster of basic amino acid resi-
dues (7, 13, 18, 19, 26, 47, 48, 58). Through a mechanism that
is poorly understood, the membrane-bound Pr55gag proteins
oligomerize into core structures and concomitantly deform the
membrane into a bud (14, 17). Five recent reports have con-
cluded that Triton X-100-resistant rafts play an important role
in this Pr55gag-mediated assembly and budding (32, 35, 36, 42,
57). Four of these reports assigned Pr55gag to the Triton X-100-
resistant rafts, since density gradient analyses indicated that a
signiﬁcant fraction of intracellular Pr55gag displayed buoyant
density in cold Triton X-100 cell lysates (32, 35, 36, 57). Results
from Lindwasser and Resh (32), however, implied that Pr55gag
does not localize to “classical” Triton X-100-resistant rafts, but
instead localizes to distinct, dense Triton X-100-resistant rafts,
which were given the name “barges.” It was speculated that
higher density of barges was caused by the presence of exten-
sive arrays of oligomeric Pr55gag assembly intermediates in a
raft-like membrane. It was suggested that assembly of HIV-1
occurs at the raft-like barge-membranes, since Triton X-100-
solubilized Pr55gag complexes from extracellular VLPs had a
density similar to that of intracellular barges, and mutant
Pr55gag proteins that exhibited increased afﬁnity for barges
were found to produce VLPs more efﬁciently than wild-type
Pr55gag (32). In addition to localization of Pr55gag to rafts or
barges, three other lines of evidence have been put forward in
support of rafts playing a critical role in assembly and budding
of HIV-1. (i) Cholesterol-depleting agents, which among other
things cause alterations in raft structures, have been demon-
strated to decrease the release of virus particles from HIV-1-
infected cells (36), as well as to reduce the infectivity of re-
leased particles (36, 57). (ii) There is localization (partial) of
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HIV-1 Env proteins to Triton X-100-resistant rafts (42). (iii)
The presence of raft-associated host proteins and lipids in
HIV-1 particles has been interpreted to signify selective bud-
ding of HIV-1 through (Triton X-100-resistant) rafts (35).
In this study, we have analyzed raft association of HIV-1
Pr55gag by using Triton X-100 and Brij98 extractions as well as
confocal ﬂuorescence microscopy. Our results demonstrate
that Triton X-100 extraction when cold readily solubilizes bulk
of VLP envelope lipids. Thus, it is questionable whether the
buoyancy of Triton X-100-treated Pr55gag complexes can be
taken as evidence for localization of the protein to rafts. How-
ever, confocal ﬂuorescence microscopy analyses indicated ex-
tensive colocalization of Pr55gag at the cell surface with
patched GM1-positive rafts. Furthermore, Brij98 extractions
indicated that a population of intracellular Pr55gag, as well as
the VLP envelope, was largely resistant to this detergent. This
raises the possibility that cell surface raft structures that are
resistant to Brij98 but sensitive to Triton X-100 could provide
a platform for Pr55gag-mediated assembly and budding of
HIV-1.
MATERIALS AND METHODS
Cell culture. Jurkat cells were maintained in RPMI 1640 medium containing
10% fetal calf serum, 10 mM HEPES (pH 7.4), 2 mM glutamine, 100 U of
penicillin per ml, and 0.1 mg of streptomycin per ml (all tissue culture reagents
were from Invitrogen Life Technologies). 293T cells were maintained in Dul-
becco’s modiﬁed Eagle’s medium containing 10% fetal calf serum, 2 mM glu-
tamine, 100 U of penicillin per ml, 0.1 mg of streptomycin per ml, nonessential
amino acids, and 1 mM sodium pyruvate.
Preparation of infectious SFV-C/HIVgag. Plasmid pSFV-C/HIVgag was used
for the production of recombinant Semliki Forest virus (SFV) particles directing
the synthesis of HIV-1 Pr55gag. In this plasmid, the Pr55gag coding sequence is
fused to the C gene of SFV. The ﬁrst step in the construction of pSFV-C/HIVgag
was cloning of the Pr55gag open reading frame from pSP64-HIV111b-BH10 (20)
as a 1,720-bp BamHI-StuI fragment into the BamHI-SmaI-linearized pSFV1 (31)
to give pSFV1-HIVgag. The fusion between SFV-C and HIV-1 Pr55gag genes was
engineered by PCR such that the second codon of Pr55gag was fused to the last
codon of SFV-C by using Vent DNA polymerase (New England Biolabs, Beverly,
Mass.) in accordance with the manufacturer’s instructions (27, 54). The terminal
primers used for the ampliﬁcation of the fused DNA fragment were 5-CA
ACGGAAAAACGCAGCAGC-3 (the C 5 primer) and 5-CCCCCTGGCC
TTAACCGAATTTTTCCC-3 (the Pr55gag 3 primer). The fusion primers
were 5-GGGGTCCGAAGAGTGGGGTGCGGAGAGCGTCA-3 (C frag-
ment primer) and 5-TGACGCTCTCGCACCCCACTCTTCGGACCCC-3
(Pr55gag fragment primer). After ampliﬁcation, the fusion fragment was cut with
AsuII and ClaI and cloned into AsuII-ClaI-digested pSFV1-HIVgag to give
pSFV-C/HIVgag(1). Subsequently the pSFV-C/HIVgag (1) was modiﬁed by
site-directed mutagenesis (9) with the primers 5-CGTGCTCAAGAGTTCCA
AGTTGGCC-3 (SacI site eliminator) and 5-GTACTGAGAGACAGGCTAA
CTTCCTGGGGAAGATCTGGCCTTCC-3 to mutate the frameshift signal so
that only Pr55gag sequences from the Gag gene insert could be translated. The
mutations were silent mutations with respect to Pr55gag coding sequence. An-
other modiﬁcation of pSFV-C/HIVgag(1) was to delete one of the two amino-
terminal repeats (LQSRPEPTAPP) of the BH10 p6 domain by using the primer
5-GGAAGGCCAGGGAATTTTCTTCAGAGCAGACCAGGCCAACAGCC
CCACCAGAAGAGAGCTTCAGGTCTGGG-3. This gave the ﬁnal version
pSFV-C/HIVgag that was used in the study. Infectious SFV particles directing
the synthesis of HIV-1 Pr55gag (SFV-C/HIVgag) were prepared by coelectropo-
rating equal amounts of in vitro-transcribed SFV-C/HIVgag and helper 1 (31)
RNAs into 107 BHK-21 cells as previously described (49, 50).
Analysis of raft association of Pr55gag. (i) Total cell lysates. Jurkat cells (3.5
106) were infected with SFV-C/HIVgag in RPMI-BSA medium (RPMI 1640
containing 0.2% bovine serum albumin [BSA], 10 mM HEPES, pH 7.4, 2 mM
glutamine, 100 U of penicillin per ml, and 0.1 mg of streptomycin per ml), and
4 h postinfection, cells were switched to methionine-free minimum essential
medium (MEM; supplemented with 0.2% BSA, 10 mM HEPES, pH 7.4, 2 mM
glutamine, 100 U of penicillin per ml, and 0.1 mg of streptomycin per ml) for 30
min. Cells were subsequently metabolically labeled in methionine-free modiﬁed
Eagle’s medium containing 100 Ci of [35S]methionine per ml for 15 min and
chased for 0 to 60 min in RPMI-BSA medium containing 10-fold excess of cold
methionine. After chase, cells were placed on ice and washed once with ice-cold
phosphate-buffered saline (PBS; with MgCl2 and CaCl2), and then the cells were
lysed in 200 l of lysis buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 20 g of phenylmethylsulfonyl ﬂuoride per ml, 1 g of
CLAP [chymostatin, leupeptin, aprotinin, and pepstatin A] per ml). After 30 min
of incubation at 0°C, lysate was mixed with 3 ml of 56% iodixanol (Optiprep;
Nycomed Pharma A/S) and overlaid with 3 ml of 40% iodixanol, 5 ml of 30%
iodixanol, and 0.5 ml of 5% iodixanol (all iodixanol solutions were in 10 mM
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100). Gradients
were centrifuged in an SW41 rotor at 77,100  g for 14 h at 4°C. One-milliliter
fractions were collected from the top, aliquots of each fractions were mixed with
sodium dodecyl sulfate (SDS) sample buffer, and equal amounts of fractions
were analyzed by SDS-polyacrylamide gel electrophoresis (PAGE). Radioactiv-
ity in Pr55gag bands was determined by using a Bas-III Image Plate and the
Bio-Image analyzer system Bas 2000 (Fuji Photo ﬁlm Co.), and the amount of
Pr55gag in each of the different fractions was expressed as a percentage of the
total (the sum of all fractions). Inﬂuenza virus NP expressed from SFV-C/NP
genome (56), transferrin receptor (TR) expressed from SFV-C/TR2 (49), and
CD55 expressed from SFV1-CD55 were used as controls. Raft association of
inﬂuenza virus NP was analyzed after a 15-min pulse and 1-h chase, and that of
TR was analyzed after a 60-min pulse and 120-min chase. Cell lysates from
SFV1-CD55-infected cells were prepared 5 h postinfection, and proteins in
gradient fractions were precipitated with 10% trichloroacetic acid and analyzed
by SDS-PAGE followed by Western blotting with anti-CD55 antibody (H-319)
from Santa Cruz Biotechnology, Inc. Lck was analyzed from gradient fractions by
Western blotting with anti-Lck antibody (3A5) from Santa Cruz Biotechnology,
Inc.
(ii) Membrane-associated Pr55gag-crude cell homogenates. Jurkat cells (107)
were infected with SFV-C/HIVgag and metabolically labeled with [35S]methi-
onine as described above. After chase, cells were placed on ice, washed once with
ice-cold PBS (with MgCl2 and CaCl2), and homogenized in buffer containing 10
mM Tris-HCl (pH 7.4), 1 mM EDTA, 20 g of phenylmethylsulfonyl ﬂuoride per
ml, and 1 g of CLAP per ml with a tight-ﬁtting Dounce homogenizer. Imme-
diately after homogenization, NaCl was added to 150 mM, and the homogenate
was diluted with 100% Nycodenz (Nycomed Pharma A/S) to give a ﬁnal 60%
Nycodenz concentration. The sample (2 ml) was overlaid with 1.5 ml of 50%
Nycodenz and 1 ml of homogenization buffer (with 150 mM NaCl), and the
gradient was centrifuged in an SW50.1 rotor at 63,000 g for 45 min at 4°C. The
total membrane fraction at the buffer–50% Nycodenz interphase was collected.
About 200 to 400 l of this membrane fraction was mixed with Triton X-100
(ﬁnal concentration, 1%) and after 30 min of incubation at 0 or 37°C, the
solubilized membranes were analyzed on iodixanol step gradients as described
above. TR was analyzed after a 60-min pulse and 30-min chase, inﬂuenza virus
NP was analyzed after a 60-min pulse, and CD55 and Lck were analyzed by
Western blotting as described above.
Subconﬂuent 293T cells grown on 10-cm-diameter plates were transfected with
28 g of pCMV-HIVgag plasmid by a calcium phosphate precipitation tech-
nique. The pCMV-HIVgag plasmid was derived from pCMVR8.91 (a generous
gift from Didier Trono) (59) by deleting a BclI-EcoRI fragment from the Pol
region. The transfected cells were collected  22 to 24 h posttransfection and
processed as described above for the SFV-C/HIVgag-infected Jurkat cells. Total
Pr55gag in gradient fractions was visualized by Western blotting using anti-p24
antibody from Biogenesis.
(iii) Membrane-associated Pr55gag postnuclear supernatants. Jurkat cells
(107) were infected with SFV-C/HIVgag and metabolically labeled with [35S]me-
thionine as described above. Transfected 293T cells were analyzed 22 to 24 h
posttransfection. After chase, cells were placed on ice, washed once with ice-cold
PBS (with MgCl2 and CaCl2), and homogenized in buffer containing 25 mM
HEPES-KOH (pH 7.4), 0.25 M sucrose, 4 mM MgCl2, 20 g of phenylmethyl-
sulfonyl ﬂuoride per ml, and 1 g of CLAP per ml by using a tight-ﬁtting Dounce
homogenizer. The crude cell homogenates were centrifuged at 1,400  g for 4
min at 4°C to pellet nuclei and cell debris. About 70 to 80% of total labeled
Pr55gag was found in the postnuclear supernatant (PNS), which was subsequently
fractionated on the Nycodenz step gradient described above to separate mem-
branes from cytosolic material (gradient solutions were prepared in 25 mM
HEPES-KOH, pH 7.4, 150 mM NaCl and 1 mM EDTA). The total membrane
fraction from the buffer–50% Nycodenz interphase was mixed with Triton X-100
(ﬁnal concentration, 1%) and protease inhibitors, and after 30 min of incubation
at 0°C, or at 37°C, the solubilized membranes were analyzed on iodixanol step
gradients as described above. For Brij98 extraction, the total membranes were
mixed with protease inhibitors and 0.5% Brij98, and after a 5-min incubation at
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37°C, the extracts were mixed with 3.5 ml of 56% iodixanol and overlaid with 2
ml of 30% iodixanol, 2 ml of 25% iodixanol, 2 ml of 20% iodixanol, and 0.5 ml
of 5% iodixanol (all iodixanol solutions were in 25 mM HEPES-KOH, pH 7.4,
150 mM NaCl, 1 mM EDTA). Gradients were centrifuged in an SW41 rotor at
77,100  g for 14 h at 4°C.
(iv) VLPs. Jurkat cells (107) were infected with SFV-C/HIVgag and metabol-
ically labeled with [35S]methionine for 3 h as described above. Culture media
were collected and clariﬁed by centrifugation at 200  g for 4 min. VLPs from
clariﬁed culture media were puriﬁed by a two-step gradient centrifugation. The
clariﬁed culture supernatant was ﬁrst applied to a linear 5 to 20% iodixanol
gradient (21). After centrifugation in an SW41 rotor at 160,000 g for 1 h at 4°C,
fractions were collected from the top, and Pr55gag-containing fractions were
pooled, 1 ml of pooled fractions was mixed with 3 ml of 56% iodixanol, and this
mixture was overlaid with 4 ml of 27% iodixanol, 3 ml of 20% iodixanol, and 0.5
ml of 5% iodixanol. The iodixanol solutions were made in a mixture of 10 mM
Tris-HCl (pH 7.4), 150 mM NaCl, and 1 mM EDTA (Triton X-100 extraction)
or a mixture of 25 mM HEPES-KOH (pH 7.4), 150 mM NaCl, and 1 mM EDTA
(Brij98 extraction). The gradients were centrifuged in a SW41 rotor at 77,100 
g for 14 h at 4°C, and VLPs from the 20 to 27% iodixanol interphase were
collected and extracted with Triton X-100 or Brij98 as described above and
analyzed on iodixanol step gradients as described above.
Production and analysis of [32P]orthophosphate- and [35S]methionine-la-
beled VLPs. Jurkat cells were prelabeled with [32P]orthophosphate as described
in reference 21. Prelabeled Jurkat cells (107) were infected with SFV-C/HIVgag
and metabolically labeled with [35S]methionine for 3 h as described above. VLPs
were harvested from clariﬁed culture supernatants as described above. Material
from SFV-C/NP-infected Jurkat cells prepared in a similar way was used as a
control to estimate contamination of VLPs by microvesicles. Triton X-100- or
Brij98-extracted VLPs or NP controls were fractionated on iodixanol step gra-
dients as described above, except that gradients were centrifuged for 4.5 h.
Buoyant Pr55gag complexes from the 30 to 40% iodixanol interphase (Triton
X-100 extraction) or the 25% iodixanol zone (Brij98 extraction) were collected,
diluted fourfold with a mixture of 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1
mM EDTA (Triton X-100) or 25 mM HEPES-KOH (pH 7.4), 150 mM NaCl, 1
mM EDTA (Brij98), and pelleted by centrifugation in a SW41 rotor (160,000 
g for 1 h at 4°C). The pelleted Pr55gag complexes and the control intact, nonex-
tracted VLPs were solubilized with 3% SDS at 70°C, mixed with SDS-PAGE
buffer, and analyzed by SDS-PAGE with 20% polyacrylamide gels (21). Radio-
activity in mixed SDS-lipid micelles was determined by using a Bas-III Image
Plate and the Bio-Image analyzer system Bas 2000. [35S]methionine label in
Pr55gag bands (analyzed by SDS-PAGE with 10% polyacrylamide gels) was used
to ensure that similar amounts of Pr55gag from the intact particles and the
buoyant detergent-treated Pr55gag complexes were loaded on 20% polyacryl-
amide gels.
Production and analysis of [3H]cholesterol-labeled VLPs. Jurkat cells (107)
were infected with SFV-C/HIVgag or with SFV-C/NP for 30 min. The virus
inoculum was removed, and the cells were metabolically labeled with 10 Ci of
[1,2(n)-3H]cholesterol per ml for 4 h in RPMI-BSA medium. The radioactive
cholesterol label was removed and cells were incubated in RPMI-BSA medium
for 3 h. VLPs were harvested from clariﬁed culture supernatants by the two-step
centrifugation procedure described above. After the last ﬂotation gradient, the
peak VLP fractions were pooled and then diluted threefold with buffer, and
VLPs were pelleted by a 2-h centrifugation in an SW50.1 rotor at 173,000  g
(4°C). For Triton X-100 extraction, the pellets were placed into 160 l of mixture
containing 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 20 g of
phenylmethylsulfonyl ﬂuoride per ml, 1 g of CLAP per ml, and 1% Triton
X-100 and incubated at 0°C for 30 min, and the extracts were mixed with 1 ml of
56% iodixanol and overlaid with solutions of 400 l of 40% iodixanol, 400 l of
30% iodixanol, and 200 l of 5% iodixanol. The gradients were centrifuged in
TLS-55 rotors at 166,000  g for 4 h at 4°C, 400-l fractions were collected from
the top, and [3H]cholesterol in fractions was quantiﬁed by scintillation counting.
The counts from the NP control were subtracted from the VLP values, and the
amount of [3H]cholesterol radioactivity in different fractions was expressed as a
percentage of the total (the sum of all fractions). For Brij98 extraction, the
pelleted VLPs were placed into a mixture containing 160 l of 25 mM HEPES-
KOH (pH 7.4), 150 mM NaCl, 1 mM EDTA, 20 g of phenylmethylsulfonyl
ﬂuoride per ml, 1 g of CLAP per ml, and 0.5% Brij98, incubated at 37°C for 5
min, and the extracts were mixed with 550 l of 56% iodixanol and overlaid with
400 l of 30% iodixanol, 800 l of 20% iodixanol, and 200 l of 5% iodixanol
solutions. The gradients were centrifuged and collected as described for the
Triton X-100 extraction.
Confocal ﬂuorescence microscopy. Subconﬂuent 293T cells seeded onto cov-
erslips (3-cm-diameter plates) were transfected with 3 g of pCMV-HIVgag.
After 20 to 22 h, cells were placed on ice and washed twice with cold PBS (with
MgCl2 and CaCl2) and then incubated for 20 min on ice with ﬂuorescein iso-
thiocyanate (FITC)-conjugated cholera toxin B subunit (10 g/ml in PBS with
MgCl2 and CaCl2; Sigma). After two washes in PBS, cells were ﬁxed in 4%
formaldehyde for 30 min at room temperature (unpatched cells) or incubated on
ice in PBS (with MgCl2 and CaCl2) containing anti-cholera toxin antibodies
(Calbiochem) for 30 min and subsequently transferred to 37°C for 30 min for
patching. After two washes in PBS, cells were ﬁxed in 4% formaldehyde as
described above, permeabilized with 0.3% Triton X-100, and stained with mouse
anti-Pr55gag antibodies (EF-7 or 38:9; generous gifts from Jorma Hinkula, De-
partment of Virology, SMI/KI, Sweden) and tetramethyl rhodamine isocyanate
(TRITC)-conjugated anti-mouse immunoglobulin G (IgG) antibodies (Southern
Biotechnology Associates, Inc.). Preparations were mounted in glycerol-PBS
(pH 8.0) containing p-phenyldiamine and analyzed with the Carl Zeiss LSM 510
confocal system. The system is based on the compact scanning module, which has
been ﬁtted to an inverted (Axiovert 200 M) microscope. The LSM system is
equipped with Zeiss software (LSM modes) and is controlled via a standard
high-end Pentium PC. Two lasers were selected—one with a wavelength of 488
nm and the other with a wavelength of 514 to 543 nm. In most cases, 40 to 50
optical horizontal sections with intervals about 0.25 m were taken through the
whole preparation (Z-stack). Selected single optical sections were then analyzed,
and ﬂuorescence images were saved and processed in Photoshop 6.0. In some
cases, the Z-stack was analyzed in the pseudo-three-dimensional LSM mode with
orthogonal function allowing us to obtain a membrane-bound intracellular sec-
tion through the whole cell.
RESULTS
Analyses of raft association of Pr55gag by using Triton
X-100. We chose to use SFV-driven expression of Pr55gag in
Jurkat cells to analyze raft association of the protein. In the
recombinant SFV genome SFV-C/HIVgag, the coding se-
quence of Pr55gag is fused to the C gene of SFV, and the re-
sulting C-Pr55gag fusion protein is cotranslationally processed
into C and Pr55gag proteins by the autoproteolytic activity of
SFV C protein (1, 34). [3H]myristic acid labeling of cells indi-
cated that Pr55gag expressed in SFV-C/HIVgag-infected cells
was efﬁciently myristoylated (data not shown). We also tested
kinetics and efﬁciency of membrane association of newly syn-
thesized Pr55gag. Cell homogenates of SFV-C/HIVgag-infected
Jurkat cells were prepared after 15 min of metabolic labeling
with [35S]methionine and a 0- or 30-min chase, and membranes
were separated from cytosolic material by fractionation on a
ﬂotation gradient. The results obtained indicated that, already
by the 0-min chase point, 34% of labeled Pr55gag was mem-
brane associated, and the membrane-bound pool increased to
50% after a 60-min chase (data not shown). Thus, the newly
synthesized Pr55gag in SFV-C/HIVgag-infected cells becomes
membrane associated with similar kinetics to Pr55gag expressed
from proviral constructs (52).
Pr55gag has been previously assigned to Triton X-100-resis-
tant rafts based on results from a biochemical ﬂotation assay
that isolates lipid rafts on the basis of their insolubility in this
detergent at low temperatures (32, 35, 36). However, as shown
in Fig. 1, the assay is problematic, since the ﬂotation phenotype
of Pr55gag varies, depending on which cellular fraction is used
as the starting material for Triton X-100 extraction. Figure 1A
shows the results from crude cell lysates. Recombinant SFV-
infected Jurkat cells expressing Pr55gag or control marker pro-
teins were extracted with 1% Triton X-100 at 0°C for 30 min,
and the extracts were analyzed on an iodixanol step gradient,
which consisted of a 56% loading zone overlaid with 40, 30,
and 5% iodixanol solutions. After ultracentrifugation, the Tri-
ton X-100-insoluble rafts ﬂoat to the 5 to 30% iodixanol inter-
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phase (fraction 1), whereas detergent-soluble proteins stay in
the loading zone (fractions 9 to 12) (4). Our positive control
for a raft-associated protein, the glycosylphosphatidylinositol
(GPI)-anchored protein CD55 (16, 46), efﬁciently ﬂoated to
fraction 1. In contrast, e.g., after a 15-min pulse with [35S]me-
thionine and a 60-min chase, only minor amounts of labeled
Pr55gag were found in fraction 1, but a clear concentration of
the protein was seen at the 30 to 40% iodixanol interphase in
fraction 6. About 37% of labeled Pr55gag was in the Triton
X-100-soluble pool (fractions 9 to 12), which could represent
cytosolic Pr55gag, or be of both cytosolic and membranous
origins. The Pr55gag complexes at the 30 to 40% interphase
correspond to the “barges” described by Lindwasser and Resh
(32). Barges have been interpreted to represent raft-like
membranes that have a higher density than classical Triton
X-100-resistant rafts due to the presence of multimeric Pr55gag
complexes in barges (32). However, our control experiments
indicated that both the inﬂuenza virus NP, a predominantly
nuclear protein (56), and the cytosolic nucleocapsid protein C
of SFV (50, 51) efﬁciently ﬂoated to the 30 to 40% iodixanol
interphase after cold Triton X-100 extraction (Fig. 1A). Sig-
niﬁcant amounts of the non-raft membrane marker TR ended
up in the 30 to 40% iodixanol interphase as well (Fig. 1A). We
also analyzed the distribution of the endogenous Src family
kinase Lck, which like Pr55gag associates with the cytoplasmic
leaﬂet of the plasma membrane. As previously reported (24),
FIG. 1. Cold Triton X-100 extraction of cells yields variable complexes for Pr55gag, depending on which cellular fraction is used as a starting
material for the detergent treatment. (A) Analyses of crude cell lysates. Pr55gag, CD55, inﬂuenza virus NP, the nucleocapsid protein C of SFV, and
the TR were expressed in Jurkat cells from recombinant SFV genomes. Cells were extracted with 1% Triton X-100 (TX-100) at 0°C, and lysates
were subjected to ﬂotation on iodixanol step gradients. Aliquots of gradient fractions were analyzed by SDS-PAGE. The Pr55gag, NP, and C
proteins were analyzed after a 15-min pulse with [35S]methionine and a 60-min chase, and TR was analyzed after a 60-min pulse and 120-min chase,
whereas CD55 and the endogenous Lck were detected by Western blotting. (B) Analyses of the total membrane fraction from Jurkat crude cell
homogenates. Pr55gag was analyzed after a 15-min pulse with [35S]methionine and a 60-min chase, NP was analyzed after a 60-min pulse, and TR
was analyzed after a 60-min pulse and 30-min chase. Total CD55 and Lck were visualized by Western blotting. (C) Analyses of the total membrane
fraction from the PNS of Jurkat cells. Pr55gag was analyzed after a 15-min pulse with [35S]methionine and a 0- or 120-min chase, and TR was
analyzed after a 90-min pulse. Total CD55 and Lck were visualized by Western blotting. (D) Analyses of membrane-bound Pr55gag from transfected
293T cells. Total Pr55gag in gradient fractions was detected by Western blotting.
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the majority of Lck was found in the Triton X-100-soluble pool
(fractions 9 to 12). Some Lck was in fraction 1, but signiﬁcant
amounts of the protein concentrated in fraction 5. Taken to-
gether, these controls demonstrated that different types of
proteins in crude Triton X-100 cell lysates ﬂoat to the 30 to
40% iodixanol interphase, and thus this ﬂotation phenotype
does not necessarily signify association of a protein with raft-
like membranes. The extreme viscosity of the SDS-solubilized
fraction 5 and 6 samples suggested that this gradient region
contained large amounts of chromatin. This raised the possi-
bility that ﬂotation of some of the marker proteins, and pos-
sibly also that of Pr55gag, to the 30 to 40% iodixanol interphase
region could actually be a postlysis artifact caused by unspeciﬁc
trapping of proteins to nuclear remnants or chromatin.
Since the results from crude cell lysates were difﬁcult to
interpret, we also tested alternative cellular fractions in the
assay. Figure 1B shows results from experiments in which the
total membrane fraction of cells was used as the starting ma-
terial for Triton X-100 extraction. Crude cell homogenates
were ﬁrst fractionated on a ﬂotation gradient to separate mem-
brane-associated proteins from cytosolic components. The to-
tal membrane fraction was extracted with 1% Triton X-100 at
cold temperatures, and the extracts were analyzed on the io-
dixanol step gradient described above. Our positive control
CD55 still efﬁciently ﬂoated to fraction 1 in this modiﬁed raft
fractionation scheme. The ﬂotation phenotype of TR was oth-
erwise unchanged as well, except that the buoyant TR had now
shifted to fraction 5. In the case of Lck, there was a clear
reduction in the relative amount of the protein in the middle of
the gradient compared to the crude cell lysates, and the buoy-
ant Lck complexes in this gradient region were now concen-
trated in fraction 6. Our total membrane fraction apparently
still contained signiﬁcant amounts of unspeciﬁed nuclear rem-
nants, since 64% of intracellular inﬂuenza virus NP cofrac-
tionated with cellular membranes in the crude cell homoge-
nates (data not shown). When this “membrane-associated” NP
was extracted with Triton X-100 at cold temperatures, this led
to scattering of the protein along the gradient, although with
some concentration in fractions 2 to 5. Also the small amounts
of the cytosolic nucleocapsid protein of SFV that copuriﬁed
with membranes were predominantly found in fractions 2 to 5
(data not shown). Analyses of membrane-bound Pr55gag after
a 15-min pulse with [35S]methionine and a 60-min chase indi-
cated that labeled Pr55gag was predominantly found in buoyant
complexes, but in contrast to the crude cell lysates, these buoy-
ant complexes were now scattered in fractions 1 to 6. The
Pr55gag panel in Fig. 1B suggests also that relatively more
Pr55gag ended up in fraction 1 in this fractionation scheme than
in crude cell lysates. However, the relative amounts of labeled
Pr55gag in fraction 1 versus fraction 6 varied signiﬁcantly be-
tween different experiments (data not shown), thus suggesting
that fraction 1 material in fact could be a postlysis artifact of
fraction 6 complexes, or vice versa. Furthermore, when com-
paring the gradient proﬁles of Pr55gag and NP in Fig. 1B, it is
obvious that the buoyant complexes of Pr55gag are strikingly
similar to those of NP. Since NP and Pr55gag are both nucleic
acid binding proteins, these heterogeneous buoyant structures
could represent yet another type of postlysis artifact induced by
nuclear remnants. In an attempt to determine whether the
Pr55gag buoyant complexes were artifacts or rafts, we tested the
sensitivity of the complexes to Triton X-100 at 37°C. Rafts are
solubilized with Triton X-100 if the extraction is performed at
37°C (6). As expected, extraction at 37°C shifted essentially all
CD55 to the detergent-soluble pool (fractions 9 to 12) (data
not shown). In the case of Pr55gag, ﬂoating of the protein to
fractions 1 to 4 was suppressed, and increased amounts of
labeled Pr55gag were found in the Triton X-100-soluble pool
(Fig. 1B). However, the material in fractions 5 and 6 was
largely resistant to extraction at 37°C. But since the buoyant
NP complexes were efﬁciently solubilized at 37°C as well (Fig.
1B), the Triton X-100 solubility of the Pr55gag complexes in
fractions 1 to 4 at 37°C cannot be taken as proof for these
complexes representing rafts. In addition to solubilization of
rafts, 37°C could also activate an enzymatic function or func-
tions that destabilize the buoyant Pr55gag and NP complexes.
As a third approach to assess association of Pr55gag with
Triton X-100-resistant rafts, we used membranes from PNS as
the starting material for the detergent extraction. In experi-
ments described above, we had used EDTA in the cell homog-
enization buffer, but the NP control indicated that nuclear
remnants in EDTA-homogenized cell extracts were not quan-
titatively pelleted by the low-speed spin used to produce PNS
(data not shown). We therefore replaced EDTA in the homog-
enization buffer with Mg2, which is known to promote nuclear
integrity during homogenization and thus to improve the re-
moval of nuclear material by low-speed spin. PNS was ﬁrst
fractionated on a ﬂotation gradient to separate membranes
from cytosol, and the total membrane fraction was extracted
with 1% Triton X-100 at cold temperatures, and the extracts
were analyzed on the iodixanol step gradient. Under these
conditions, no NP cofractionated with cellular membranes
(data not shown). As shown in Fig. 1C, the relative amount of
CD55 in fraction 1 was somewhat reduced compared to that of
the membranes from crude cell homogenate, whereas the gra-
dient proﬁle of TR was essentially unchanged. Relatively more
Lck was now found in fraction 1 than that shown in Fig. 1B, but
most signiﬁcantly, only trace amounts of Lck were present in
fractions 5 and 6. In contrast, the majority of Pr55gag was
concentrated in the middle of the gradient. After a 15-min
pulse with [35S]methionine and a 0-min chase, about equal
amounts of labeled Pr55gag were found in fraction 6 and the
Triton X-100-soluble pool (fractions 9 to 12), whereas after a
60-min chase (data not shown) or 120-min chase, the protein
was predominantly in fractions 5 and 6 (Fig. 1C). Similar re-
sults were obtained if the detergent concentration was reduced
to 0.25% (data not shown). As shown in the lowest panel in
Fig. 1C, the Pr55gag complexes at the 30 to 40% iodixanol
interphase were resistant to Triton X-100 at 37°C.
Taken together, the results in Fig. 1A to C demonstrate that
cold Triton X-100 extraction yields variable buoyant complexes
for Pr55gag depending on which cellular fraction is used in the
experiment. To ascertain that the variability is not an artifact of
the SFV expression system, we also analyzed the Triton X-100
resistance of Pr55gag expressed in transfected 293T cells. West-
ern blotting of the gradient fractions was used to visualize total
Pr55gag. Also in these transfected cells, the different cellular
fractions yielded variable buoyant complexes for Pr55gag: Tri-
ton X-100 extraction of membranes of crude homogenates
yielded buoyant Pr55gag complexes that were scattered in frac-
tions 1 to 6, whereas the membranes of PNS gave Pr55gag
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complexes that were concentrated into fractions 5 and 6 (Fig.
1D). Thus, the variability is a feature of Pr55gag, and is not due
to the expression system used.
Triton X-100-treated buoyant Pr55gag complexes from VLPs
are not physically associated with a raft-like membrane. The
technical problems associated with the ﬂotation assay made it
difﬁcult to determine with certainty what was a genuine Triton
X-100-resistant complex and what was an artifact in the case of
the intracellular Pr55gag. However, one factor common to all of
the fractionation schemes used in Fig. 1 was that some Pr55gag
consistently ﬂoated to the 30 to 40% iodixanol interphase
(fraction 6). In agreement with previously published results
(32), we found that extraction of VLPs with Triton X-100 at
either 0 or 37°C also yielded Pr55gag complexes that ﬂoated to
fraction 6 (Fig. 2). Thus, the Pr55gag complexes at the 30 to
40% iodixanol interphase most likely are not artifacts but rep-
resent genuine Triton X-100-resistant complexes. Figure 2
shows analyses of VLPs produced from SFV-C/HIVgag-in-
fected Jurkat cells, but VLPs from transfected 293T cells gave
similar results (data not shown).
Since VLPs can be obtained in a relatively pure form, this
prompted us to determine whether ﬂoating of VLP-derived
Pr55gag to the 30 to 40% iodixanol interphase indeed is a result
of these complexes being physically associated with Triton
X-100-resistant membranes as has been previously suggested
(32). To determine whether envelope cholesterol was retained
in the Triton X-100-extracted Pr55gag complexes, we labeled
SFV-C/HIVgag-infected Jurkat cells with [3H]cholesterol and
puriﬁed VLPs from the culture media by a two-step gradient
centrifugation as described in Materials and Methods. Since
cultured cells are known to shed microvesicles, which have
densities similar to that of retrovirus particles, we ﬁrst con-
trolled how much of the total 3H radioactivity in our VLP
sample was of microvesicular origin. To this end, we collected
medium from [3H]cholesterol-labeled Jurkat cells infected
with a recombinant SFV encoding inﬂuenza virus NP and
subjected that medium to the same puriﬁcation procedure
used for VLPs. The 3H counts in VLPs and the NP control
samples produced from parallel experiments were determined
by liquid scintillation counting, and comparison of the two
values indicated that the radioactivity in the NP control
amounted to only10% of that of the VLPs (data not shown).
Thus, the vast majority of the radioactive cholesterol in our
VLP sample was likely to reside on the VLP envelope. To
determine whether this envelope-associated radioactive cho-
lesterol was retained on Pr55gag complexes after extraction
with Triton X-100, the [3H]cholesterol-labeled VLPs and con-
trol NP samples were treated with Triton X-100 at 0°C, and the
extracts were analyzed on an iodixanol step gradient otherwise
similar to that in Fig. 1, except the gradient used was shorter.
[35S]methionine-labeled VLPs were used as a control to track
the position of Pr55gag complexes on the gradient. Five frac-
tions were collected from the top of the gradient, and aliquots
of fractions were analyzed by SDS-PAGE ([35S]methionine-
labeled VLPs) or by scintillation counting ([3H]cholesterol-
labeled VLPs and the NP control; the counts from the NP
sample were subtracted from the VLP values). As already
demonstrated in Fig. 2, the [35S]methionine-labeled Pr55gag
complexes from the Triton X-100-extracted VLPs ﬂoated to
the 30 to 40% iodixanol interphase (fraction 2, Fig. 3). In con-
trast, the majority of the radioactive cholesterol counts (88%
of total) were found in the Triton X-100-soluble pool (fractions
3 to 5). These results indicated that Triton X-100 extraction
efﬁciently stripped envelope cholesterol from the VLP-Pr55gag
complexes.
We used VLPs containing radioactively labeled phospho-
lipids to determine whether the Triton X-100-treated Pr55gag
complexes retain envelope phospholipids. The VLPs were
collected from SFV-C/HIVgag-infected Jurkat cells that
had been metabolically labeled with [32P]orthophosphate. The
[32P]orthophosphate label is incorporated into both glycero-
phospholipids and sphingomyelin of VLPs. The VLPs were
puriﬁed from the culture media by the same two-step centrif-
ugation procedure used in the [3H]cholesterol experiments
described above. Material collected from [32P]orthophosphate-
labeled Jurkat cells infected with the recombinant SFV encod-
ing inﬂuenza virus NP was used as a control for microvesicular
contamination. The radioactively labeled phospholipids were
quantitated by solubilization of samples with excess hot SDS
and by analyzing the solubilized material by SDS-PAGE. On
20% polyacrylamide gels, the mixed SDS-lipid micelles are
separated from other 32P-labeled components (proteins and
RNA) (21), and this enables easy quantiﬁcation of the glyc-
FIG. 2. Triton X-100 extraction of VLPs at 0°C or 37°C yields
buoyant Pr55gag complexes that ﬂoat to the 30 to 40% iodixanol inter-
phase. VLPs were collected from SFV-C/HIVgag-infected Jurkat cells
which had been metabolically labeled with [35S]methionine for 180
min. VLPs were extracted with 1% Triton X-100 (TX-100) and frac-
tionated on iodixanol step gradients.
FIG. 3. Triton X-100 extraction efﬁciently strips envelope choles-
terol from VLP-Pr55gag. VLPs were collected from SFV-C/HIVgag-
infected Jurkat cells that had been metabolically labeled with [35S]me-
thionine or [3H]cholesterol. VLPs were extracted with 1% Triton X-100
at 0°C, and the extracts were fractionated on iodixanol step gradients.
Aliquots of gradient fractions were analyzed by SDS-PAGE ([35S]me-
thionine-labeled VLPs) or by scintillation counting ([3H]cholesterol-
labeled VLPs). Labeled Pr55gag and [3H]cholesterol in gradient frac-
tions are expressed as percentages of the total (sum of all fractions).
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erophospholipid and sphingomyelin contents of samples. We
ﬁrst estimated what percentage of the radioactivity in the VLP-
derived SDS-lipid micelles truly originated from VLPs by com-
paring the radioactive signal of VLP sample to that of the
control NP sample from a parallel experiment. Surprisingly,
the SDS-lipid micelles from both the VLP and the control NP
samples contained considerable amounts of radioactivity
(data not shown), thus suggesting that Jurkat cells shed large
amounts of microvesicles that were rich in phospholipids, but
apparently poor in cholesterol, since the [3H]cholesterol-ex-
periments described above had indicated only 10% micro-
vesicular contamination for our VLP sample. The microvesi-
cles were not an artifact of the SFV expression system used,
since similar amounts of vesicles were also shed from nonin-
fected Jurkat cells labeled with [32P]orthophosphate (data not
shown). The exact degree of contamination of the VLP sam-
ples by microvesicles was difﬁcult to establish, because the
relative ratios of the VLP- and control NP-associated radioac-
tivities differed between different experiments. From three dif-
ferent experiments though, we estimated that the microvesicle
contamination accounted for 30 to 51% of the total phospho-
lipid signal in VLP samples. To test what percentage of the
VLP-envelope phospholipids were retained on Pr55gag com-
plexes after extraction with Triton X-100, we collected VLPs
from cells that had been metabolically labeled with both
[32P]orthophosphate and [35S]methionine. The VLPs were ex-
tracted with Triton X-100 at 0°C, and extracts were fraction-
ated on the iodixanol step gradient described in the legend to
Fig. 1. Material from the 30 to 40% iodixanol interphase was
recovered and concentrated by pelletation. The pellet was sol-
ubilized in hot SDS, and equal volumes of the solubilized
sample were analyzed on 10 and 20% gels along with intact
VLPs. A representative experiment is shown in Fig. 4. [35S]me-
thionine label in Pr55gag bands (10% gels) was used to quan-
titate the amount of Pr55gag in the two samples. In the exper-
iment shown in Fig. 4, the Triton X-100-treated sample
contained 30% more Pr55gag than the intact VLP sample.
However, as shown by the right-hand panel in Fig. 4, the two
samples signiﬁcantly differed in their phospholipid contents:
the radioactive lipid signal was readily detected in the intact
VLP sample, whereas the lipid signal was very weak in the
Triton X-100-extracted sample. Assuming that 49 to 70% of
the total phospholipid signal from the intact VLP sample was
from VLP envelopes, quantitation of the Pr55gag and lipid
signals of the two samples suggested that only 12 to 17% of the
envelope phospholipids were retained on the Triton X-100-
extracted buoyant Pr55gag complexes. Taken together, these
results and the [3H]cholesterol results described above strongly
suggest that cold Triton X-100 extraction solubilizes the bulk
of VLP envelope lipids. Thus ﬂoating of Triton X-100-treated
VLP-Pr55gag to the 30 to 40% iodixanol interphase is not due
to these complexes being associated with a Triton X-100-resis-
tant raft-like membrane.
Analyses of raft association of Pr55gag by confocal ﬂuores-
cence microscopy. The results shown in Fig. 1 to 4 suggested
that Pr55gag does not associate with Triton X-100-resistant
rafts. However, the results do not exclude the possibility that
Pr55gag is a raft-associated protein, since not all rafts are re-
sistant to Triton X-100 (11, 41). We therefore probed raft
association of Pr55gag by confocal ﬂuorescence microscopy as
well. Individual raft domains at the plasma membrane are
small (50 nm in diameter) (40) and thus are below the
detection level of standard light microscopes. However, cell
surface rafts can be induced to form larger patches by anti-
body-mediated cross-linking of raft components (23). Since the
raft-lipid marker GM1 has been reported to be incorporated
into HIV-1 virions (35), we decided to cross-link rafts at the
cell surface via GM1 and to test whether Pr55gag localizes
to these cross-linked raft structures. Transfected 293T cells
were used in the experiment. Pr55gag has been previously re-
ported to localize at the cell surface in a punctate pattern (25).
However, as shown in Fig. 5A, the staining pattern for plas-
ma membrane-associated Pr55gag is dependent on the anti-
body used: the monoclonal EF-7 anti-Pr55gag antibody gave a
smooth staining pattern (Fig. 5A.1), whereas a punctate pat-
tern was obtained with another anti-Pr55gag monoclonal anti-
body (MAb 38:9; Fig. 5.A2). Since a possible raft localization
of Pr55gag would be easier to score with a staining pattern that
was initially smooth, we decided to use the EF-7 antibody in
our raft cross-linking experiments. Cholera toxin B subunit
speciﬁcally binds to GM1 (23), and the GM1-containing rafts
were patched with this toxin and antibodies directed against it.
The cells were subsequently ﬁxed, permeabilized, and stained
for Pr55gag. Figure 5B shows confocal analyses of nonpatched
cells. Pr55gag (red, Fig. 5.B1) and GM1 (green, Fig. 5.B2) were
both uniformly distributed on the plasma membrane of these
nonpatched cells. Figure 5.C1 to C3 show three representative
examples of cross-linked cells with the Pr55gag and GM1 sig-
nals superimposed. Both Pr55gag and GM1 were distributed in
a patchy, dot-like pattern on these cells. Three different types
of patches could be distinguished: patches that were positive
only for GM1 (green), patches that were strongly positive for
both GM1 and Pr55gag (yellow), and patches that appeared to
FIG. 4. Triton X-100 extracts the bulk of envelope phospholipids
from the VLP-Pr55gag. VLPs were collected from SFV-C/HIVgag-
infected Jurkat cells that had been metabolically labeled with [35S]me-
thionine and [32P]orthophosphate. VLPs were extracted with 1% Tri-
ton X-100 at 0°C, and the lysate was fractionated on an iodixanol step
gradient as shown in Fig. 1. Buoyant Pr55gag complexes from the 30 to
40% iodixanol interphase were concentrated by ultracentrifugation.
The resulting pellet (TX), as well as an intact, non-Triton X-100-
extracted VLP sample (	), were solubilized with hot SDS and ana-
lyzed by SDS-PAGE. Equivalent amounts of samples were loaded
on 10% (Pr55gag) and 20% (SDS-lipid micelles) polyacrylamide gels.
On 20% polyacrylamide gels, mixed SDS-lipid micelles separate from
other 32P-labeled material. Comparison of the 10 and 20% polyacryl-
amide gels demonstrates that although the intact VLP and the Triton
X-100-treated samples contained similar amounts of Pr55gag com-
plexes, the two samples signiﬁcantly differed in their phospholipid
contents. The radioactive signal in the mixed SDS-lipid micelles orig-
inates from both glycerophospholipids and sphingomyelin.
VOL. 77, 2003 HIV-1 Gag AND LIPID RAFTS 4811
be positive only for Pr55gag (red). However, from the nonover-
lapped images, it was evident that the latter Pr55gag-containing
patches were actually positive for GM1 as well, but the GM1
signal was weak in these patches (data not shown). Collec-
tively, these results suggest that a signiﬁcant fraction of Pr55gag
at the cell surface might be localized to GM1-positive rafts, but
according to the results from Fig. 1 to 4, these rafts apparently
are Triton X-100 sensitive.
Intracellular membrane-bound Pr55gag, as well as VLP-as-
sociated Pr55gag, is largely resistant to extraction with Brij98.
To obtain further evidence for localization of Pr55gag to dis-
tinct Triton X-100-sensitive rafts, we turned back to the bio-
chemical assay and tested the sensitivities of membrane-bound
Pr55gag to different detergents by using transfected 293T cells.
Since we judged that chromatin and nuclear remnants were the
main sources of artifacts in the biochemical assay, we chose the
total membrane fraction of PNS as the starting material for
detergent extractions. Our pilot assays indicated that the mem-
brane-bound Pr55gag was partially resistant to Brij35, Brij56,
Brij58, Brij98, Lubrol, and CHAPS (data not shown). We de-
cided to focus on Brij98, since this is a detergent that detects
rafts at physiological temperatures (11). Figure 6A shows anal-
ysis of Pr55gag-containing membranes either nonextracted or
extracted with 0.5% Brij98 at 37°C for 5 min. The samples were
analyzed on an iodixanol step gradient consisting of a 56%
loading zone overlaid with 30, 25, 20, and 5% iodixanol solu-
tions. Western blotting of the gradient fractions was used to
visualize total Pr55gag. In the nonextracted sample, Pr55gag was
predominantly found in fractions 1 to 4. After extraction with
FIG. 5. Confocal ﬂuorescence microscopy of transfected 293T cells. (A) Different anti-Pr55gag antibodies give different staining patterns for
Pr55gag at the cell surface. (A.1) MAb EF-7. (A.2) MAb 38:9. (B) Both Pr55gag and GM1 exhibit smooth staining patterns on transfected 293T cells
if GM1-containing rafts have not coalesced. Live cells were ﬁrst incubated with FITC-conjugated cholera toxin B subunit at a cold temperature
to detect GM1, and the cells were subsequently ﬁxed, permeabilized, and incubated with MAb EF-7 and TRITC-conjugated antimouse IgG
antibodies to detect Pr55gag. (B.1) Pr55gag. (B.2) GM1. (B.3) Pr55gag and GM1 images superimposed. (C) Coalescence of GM1-positive rafts at the
cell surface transforms the smooth staining pattern of Pr55gag into a patchy one. Live cells were ﬁrst incubated with FITC-conjugated cholera toxin
B subunit at a cold temperature, and the GM1-positive rafts were subsequently patched by brief incubation at 37°C in the presence of anti-cholera
toxin antibodies. Cells were then ﬁxed, permeabilized, and immunostained with MAb EF-7 and TRITC-conjugated antimouse IgG antibodies to
detect Pr55gag. Three representative examples of patched cells (C.1 to C.3) are shown with Pr55gag (red) and GM1 (green) images superimposed.
Yellow indicates extensive colocalization of Pr55gag and GM1. A single optical section is shown in panels A and B, whereas all optical sections (the
Z-stack) were superimposed in panel C and tilted with the orthogonal function to show the view through the whole cell.
FIG. 6. Intracellular membrane-bound Pr55gag is largely resistant
to Brij98. (A) Analyses of transfected 293T cells. The total membrane
fraction from PNS was extracted with Brij98 for 5 min at 37°C or left
untreated, and the samples were subjected to ﬂotation on iodixanol
step gradients. Total Pr55gag in gradient fractions was visualized by
Western blotting. (B) Brij98 resistance of newly synthesized Pr55gag.
The wild type and NC (MA-CA-p2) mutant of Pr55gag were ex-
pressed in Jurkat cells from recombinant SFV genomes. Cells were
metabolically labeled with [35S]methionine for 15 min and chased for
0 min and 2 h (Pr55gag) or for 2 h (NC). The total membrane fraction
from PNS was extracted with Brij98 as described above, and the ex-
tracts were fractionated on iodixanol step gradients. Aliquots of gra-
dient fractions were analyzed by SDS-PAGE.
4812 HOLM ET AL. J. VIROL.
Brij98, the protein was scattered in fractions 2 to 12 (i.e., from
the 20% iodixanol zone to the loading zone). Most impor-
tantly, signiﬁcant amounts of the protein were found in the
light-density fractions 2 to 5, thus suggesting that at steady
state, a population of the membrane-bound Pr55gag was largely
resistant to Brij98. To test the sensitivity of newly synthesized
Pr55gag to Brij98, we turned to Jurkat cells and the SFV ex-
pression system. SFV-C/HIVgag-infected Jurkat cells were
metabolically labeled with [35S]methionine for 15 min, and
membrane-bound Pr55gag was analyzed after a 0- or 120-min
chase. As shown in Fig. 6B, after a 0-min chase, labeled Pr55gag
was broadly distributed along the gradient, with a minor con-
centration of the protein in fraction 3. After a 120-min chase,
the amount of the protein in the loading zone was decreased,
and a clear accumulation of the protein (61% of total) was
observed in fractions 3 to 5. This suggested that Pr55gag accu-
mulated in Brij98-resistant membrane domains of light density
in a time-dependent fashion. In contrast to the wild-type
Pr55gag, a carboxy-terminally-deleted mutant form of the pro-
tein consisting of MA-CA-p2-domains (NC) remained sensi-
tive to Brij98 even after 2 h of chase.
In order to determine whether the Brij98-resistant intracel-
lular Pr55gag complexes were precursors for VLPs, we tested
the sensitivity of VLPs to Brij98 extraction. Extracellular VLPs
were extracted with 0.5% Brij98 at 37°C for 5 min, and the
extracts were fractionated on an iodixanol step gradient similar
to that shown in Fig. 6. As shown in Fig. 7, nonextracted VLPs
produced from SFV-C/HIVgag-infected Jurkat cells ﬂoated
through 25% iodixanol to fractions 2 and 3. After extraction
with 0.5% Brij98 (5 min at 37°C), a slight shift in the density
was evident, and Pr55gag peaked in fraction 5, thus overlapping
the intracellular Brij98-resistant complexes. Similar results
were obtained with VLPs produced from transfected 293T
cells (data not shown). These results suggested that VLP en-
velope was largely resistant to Brij98, and the intracellular
Brij98-resistant Pr55gag complexes banding at 25% iodixanol
most likely represented precursors for VLPs.
To conﬁrm that the VLP envelope was indeed largely resis-
tant to Brij98, we monitored the extractability of envelope
lipids by the detergent. To determine whether envelope cho-
lesterol was retained on Brij98-extracted Pr55gag complexes,
we performed an assay similar to that described above for
Triton X-100 extractions. [3H]cholesterol- or [35S]methionine-
labeled VLPs were extracted with 0.5% Brij98 for 5 min at
37°C, and the extracts were analyzed on a iodixanol step gra-
dient consisting of a 56% loading zone overlaid with 30, 20,
and 5% iodixanol solutions. As shown in Fig. 8A, the majority
of both the [35S]methionine-labeled Pr55gag complexes and the
envelope [3H]cholesterol label (80 and 58% of the total, re-
spectively) was found in fraction 3 at the 20 to 30% iodixanol
interphase. This indicated that a large fraction of the envelope
cholesterol was resistant to Brij98.
To test the extractability of the envelope phospholipids by
Brij98, we carried out an assay similar to that described above
for Triton X-100 extractions. [35S]methionine- and [32P]ortho-
phosphate-labeled VLPs and the [32P]orthophosphate-labeled
NP control material were extracted with 0.5% Brij98 for 5 min
at 37°C, and the extracts were fractionated on an iodixanol step
gradient as described in the legend to Fig. 6. The buoyant
Pr55gag complexes or the control NP material from fractions 3
to 5 was pooled and concentrated by pelletation, and the pel-
lets were solubilized with excess hot SDS and analyzed on 10
and 20% polyacrylamide gels along with intact VLPs. As
shown in Fig. 8B, the Brij98-treated Pr55gag complexes re-
tained signiﬁcant amounts of the envelope phospholipids.
Comparison with the Brij-treated NP control indicated that
FIG. 7. Brij98-treated VLPs retain low buoyant density. VLPs were
collected from SFV-C/HIVgag-infected Jurkat cells that had been met-
abolically labeled with [35S]methionine for 180 min. The VLPs were
extracted with Brij98 and analyzed as described in the legend to Fig. 6.
No Brij indicates intact, nonextracted VLPs.
FIG. 8. Large fraction of envelope phospholipids and cholesterol
remains attached to Brij98-treated VLP-Pr55gag. (A) Brij98 extraction
of [35S]methionine- or [3H]cholesterol-labeled VLPs produced from
SFV-C/HIVgag-infected Jurkat cells. The VLPs were extracted with
Brij98 for 5 min at 37°C, and the samples were processed as described
in the legend to Fig. 3, with the exception that the iodixanol step
gradient used was slightly different. (B) Brij98 extraction of [35S]me-
thionine- and [32P]orthophosphate-labeled VLPs produced from SFV-
C/HIVgag-infected Jurkat cells. The VLPs were extracted with Brij98
for 5 min at 37°C, and the extracts were fractionated on iodixanol step
gradients as described in the legend to Fig. 6. The buoyant Pr55gag
complexes from fractions 3 to 5 were pooled and concentrated by
pelletation. The pellets, as well as intact, nonextracted VLP samples
(	) were analyzed as described in the legend to Fig. 4. NP is a Brij98-
treated control sample that was collected from [32P]orthophosphate-
labeled Jurkat cells infected with recombinant SFV encoding inﬂuenza
virus NP. The NP control demonstrates that the majority of phospho-
lipid signal in the Brij98-treated VLP sample originates from VLPs,
not from contaminating microvesicles.
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majority of the Brij-resistant Pr55gag signal originated from
VLPs. Assuming that microvesicles accounted for 30 to 51%
of the total phospholipid signal in intact VLPs, quantitations of
the Pr55gag and the SDS-lipid micelle signals from two separate
experiments suggested that 37 to 53% of envelope phospho-
lipids were retained on Brij98-treated Pr55gag complexes.
Taken together, these results indicated that the VLP envelope
was largely resistant to extraction with Brij98.
DISCUSSION
HIV-1 is one of the enveloped viruses whose assembly and
budding has been proposed to be critically dependent on lipid
rafts (32, 35, 36, 42). The strongest evidence for this raft con-
nection has been the localization of Pr55gag, the protein that
drives the assembly of virus, to Triton X-100-resistant rafts (32,
35, 36, 57). Localization of Pr55gag to the Triton X-100-resis-
tant rafts was based on results from the commonly used bio-
chemical raft fractionation assay, which involves extraction of
cells with Triton X-100 at cold temperatures. Triton X-100-
resistant rafts retain buoyant density after cold detergent treat-
ment and ﬂoat to a low density when the detergent extracts are
fractionated on density gradients. However, our results indi-
cate that the buoyancy of Triton X-100-treated Pr55gag com-
plexes does not provide solid evidence for raft localization of
Pr55gag.
Nguyen and Hildreth (35) have reported that the majority of
[3H]myristic acid-labeled intracellular Pr55gag is associated
with buoyant Triton X-100-resistant structures in cold cell ly-
sates, and in a report by Zheng et al. (57), Nef was found to
increase cofractionation of Pr55gag with Triton X-100-resistant
buoyant structures. However, in these two reports, the buoyant
structures were not further characterized. Lindwasser and
Resh (32) reported that cold Triton X-100-extracted crude cell
lysates, as well as Triton X-100-treated VLPs, yield buoyant
Pr55gag complexes that band at the 30 to 40% iodixanol inter-
phase. These buoyant Pr55gag complexes were of higher
density than “classical” Triton X-100-resistant rafts, which
ﬂoat through 30% iodixanol. Ono and Freed (36) analyzed
raft association of Pr55gag by using postnuclear supernatants
of HIV-1-infected cell homogenates. They estimated that up to
approximately half of membrane-bound Pr55gag associated
with Triton X-100-resistant buoyant structures in cold lysates,
and these structures were soluble in the detergent if the ex-
traction was carried out at 37°C. In contrast to the study by
Lindwasser and Resh (32), the buoyant Pr55gag complexes in
the study by Ono and Freed (36) appeared to have a density
similar to that of classical raft markers, but this discrepancy
was most likely due to the different gradients used. Ono and
Freed separated Triton X-100-sensitive and -resistant pools of
proteins from each other by using sucrose gradients with a
single, rather dense (65% [wt/vol] sucrose) separating layer.
Nguyen and Hildreth (35), Lindwasser and Resh (32), Zheng
et al. (57), and Ono and Freed (36) all interpreted that their
buoyant Pr55gag complexes reﬂected association of the protein
with rafts. However, our data presented in Fig. 1 indicate that,
in the case of Pr55gag, the results from the biochemical raft
fractionation assay have to be interpreted with caution, since
the assay is very prone to artifacts. Figure 1 demonstrates that
variable buoyant complexes are obtained for Pr55gag, depend-
ing on which cellular fraction is used as the starting material
for the Triton X-100 treatment. Whole-cell lysates, as well as
membranes from PNS, predominantly yielded buoyant Pr55gag
complexes, which banded at the 30 to 40% iodixanol inter-
phase, whereas membranes from crude cell homogenates gave
buoyant complexes of more heterogeneous density. Further-
more, the inﬂuenza virus NP control (Fig. 1B) demonstrated
that the sensitivity of a buoyant protein structure to Triton
X-100 at 37°C does not necessarily mean that the structure
represents rafts. Although it is difﬁcult to determine with cer-
tainty which of the buoyant Pr55gag complexes reﬂect true in
vivo Pr55gag structures and which are artifacts, our control
experiments suggested that chromatin and other nuclear rem-
nants could comprise a major source for artifacts. We there-
fore favor the interpretation that membranes from PNS are the
best starting material for the detergent treatment, and, conse-
quently, the Pr55gag complexes at the 30 to 40% iodixanol
interphase represent the true intracellular Triton X-100-resis-
tant structures of Pr55gag. This interpretation is further sup-
ported by the fact that similar complexes are obtained from
Triton X-100-treated VLPs as well. Due to their higher relative
purity, the VLP preparations are less likely to yield artifacts
than the molecularly complex cell extracts.
Lindwasser and Resh coined the name “barges” for the
Triton X-100-treated buoyant Pr55gag structures at the 30 to
40% iodixanol interphase (32). Since their results indicated
that localization of Pr55gag to barges correlated with oligomer-
ization of the protein, their interpretation was that barges
represent Triton X-100-resistant rafts, which have an increased
density due to the presence of high-valence Pr55gag multimers
(32). However, they did not validate their interpretation by
performing lipid analyses of the barge-associated Pr55gag. Our
lipid analyses of the [32P]orthophosphate- and [3H]cholesterol-
labeled VLPs do not support the notion that ﬂoating of the
Triton X-100-treated Pr55gag to the 30 to 40% iodixanol-inter-
phase reﬂects association of the protein with Triton X-100-
resistant rafts. [32P]orthophosphate labeling of cells produces
VLPs with radioactively labeled glycerophospholipids and
sphingomyelin, and comparison of SDS-lipid micelles from
intact VLPs and the Triton X-100-treated Pr55gag complexes
indicated that the buoyant Pr55gag complexes were largely de-
void of envelope glycerophospholipids and sphingomyelin.
Furthermore, fractionation of [3H]cholesterol-labeled Triton
X-100-extracted VLPs on an iodixanol step gradient indicated
that the detergent extraction efﬁciently stripped envelope cho-
lesterol from the VLP-Pr55gag. Since glycerophospholipids,
sphingomyelin, and cholesterol together constitute the vast
majority of HIV-1 envelope lipids (2, 3), these results strongly
suggest that envelope lipids do not remain attached to the
buoyant Triton X-100-treated Pr55gag complexes in large
amounts. This conclusion is further supported by the fact that
the Triton X-100 extraction causes a considerable shift in the
density of membrane-bound Pr55gag (compare, e.g., Fig. 1D,
PNS panel, with Fig. 6A, no-detergent-panel). The most plau-
sible explanation for this shift is that the detergent extracts the
bulk of membrane lipids from the Pr55gag complexes. Recently,
Ding et al. (10) published a study demonstrating that only
Pr55gag, but not classical raft markers, undergoes this clear
shift in density upon cold Triton X-100 extraction. Thus, it
is questionable whether the buoyant Triton X-100-resistant
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Pr55gag complexes can be interpreted to signify localization of
the protein to rafts. Our ﬁnding that the buoyant Pr55gag com-
plexes at the 30 to 40% iodixanol interphase, unlike classical
raft markers, are insensitive to Triton X-100 at 37°C or that the
buoyant Pr55gag complexes are insensitive to cholesterol deple-
tion (10) provides a further argument against the buoyant
Pr55gag structures representing Triton X-100-resistant raft
membranes. At present, however, we have no explanation to
offer for the ﬂoating phenotype of the Triton X-100-treated
Pr55gag. Since we estimated that 12 to 17% of total membrane
phospholipids could remain attached to the Triton X-100-
treated Pr55gag, it is possible that these residual phospholipids,
perhaps together with membrane lipids that were not scored in
our assay (e.g., gangliosides), cause the buoyancy of the Pr55gag
complexes. Our attempts to reliably measure the retention of
GM1 on the Triton X-100-treated Pr55gag complexes were
unsuccessful due to the low speciﬁc GM1 signal from VLPs
(data not shown). Interestingly, only the unprocessed HIV-1
Pr55gag yielded buoyant Triton X-100-resistant complexes,
whereas MA and CA of processed HIV-1 cores, as well as the
unprocessed Gag precursor of Moloney murine leukemia virus
VLPs, fractionated with the detergent-soluble pool (data not
shown).
Triton X-100 has been the most commonly used detergent in
raft-studies, but not all rafts are resistant to Triton X-100 (11,
41). We therefore probed the possible raft association of
Pr55gag by confocal ﬂuorescence microscopy and with deter-
gents other than Triton X-100. The smooth cell surface stain-
ing pattern of Pr55gag in transfected 293T cells could be trans-
formed into a patchy one by antibody-mediated coalescence of
GM1-positive rafts. Furthermore, extraction of the total mem-
brane fraction of PNS from transfected 293T cells suggested
that at steady state, a population of membrane-bound Pr55gag
was largely resistant to Brij98. In contrast to the Triton X-100-
treated buoyant Pr55gag complexes, the Brij98-resistant com-
plexes were of lighter density and banded at 25% iodixanol.
Pulse-chase studies in Jurkat cells indicated that newly synthe-
sized Pr55gag accumulated in these low-density Brij98-resistant
structures in a time-dependent manner. In contrast, a mutant
form of Pr55gag consisting of MA-CA-p2 remained sensitive to
Brij98 even after extended chase periods. Since the MA-CA-
p2-mutant is impaired in oligomerization (8; K. Holm and M.
Suomalainen, unpublished data), the time-dependent accumu-
lation of wild-type Pr55gag in the low-density Brij98-resistant
structures could reﬂect oligomerization of the protein. The
intracellular Brij98-resistant complexes most likely represent
assembly intermediates, since Brij98 extraction of VLPs
produced Pr55gag complexes of similar density. Analyses of
[32P]orthophosphate- and [3H]cholesterol-labeled VLPs con-
ﬁrmed that the buoyant density of the ﬂoating Brij98 com-
plexes was due to these complexes being associated with a
membrane that was largely resistant to the detergent. We es-
timated that37 to 53% of envelope phospholipids and53%
of cholesterol remained attached to the buoyant Brij98-treated
VLP-Pr55gag. One possible explanation for this partial resis-
tance is that the VLP membrane is a mosaic, consisting of
both Brij98-resistant and Brij98-sensitive membrane domains.
Taken together, these confocal and Brij98 results could indi-
cate that Pr55gag associates with raft microdomains at the cell
surface that are resistant to Brij98, and these microdomains
form a part of the platform for Pr55gag-mediated assembly and
budding of HIV-1. However, at present, we cannot exclude the
possibility that oligomerization of Pr55gag induces a structural
alteration in the membrane that results in increased Brij98
resistance (i.e., that the Brij98 resistance of membrane-bound
Pr55gag has nothing to do with cellular rafts). Since Brij98-
resistant rafts are newcomers in the raft ﬁeld and are still
poorly characterized, it is unknown at present whether any
cellular rafts have a similar density to the Brij98-resistant
Pr55gag structures described here. Of our three cellular marker
proteins, only TR partially overlapped with Pr55gag complexes
after Brij98 treatment, whereas CD55 ﬂoated through 20%
iodixanol and Lck stayed in the loading zone (data not shown).
The growing list of viral raft-associated structural proteins
has created a lot of excitement in the ﬁeld of virus assembly.
Even a partial localization of a viral structural protein to rafts
has commonly been taken as evidence for rafts playing a crit-
ical role in the assembly of the virus in question. However,
concrete evidence for rafts being mechanistically important for
assembly and budding of enveloped viruses is actually scarce.
In the case of HIV-1, it amounts to one observation—namely,
that cholesterol-depleting agents inhibit particle release from
HIV-1-infected cells (36). Cholesterol is essential for structural
integrity of rafts (5, 45), and disruption of rafts by cholesterol
depletion is expected to reduce virus production if assembly
and budding of HIV-1 are dependent on rafts. However, since
cholesterol depletion affects many different cellular processes
(28, 29, 44, 45), it could bring about reduction in HIV-1 par-
ticle production entirely through indirect effects as well. The
observations that viral spike proteins appear to localize (par-
tially) to rafts and that cellular raft lipids and proteins are
found in HIV-1 particles have been put forward as another
piece of evidence for the importance of rafts in the assembly
and budding of HIV-1 (35, 38, 42, 57). However, whether these
observations indicate an obligatory linkage between rafts and
the assembly and budding mechanisms of HIV-1 is unknown.
With respect to the presence of host raft lipids and proteins in
the HIV-1 envelope, it is worthwhile to remember that there
are indications that rafts actually might be relatively abundant
structures at the cell surface (12, 15, 22, 33, 39) and that
retroviruses seem to be quite indiscriminate in choosing their
envelope components (21, 37). Furthermore, in the case of
viral spike proteins, the rafts in question appear to belong to
the class of Triton X-100-resistant rafts. It is unclear how these
rafts correlate with viral assembly intermediates, since accord-
ing to our data, Pr55gag does not appear to have intrinsic
afﬁnity for Triton X-100-resistant rafts, and there are no data
on Triton X-100 sensitivity or resistance of spike proteins in
virus particles. In principle, it is possible that the Triton X-100-
resistant rafts containing viral spike proteins and the Brij98-
resistant Pr55gag membrane domains described here are similar
types of rafts and that Pr55gag and viral envelope proteins only
exhibit different sensitivities to Triton X-100 within these raft
structures. However, we did not ﬁnd any indications for Triton
X-100-resistant raft-like lipid domains in the envelope of
Pr55gag VLPs with cold Triton X-100 extractions: both the
radioactive cholesterol (Fig. 3) and the bulk of radioactively
labeled phospholipids (data not shown) in the VLP envelope
were readily solubilized with cold Triton X-100. In summary,
before it can be ﬁrmly concluded that rafts play a critical role
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in the assembly of HIV-1, direct evidence is needed that rafts
or raft-associated host factors are important for some discrete
step or steps in the viral assembly process.
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Vpu and Tsg101 Regulate Intracellular Targeting of the Human
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Assembly of human immunodeﬁciency virus type 1 (HIV-1) is directed by the viral core protein Pr55gag.
Depending on the cell type, Pr55gag accumulates either at the plasma membrane or on late endosomes/
multivesicular bodies. Intracellular localization of Pr55gag determines the site of virus assembly, but molecular
mechanisms that deﬁne cell surface or endosomal targeting of Pr55gag are poorly characterized. We have
analyzed targeting of newly synthesized Pr55gag in HeLa H1 cells by pulse-chase studies and subcellular
fractionations. Our results indicated that Pr55gag was inserted into the plasma membrane and, when coex-
pressed with the viral accessory protein Vpu, Pr55gag remained at the plasma membrane and virions assembled
at this site. In contrast, Pr55gag expressed in the absence of Vpu was initially inserted into the plasma
membrane, but subsequently endocytosed, and virus assembly was partially shifted to internal membranes.
This endocytosis of Pr55gag required the host protein Tsg101. These results identiﬁed a previously unknown
role for Vpu and Tsg101 as regulators for the endocytic uptake of Pr55gag and suggested that the site of HIV-1
assembly is determined by factors that regulate the endocytosis of Pr55gag.
Assembly and budding of human immunodeﬁciency virus
type 1 (HIV-1) is driven by the viral core protein precursor
Gag (Pr55gag), which assembles into enveloped virus-like par-
ticles (VLPs) when expressed in the absence of other viral
proteins (9, 21). Pr55gag is a myristoylated, peripheral mem-
brane protein (3, 9, 14, 40, 47). Concomitantly with assembly
and budding, Pr55gag is processed into matrix, capsid (CA),
nucleocapsid, and p6 proteins and two smaller peptides SP1
and SP2 by a viral protease present in the minor core compo-
nent, the Gag-Pol precursor. An intriguing feature of the
Pr55gag-mediated assembly of HIV-1 is that different cellular
membranes serve as a platform for virus assembly in different
cell types. Electron microscopy (EM) and ﬂuorescence micros-
copy studies have indicated that Pr55gag predominantly accu-
mulates at the plasma membrane, and progeny virions are
formed at this site in T cells and model cell lines such as HeLa,
293T, and Cos-1 (see, for example, references 8, 16, and 27),
although some Pr55gag has also been identiﬁed on late endo-
somes in these cells (6, 10, 26, 39, 46). In contrast, in macro-
phages Pr55gag almost exclusively concentrates on late endo-
somes/multivesicular bodies (MVBs) and progeny virions bud
into the lumen of MVBs (25, 28, 31, 33). Egress of virus
particles from the cell surface, and probably also from the
endosomal assembly sites, is critically dependent on interaction
of the Pr55gag p6 domain with the host protein Tsg101 (tumor
susceptibility gene 101) (7, 23, 45, 46), which normally func-
tions in formation of MVB vesicles (24). Since ablation of
Pr55gag-Tsg101 interactions arrests virus budding at a stage
after membrane distortion (7, 46), the primary function of
Tsg101 in HIV-1 assembly and budding is thought to be the
recruitment of downstream factors essential for the completion
of budding and release of virions from the donor membrane
(24, 46).
Molecular mechanisms that control cell surface versus en-
dosomal accumulation of Pr55gag, and consequently the choice
of virus budding site, are poorly understood. One aspect that
remains to be clariﬁed is the route by which Pr55gag reaches its
cell surface or endosomal steady-state localization. Like other
myristoylated proteins, Pr55gag is expected to be synthesized on
cytosolic ribosomes and inserted into membranes posttransla-
tionally (20). It is assumed that the classical endoplasmic re-
ticulum-Golgi secretory route to the plasma membrane and
endosomes is not involved in intracellular targeting of Pr55gag,
since inhibitors of this transport pathway, such as brefeldin A
or monensin, have no effect on the assembly of Pr55gag into
extracellular particles (29, 30). Since Pr55gag has been observed
on endosomal membranes in a number of different cell types
(6, 10, 26, 39, 46), it is possible that the protein is ﬁrst inserted
into endosomal membranes and either retained in these com-
partments (macrophages) or transported further to the plasma
membrane (e.g., HeLa, 293T, or T cells). Alternatively, newly
synthesized Pr55gag could be ﬁrst targeted to the plasma mem-
brane, and endosomal localization could be achieved via en-
docytosis of the cell surface-associated protein. A third possi-
bility is that a newly synthesized Pr55gag is selectively inserted
either into the plasma membrane or endosomal membranes
depending on the host cell type.
In the present study, we analyzed targeting of newly synthe-
sized Pr55gag in HeLa H1 cells by pulse-chase studies and a
subcellular fractionation assay that efﬁciently separated plasma
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membrane from internal membranes. Our results demon-
strated that a newly synthesized Pr55gag was initially targeted to
the plasma membrane. Pr55gag accumulated at the plasma
membrane when coexpressed with the viral accessory protein
Vpu but, in the absence of Vpu, a signiﬁcant fraction of the cell
surface-associated Pr55gag proteins was retargeted to internal
membranes by endocytosis. This retargeting partially shifted
virus assembly from the cell surface to internal membranes.
RNA interference (RNAi)-mediated knockdown of Tsg101, or
deletion of the p6 domain from Pr55gag suppressed the endo-
cytic uptake of Pr55gag when the protein was expressed in the
absence of Vpu. Taken together, these results suggest that the
site of HIV-1 assembly is determined by factors that regulate
endocytosis of Pr55gag, and the results identiﬁed a previously
unknown role for Vpu and Tsg101 as regulators of the endo-
cytic uptake of Pr55gag.
MATERIALS AND METHODS
Cell culture and transfection. HeLa H1 cells (American Type Culture Collec-
tion) were grown in Dulbecco’s modiﬁed Eagle medium supplemented with 7% fetal
bovine serum (EuroClone) and nonessential amino acids (i.e., HeLa growth
medium). 293T cells were cultured as previously described (18). Vesicular sto-
matitis virus (VSV) G-protein-pseudotyped infectious lentivirus vectors carrying
modiﬁed HIV-1 genomes were produced by cotransfecting pCMVR8.91 and
pMD2.VSV.G (generous gifts from Didier Trono [48]), together with a plasmid
directing the synthesis of a recombinant HIV-1 genome into 293T cells by a
calcium phosphate precipitation technique.
Plasmid constructs. pHXB2D and pNL4-3 were originally obtained from the
NIBSC Centralized Facility for AIDS Reagents (the plasmids were donated by
Robert Gallo and Mikulas Popovic and by Malcolm Martin, respectively).
pHXB2D is a HIV-1 molecular clone with a defective vpu gene and truncated vpr
and nef genes (38). Plasmid pHXB2D-Gag is a derivative of pHXB2D that
expresses an unprocessed Pr55gag due to an inactivation of the Pol coding region.
The plasmid was constructed by replacing the 423-bp ApaI-BclI fragment with a
PCR-derived 297-bp ApaI-BclI fragment in which the stop codon of Pr55gag was
immediately followed by SmaI and BclI sites. pHXB2D-GagHA and pHXB2D-
Gagﬂag are derivatives of pHXB2D-Gag which express unprocessed Pr55gag
proteins that contain hemagglutinin (HA) or FLAG epitopes at their carboxy
termini. pNL4-3(Gag), a derivative of pNL4-3 (1), has an inactive Pol-region and
expresses an unprocessed Pr55gag. The plasmid was constructed by replacing the
3,779-bp ApaI-SalI fragment with the equivalent ApaI-SalI fragment of
pHXB2D-Gag. pNL4-3(Gag/Vpu), a derivative of pNL4-3(Gag), has a defec-
tive vpu gene due to a point mutation in the AUG start codon of vpu. The
construct was created by replacing the 558-bp SalI-KpnI fragment with the
equivalent fragment of pHXB2D. The plasmid pNL4-3(Gagp6/Vpu) encod-
ing a carboxy terminally truncated unprocessed Pr55gag lacking the p6 domain
was made from pNL4-3(Gag/Vpu) by replacing the 791-bp SpeI-SmaI fragment
with a PCR-created 635-bp SpeI-SmaI fragment in which a stop codon and a
SmaI site were placed immediately after the last codon of SP2 peptide. pNL4-
3(Env/Nef) is a derivative of pNL4-3 with defective env and nef genes. The
ﬁrst step in construction of pNL4-3(Env/Nef) involved inactivation of the env
gene on pNL4-3(Gag) by deleting the 580-bp BglII-BglII fragment from the Env
coding region. This created the plasmid pNL4-3(Gag/Env). pNL4-3(Env/
Nef) was made by replacing the 2,680-bp SalI-BamHI fragment of pNL4-3-
R71.Nef- (35): the plasmid contains an inactivated nef gene) with the equivalent
fragment from pNL4-3(Gag/Env). pHXB2D-(Vpu/Env/Nef) contains in-
active vpu, env, and nef genes. The ﬁrst step in the construction of pHXB2D-
(Vpu/Env/Nef) was inactivation of the env gene on pHXB2D by deleting a
1,278-bp region between KpnI and BglII sites on env which in addition to an
internal deletion also introduced a frameshift mutation on the gene. This created
the plasmid pHXB2D-(Vpu/Env). pHXB2D-(Vpu/Env/Nef) was made
from pHXB2D-(Vpu/Env) by inactivating the truncated nef gene via convert-
ing cohesive ends of XhoI-linearized pHXB2D-(Vpu/Env) into blunt ends by
Klenow and subsequently religating the plasmid.
Subcellular fractionations. HeLa H1 cells were seeded on 10-cm plates at a
density which gave 70% conﬂuence after o/n growth. Cells were infected the
following day with VSV-G-pseudotyped lentivirus vectors carrying modiﬁed
HIV-1 genomes. At24 h postinfection the now-conﬂuent cell monolayers were
metabolically labeled with 50 Ci of [35S]methionine for 30 min (18) and chased
for various times in HeLa growth medium containing a 10-fold excess of cold
methionine. After the chase, cell monolayers were washed twice with phosphate-
buffered saline containing 0.02% EDTA (PBS-EDTA), and the cells were
brought into suspension by a 2-min incubation in PBS-EDTA at 37°C. Subse-
quently, the suspension cells were coated at 4°C with cationic silica beads essen-
tially as previously described (4, 41), except that the coating buffer used was 20
mM 2-[N-morpholine]ethanesulfonic acid (pH 6.66 to 6.68) and 150 mM NaCl.
After coating, cells were homogenized with a tight-ﬁtting Dounce homogenizer
in buffer containing 25 mM HEPES (pH 7.4), 150 mM NaCl, 2 mM MgCl2, 20
g of phenylmethylsulfonyl ﬂuoride, 1 g of CLAP (chymostatin, leupeptin,
aprotinin, and pepstatin A), and 2.5 mg of heparin per ml (the heparin was
included to suppress binding of Pr55gag to chromatin released from broken
nuclei). The crude cell homogenates were mixed with 100% Nycodenz solution
(AXIS-SHIELD PoC AS) to give a ﬁnal 60% Nycodenz concentration. The
sample (2 ml) was placed on a 1-ml cushion of 70% Nycodenz and overlaid with
1.5 ml of 50% Nycodenz and 0.5 ml of 25 mM HEPES (pH 7.4), 150 mM NaCl,
and 1 mM EDTA. The gradient was centrifuged in an SW55 Ti rotor at 63,000 
g for 45 min at 4°C. The pellet (i.e., the plasma membrane fraction) was resus-
pended in hot 0.5% sodium dodecyl sulfate (SDS)–0.5 M NaCl buffer and then
boiled for 5 min, and silica beads were removed from the resuspended samples
by centrifugation in an Eppendorf centrifuge at full speed for 1 min. The internal
membrane fraction at the 50% Nycodenz-buffer interphase was collected and
diluted ﬁvefold with 25 mM HEPES (pH 7.4), 150 mM NaCl, and 1 mM EDTA,
and membranes were pelleted by centrifugation at 100,000 g for 1 h at 4°C. The
internal membrane pellet was solubilized as described above for the plasma
membrane, and the samples were diluted with a 10-fold excess of lysis buffer (1%
Triton X-100, 25 mM HEPES [pH 7.4], 150 mM NaCl, 1 mM EDTA, 20 g of
phenylmethylsulfonyl ﬂuoride, and 1 g of CLAP per ml). Pr55gag proteins were
immunoprecipitated from the lysates with mouse anti-HIV-1 CA monoclonal
antibody 38:9 (17), the Pr55gag processing intermediates and CA with a mixture
of monoclonal antibody 38:9 and mouse monoclonal anti-p24 antibody 32/5.17.76
(Abcam, Ltd.), and the HA-tagged Pr55gag with a rabbit polyclonal anti-HA
antibody (Sigma).
For biotinylation of the cell surface proteins, HeLa H1 cells were brought into
suspension by treatment with PBS-EDTA and incubated in PBS (with MgCl2 and
CaCl2) containing 0.5 mg per ml of EZ-Link Sulfo-NHS-SS-biotin (Pierce) for 30
min at 0°C. The sample was quenched with 50 mM NH4Cl before silica coating.
Biotin-tagged proteins in the plasma membrane and the internal membrane
fractions were visualized by dot blots using streptavidin-peroxidase polymer
(Sigma). Biotin-tagged transferrin proteins (15 g per ml; Molecular Probes)
that had been bound to HeLa H1 cells at 0°C or internalized for 20 min at 37°C
in serum-free medium were used as markers for the plasma membrane and
recycling endosomes, respectively. In the case of the internalized transferrin,
cells were incubated in a pH 4.5 buffer containing 25 mM citric acid, 24 mM
trisodiumcitrate, 280 mM sucrose, and 10 M deferoxamine mesylate for 2 min
to remove cell surface-bound transferrin proteins prior to silica coating. Trans-
ferrin proteins in the plasma membrane and internal membrane fractions were
visualized by Western blotting with streptavidin-peroxidase polymer. The
amounts of the endoplasmic reticulum (ER) marker protein calnexin and the late
endosome/lysosome marker protein Lamp-1 in the plasma membrane and inter-
nal membrane fractions were determined by Western blotting with rabbit poly-
clonal anti-calnexin (StressGen Biotechnologies Corp.) and goat polyclonal anti-
Lamp-1 (C-20; Santa Cruz Biotechnology, Inc.), respectively.
Electron miscroscopy. Cells were ﬁxed at 24 h postinfection with 2% glutar-
aldehyde in 100 mM HEPES (pH 7.4). The ﬁxed samples were ﬁrst stained with
1% osmium tetroxide, followed by staining with 0.5% alcoholic uranyl acetate,
dehydration in ethanol, and embedding in Agar 100 resin. Sections (60 nm) were
cut on an LKB ultramicrotome and imaged in an FEI Tecnai Spirit transmission
electron microscope.
RNAi. HeLa H1 cells were seeded on 10-cm plates at a density which gave
50% conﬂuence after overnight growth. siRNAs directed against the Tsg101
(7) or a control siRNA (GGUCUCUCUUUCGACGUGCdTdT; BLAST
searches against the human genome sequence did not identify any target for this
siRNA) were transfected into HeLa H1 cells by using Oligofectamine (Invitro-
gen) in accordance with the manufacturer’s instructions. Transfections were
carried out in HeLa growth medium containing 7% fetal bovine serum, and 40
l oligofectamine and 20 pmol siRNA per 10-cm plate were used. Mock-trans-
fected cells were treated with Oligofectamine alone. At about 22 h posttransfec-
tion the cells were infected with recombinant lentivirus vectors and then analyzed
about 24 h postinfection. The intracellular levels of Tsg101 in mock- and siRNA-
treated cells were determined from postnuclear supernatants of cell extracts by
Western blotting with a monoclonal anti-Tsg101 antibody (C-2; Santa Cruz
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Biotechnology, Inc.). The monoclonal anti-actin antibody (Chemicon) was used
as a control.
RESULTS
Subcellular fractionation method to separate plasma mem-
brane from internal membranes. We have expressed Pr55gag in
HeLa H1 cells and analyzed the targeting of the newly synthe-
sized Pr55gag by pulse-chase studies and subcellular fraction-
ations of cell extracts. HeLa H1 cells were chosen since our
pilot experiments indicated that Pr55gag can accumulate in
these cells either at the plasma membrane or at the internal
membranes. Thus, these cells provide a good model system for
studying how plasma membrane versus internal localization of
the protein is achieved. To determine whether Pr55gag is ini-
tially targeted to the plasma membrane or internal membranes
requires efﬁcient separation of these membranes. During ho-
mogenization, plasma membrane breaks into vesicles and
membrane sheets of various density (see, for example, refer-
ence 42) that are difﬁcult to separate from, for example, en-
dosomal membranes on conventional sucrose or iodixanol den-
sity gradients. Therefore, we chose a fractionation method in
which intact cells were coated with cationic silica beads at 4°C
prior to homogenization (4, 41), and crude cell extracts were
fractionated on a Nycodenz step gradient. The step gradient
consisted of a 70% cushion and a 60% sample loading zone
overlaid with 50% Nycodenz and buffer solutions. Since the
bound silica beads greatly increase density of the plasma mem-
brane, the plasma membrane-derived vesicles and membrane
sheets pellet through the 70% Nycodenz cushion during ultra-
centrifugation (the PM fraction), whereas internal membranes
ﬂoat to the 50% Nycodenz-buffer interphase (I, the internal
membrane fraction). Figure 1 shows controls for this fraction-
ation method. In Fig. 1A, externally exposed cell surface-asso-
ciated proteins were tagged with biotin prior to coating, and
biotinylated proteins in the PM and I fractions were visualized
by dot blots with horseradish peroxidase-conjugated streptavi-
din. The majority of biotin-tagged proteins were found in the
PM fraction. Similarly, biotin-conjugated transferrin that was
bound to cells at 0°C prior to coating was predominantly in the
PM fraction (Fig. 1B, Tf surface). In contrast, biotin-conju-
gated transferrin that had been concentrated into recycling
endosomes by internalization at 37°C for 20 min was in the I
fraction (Fig. 1B, Tf internalized). The ER protein calnexin, as
well as the endosomal/lysosomal marker lysosome-associated
membrane protein 1 (Lamp-1), were predominantly in the I
fraction (Fig. 1B). Taken together, these results demonstrate
that the fractionation method can separate the plasma mem-
brane from internal membranes in HeLa H1 cell extracts.
Newly synthesized Pr55gag is inserted into the plasma mem-
brane. To analyze targeting of newly synthesized Pr55gag, HeLa
H1 cells were infected with VSV-G-pseudotyped lentivirus
vectors carrying modiﬁed HIV-1 genomes. At 24 h postin-
fection, cells were metabolically labeled with [35S]methionine
for 30 min and chased for various times prior to coating and
fractionation. Conﬂuent cell monolayers were used in the stud-
ies. Amounts of labeled Pr55gag proteins in the PM and I
fractions were determined by immunoprecipitation and by
SDS-polyacrylamide gel electrophoresis analysis of the immu-
noprecipitates. Figure 2A shows analysis of newly synthesized,
unprocessed Pr55gag expressed from a NL4-3 proviral genome
from which the Pol region was deleted [the NL4-3(Gag) ge-
nome]. After a 5-min chase, a signiﬁcant amount of labeled
Pr55gag was detected in the PM fraction, but essentially no
labeled Pr55gag was present in the I fraction. Similar results
were obtained with a 15-min chase (data not shown). Begin-
ning from the 60-min chase point, small amounts of labeled
Pr55gag appeared in the I fraction, but the majority of the protein
(80%) was found in the PM fraction at all chase points
tested. The NL4-3(Gag) proviral construct efﬁciently produced
VLPs, since large amounts of labeled Pr55gag was found in the
culture medium already after 2 h of chase (data not shown). If
silica coating was omitted, all labeled Pr55gag was in the I
fraction (Fig. 2B), thus conﬁrming that Pr55gag found in the
PM fraction in coated cells represented cell surface-associated
proteins, and no unspeciﬁc protein aggregates. A nonmyristoy-
FIG. 1. Coating of HeLa H1 cells with cationic silica beads enables
separation of the plasma membrane from internal membranes. HeLa
H1 cells were coated with cationic silica beads at 4°C prior to homog-
enization, and crude cell extracts were fractionated on a Nycodenz step
gradient to yield a plasma membrane fraction (PM) and an internal
membrane fraction (I). Distribution of marker proteins between PM
and I fractions was determined by dot blotting (A) or by Western
blotting (B). (A) Plasma membrane-associated proteins were tagged
by biotin prior to coating and fractionation, and biotinylated proteins
were visualized by streptavidin-peroxidase polymer. (B) Biotin-tagged
transferrin proteins bound to cells at 0°C degrees were used as a
marker for the plasma membrane (Tf, surface; biotinylated transferrin
was visualized by streptavidin-peroxidase polymer). Biotin-tagged
transferrin internalized into cells for 20 min at 37°C was used as a
marker for recycling endosomes (Tf, internalized). Calnexin and
Lamp-1 were used as markers for the ER and late endosomes/lyso-
somes, respectively.
FIG. 2. Newly synthesized Pr55gag is targeted to the plasma mem-
brane and remains at the cell surface when coexpressed with Vpu.
(A) NL4-3(Gag)-infected HeLa H1 cells were metabolically labeled
with [35S]methionine for 30 min and chased for the indicated times
before coating and fractionation of the cell extracts on a Nycodenz step
gradient. Pr55gag proteins were immunoprecipitated from the plasma
membrane (PM) and internal membrane (I) fractions, and immuno-
precipitates were analyzed by SDS-polyacrylamide gel electrophoresis.
(B) Distribution of labeled Pr55gag between the PM and I fractions
when silica coating was omitted. NL4-3(Gag)-infected cells were met-
abolically labeled for 210 min and chased for 45 min.
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lated mutant of Pr55gag in which the amino-terminal glycine
residue was mutated to alanine failed to associate with either
the PM or I fractions (data not shown). Taken together, these
results indicated that newly synthesized Pr55gag was inserted
into the plasma membrane, and the majority of the proteins
remained at the cell surface.
Deletion of the vpu gene induces endocytosis of the plasma
membrane-associated Pr55gag. We next tested whether local-
ization of Pr55gag to the plasma membrane was an intrinsic
property of the protein, or whether other viral proteins had an
effect on intracellular targeting of Pr55gag. Elimination of env
or nef genes did not signiﬁcantly alter the targeting of newly
synthesized Pr55gag, i.e., the protein was inserted into the
plasma membrane and the majority of labeled Pr55gag re-
mained at the plasma membrane in the absence of Env or Nef
expressions (data not shown). In contrast, deletion of the vpu
gene produced a dramatic change in the intracellular localiza-
tion of Pr55gag. As shown in Fig. 3A, after a 15-min chase, or
30-min chase (data not shown), the vast majority of labeled
Pr55gag was present in the PM fraction in NL4-3(Gag/Vpu)-
infected cells. Beginning from the 60-min chase point, signiﬁ-
cant amounts of labeled Pr55gag appeared in the I fraction. By
2 h of chase, 70% of labeled Pr55gag was shifted to internal
membranes. As previously reported for HeLa cells (22), Vpu
was also required for efﬁcient virus production from HeLa H1
cells, since NL4-3(Gag)-infected cells produced18-fold more
VLPs than NL4-3(Gag/Vpu)-infected cells (data not shown).
Since newly synthesized cytosolic Pr55gag is rapidly targeted to
membranes, within 30 min of synthesis (43), the results pre-
sented in Fig. 3A suggest that in the absence of Vpu expression
Pr55gag is initially targeted to the plasma membrane but is
subsequently redistributed to the internal membranes by en-
docytosis. As shown in Fig. 3B, a carboxy-terminal HA tag, but
not a FLAG tag, suppressed endocytosis of cell surface-asso-
ciated Pr55gag. After 15-min chase, Pr55gag/HA and Pr55gag/
FLAG expressed in the absence of Vpu were primarily at the
plasma membrane (data not shown) but after 3 h of chase,
60% of labeled Pr55gag/FLAG had redistributed to internal
membranes, whereas 80% of Pr55gag/HA remained at the
cell surface even after 4 h of chase.
The effect of Vpu was also tested in the context of Gag and
Gag-Pol coexpression. Figure 4A shows an analysis of pro-
cessed Pr55gag that was expressed from a modiﬁed NL4-3 pro-
viral genome lacking env and nef genes but expressing Vpu [the
NL4-3(Env/Nef)]. At all of the time points tested, most of
the labeled Pr55gag, its processing intermediates, or the p25/
p24 CA forms were found in the PM fraction. Only trace
amounts of the proteins could be detected in the I fraction. In
contrast, if in addition to the env and nef genes the vpu gene
was also deleted [the HXB2D-(Vpu/Env/Nef) construct],
the intracellular localization of CA forms was changed (Fig.
4B). After 15 min of chase, Pr55gag and two of its early pro-
cessing intermediates were detected in the PM fraction but not
in the I fraction, thus indicating that Pr55gag was ﬁrst targeted
to the plasma membrane. After 2 h of chase, Pr55gag and its
early processing intermediates were still found in the PM frac-
tion but, signiﬁcantly, 60% of the processed CA forms were
in the internal membrane fraction. At the 4-h chase point, only
the p25 and p24 CA forms were evident, and the majority of
these proteins was found in internal membranes. Although CA
was the only Gag form detected in the I fraction in the radio-
actively labeled samples, Western blot analysis of the PM and
I fractions indicated that small amounts of Pr55gag and its
processing intermediates were present in internal membranes
as well (Fig. 4C). Taken together, the results in Fig. 4 demon-
strate that deletion of vpu gene induced uptake of plasma
membrane-associated core proteins also when Gag and Gag-
Pol were coexpressed. These results were conﬁrmed by EM.
EM analysis of NL4-3(Env/Nef)-infected cells identiﬁed nu-
merous budding proﬁles at the cell surface (Fig. 5A). Budding
proﬁles were detected at the plasma membrane in HXB2D-
(Vpu/Env/Nef)-infected cells as well (Fig. 5C), but these
cells also contained endosome-like intracellular compartments
full of VLP-sized vesicles (Fig. 5B). Occasionally, budding pro-
ﬁles resembling nascent VLPs could be observed on the lim-
FIG. 3. Newly synthesized Pr55gag is ﬁrst inserted into the plasma
membrane but subsequently endocytosed when expressed in the ab-
sence of Vpu. (A) Distribution of newly synthesized Pr55gag proteins
between the plasma membrane (PM) and internal membranes (I) at
different chase points in NL4-3(Gag/Vpu)-infected HeLa H1 cell
extracts. Cells were metabolically labeled and analyzed as described in
the legend for Fig. 2. (B) Carboxy-terminal HA tag but not FLAG tag
inhibits the endocytosis of cell surface-associated Pr55gag expressed in
the absence of Vpu. HXB2D-GagHA- and HXB2D-GagFLAG-in-
fected HeLa H1 cells were metabolically labeled for 30 min and chased
for the indicated times prior to coating and fractionation.
FIG. 4. Vpu inhibits endocytosis of cell surface-associated Pr55gag
also when the protein is expressed together with Gag-Pol. (A) Analysis
of NL4-3(Env/Nef)-infected HeLa H1 cells. Cells were metaboli-
cally labeled and analyzed as described in the legend to Fig. 2. Pr55gag
and the p25/p24 CA forms are indicated. Labeled bands between
Pr55gag and p25/p24 represent processing intermediates. (B) Analysis
of metabolically labeled HXB2D-(Vpu/Env/Nef)-infected HeLa
H1 cells. (C) Western blot analysis of steady-state distribution of
Pr55gag and its processing products between PM and I fractions in
HXB2D-(Vpu/Env/Nef)-infected cell extracts. The sample was
collected at 26 h postinfection.
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iting membrane of these compartments (Fig. 5D). When 10
randomly selected NL4-3(Env/Nef)- and HXB2D-(Vpu/
Env/Nef)-infected cells, i.e., cells that had budding struc-
tures at the cell surface, were scored for VLP-containing en-
dosomal structures, these structures were found in all of the
inspected HXB2D-(Vpu/Env/Nef)-infected cells. In con-
trast, only one of the NL4-3(Env/Nef)-infected cells had
clearly identiﬁable endosomal VLPs.
Knockdown of Tsg101 inhibits targeting of Pr55gag to inter-
nal membranes. The PTAP motif on the p6 domain of Pr55gag
binds Tsg101, and this interaction is necessary for the efﬁcient
release of progeny particles (7, 23, 45). We tested the effect of
a previously described Tsg101-speciﬁc small interfering RNAs
(siRNAs) (7) in NL4-3(Gag/Vpu)-infected cells to probe
whether Tsg101 is involved in endocytosis of Pr55gag. Western
blot analysis of cell lysates demonstrated that Tsg101 siRNAs
effectively reduced intracellular levels of Tsg101 (Fig. 6A).
After a 30-min pulse and 3 h of chase, 58% of labeled Pr55gag
remained at the cell surface in Tsg101 siRNA-transfected cells,
whereas 73% of labeled Pr55gag was in internal membranes in
FIG. 5. EM analysis of NL4-3(Env/Nef)- and HXB2D-(Vpu/Env/Nef)-infected HeLa H1 cells. (A) NL4-3(Env/Nef)-infected cells.
Numerous budding structures are seen at the cell surface. (B to D) HXB2D-(Vpu/Env/Nef)-infected cells. In addition to the budding
structures at the plasma membrane (C), the cells also contain endosome-like structures (❋) full of VLP-sized vesicles (B). (D) Virus-like budding
proﬁles (arrow heads) on the internal VLP-containing compartments. Bar, 200 nm.
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mock-transfected cells (Fig. 6B). Cells transfected with control
siRNAs of scrambled sequence had 63% of labeled Pr55gag in
internal membranes (Fig. 6B). The less-efﬁcient Pr55gag uptake
in Tsg101 siRNA-transfected cells could be due to ablation of
Pr55gag interaction with Tsg101, or, alternatively, due to un-
speciﬁc and/or pleiotropic effects of the Tsg101 siRNAs. To
distinguish between these possibilities, we tested uptake of a
carboxy-terminally truncated Pr55gag lacking the p6 domain.
The truncated protein was expressed from the recombinant
proviral genome NL4-3(Gagp6/Vpu). After a 30-min pulse
and a 15-min chase, the labeled Gagp6 protein was in the PM
fraction (data not shown). Deletion of the p6 domain inhibited
endocytosis of the cell surface-associated protein, since 75% of
the truncated proteins were still at the plasma membrane after
3 h of chase (Fig. 6C). Taken together, these results suggest
that endocytosis of Pr55gag is critically dependent on interac-
tion of Tsg101 with the p6 domain of Pr55gag.
DISCUSSION
In the present study, we have analyzed targeting of newly
synthesized Pr55gag in HeLa H1 cells by pulse-chase studies
and by using a subcellular fractionation method that efﬁciently
separates plasma membrane from internal membranes. Our
results indicate that Pr55gag is initially targeted to the plasma
membrane, and the protein is delivered to internal membranes
by endocytosis. Our study also identiﬁed Vpu as a key regula-
tor of intracellular targeting of Pr55gag. In the presence of Vpu,
the bulk of Pr55gag remained at the plasma membrane after the
initial membrane insertion, whereas in the absence of coex-
pressed Vpu a signiﬁcant fraction of the cell surface-associated
Pr55gag proteins was retargeted to internal membranes. Similar
retargeting was observed regardless of whether Pr55gag was
expressed as a nonprocessed precursor protein or whether
Pr55gag was expressed together with Gag-Pol. These results are
in agreement with previous reports indicating that deletion of
the vpu gene increases virus budding into intracellular com-
partments in HeLa and T cells (13, 22). We observed a similar
increase of VLPs in internal membrane compartments in
the absence of Vpu when NL4-3(Env/Nef)- and HXB2D-
(Vpu/Env/Nef)-infected cells were compared by EM. Fur-
thermore, it is noteworthy that in all of the studies that have
identiﬁed Pr55gag in internal membranes in transfected or in-
fected, but otherwise nonperturbed HeLa, Cos-1, or 293T cells,
the protein was expressed in the absence of Vpu (6, 10, 26, 39).
Consistent with our results, Rudner et al. (34) recently identi-
ﬁed plasma membrane as the primary target membrane for
Pr55gag in HeLa cells. The method used was the ﬂuorescent
imaging of cells expressing a tetracysteine-tagged Pr55gag and
sequential staining of the cells with two biarsenical compounds
that produced different ﬂuorescent signals upon binding to the
tetracysteine tag. The dual-labeling procedure enabled the de-
tection of newly synthesized Pr55gag. However, in contrast to
our results, the presence or absence of Vpu was reported to
have no effect on the association of Pr55gag with the plasma
membrane. This discrepancy could perhaps be explained by the
carboxy-terminal tetracysteine tag; as exempliﬁed by our HA-
tagged Pr55gag, a carboxy-terminal tag can inhibit the endocy-
tosis of cell surface-associated Pr55gag. Since our subcellular
fractionation method did not separate internal membrane
compartments from each other, the identity of the internal
membranes harboring Pr55gag was not established. Fluores-
cence microscopy analysis of HXB2D-(Vpu/Env/Nef)-in-
fected cells indicated a vesicular staining pattern for intracel-
lular Gag (data not shown), but the intracellular Gag-signal in
this particular viral genetic background did not extensively
colocalize with any of the tested early or late endosomal mark-
ers (CD63, Lamp-1, EEA1, or internalized ﬂuorescein isothio-
cyanate-conjugated transferrin; data not shown).
It is formally possible that the Gag signal in the internal
membrane fraction in our silica coating experiments originated
from internalized extracellular VLPs rather than from endo-
cytosed plasma membrane-associated Pr55gag. However, we
think this is unlikely for the following reasons. First, very little
Gag was detected in the internal membrane fraction in NL4-
3(Gag)- and NL4-3(Env/Nef)-infected cells despite the fact
that these cells released 18-fold more VLPs than cells ex-
pressing the respective Vpu-genomes (data not shown). Sec-
ond, although rare, virus-like budding structures could be
identiﬁed on internal membrane compartments, and early pro-
cessing intermediates of Pr55gag, although not as abundant as
CA, were observed in internal membrane fraction by Western
blotting. Thus, unless VLPs produced in the absence of Vpu
have some feature that promotes their rapid uptake after bud-
ding from the cell surface, these observations strongly suggest
that Gag localization to internal membranes is the conse-
quence of endocytosis of plasma membrane-associated pro-
teins rather than internalization of extracellular VLPs. The
mechanism by which Vpu suppresses endocytosis of Pr55gag
remains to be elucidated. Since there are no indications that
Vpu directly interacts with Pr55gag, Vpu most likely exerts its
effect indirectly, e.g., by inducing modiﬁcations on the plasma
FIG. 6. The p6 domain of Pr55gag, as well as the host protein
Tsg101, are required for the endocytic uptake of Pr55gag. (A) Tsg101-
siRNAs effectively reduce the intracellular levels of Tsg101. HeLa H1
cells were transfected with Tsg101-speciﬁc siRNAs () or mock-trans-
fected () prior to infection with NL4-3(Gag/Vpu) recombinant
viruses. Tsg101 levels in postnuclear supernatants were probed by
Western blotting, and actin was used as a control to conﬁrm that equal
amounts of the two samples were analyzed. (B) HeLa H1 cells were
transfected with Tsg101-siRNAs, with control siRNAs of scrambled
sequence (control) or mock-transfected (mock) prior to infection with
the NL4-3(Gag/Vpu) recombinant viruses. Cells were metabolically
labeled for 30 min and chased for 3 h prior to silica coating and
fractionation. (C) HeLa H1 cells were infected with NL4-3(Gagp6/
Vpu) recombinant virus that directs the synthesis of a carboxy-ter-
minally truncated Pr55gag lacking the p6 domain. Cells were metabol-
ically labeled for 30 min and chased for 3 h.
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membrane or by exerting broader modifying effects on the
membrane trafﬁcking pathways of the host cell. In order to
elucidate how Vpu suppresses endocytosis of Pr55gag, it is es-
sential to understand the molecular basis of endocytosis of
Pr55gag when the protein is expressed in the absence of Vpu.
Our initial analyses suggest that this uptake requires interac-
tions between the cell surface-associated Pr55gag and Tsg101.
siRNAs directed against Tsg101, or deletion of the p6 domain
that mediates Pr55gag and Tsg101 interactions (7, 23, 45), in-
hibited the endocytosis of Pr55gag. siRNAs can cause various
off-target effects that are difﬁcult to control for in conventional
experimental settings (32, 36), and therefore RNAi-mediated
knockdown results have to be interpreted with caution. How-
ever, since the endocytosis of Pr55gag was suppressed by dele-
tion of p6 domain, this suggests that the effect of Tsg101
siRNAs was due to ablation of Tsg101 and Pr55gag interactions.
Tsg101 was initially identiﬁed as being essential for efﬁcient
egress of progeny particles from the cell surface assembly sites
(7, 23, 45). Tsg101 is a component of the ESCRT-I (endocytic
sorting complex required for trafﬁcking) and recruits the so-
called class E proteins, which normally function in MVB bio-
genesis, to the site of HIV-1 assembly and budding (24). The
class E proteins also participate in the budding of other retro-
viruses, ﬁloviruses, and arenaviruses (24). Since HIV-1 assem-
bly is arrested at a late stage (after membrane distortion) when
p6-Tsg101 interactions are disrupted (24), it has been assumed
that Tsg101 and other class E proteins facilitate the ﬁnal steps
in budding. However, since our results indicate that Tsg101
also has an impact on intracellular localization of Pr55gag, this
suggests that the function of Tsg101 in HIV-1 assembly and
budding might be more complex than was previously thought.
Several biological activities have been attributed to Vpu (2, 19,
44). One of these is the enhancement of virus release from HIV-
1-infected cells. Interestingly, Vpu can also increase virus release
from cells infected by other retroviruses (13) and even alpha-
viruses (11). Since Vpu enhances virus production from most
human cells, as well as from human-simian heterokaryons, but not
from simian cells, Varthakavi et al. (44) postulated that Vpu
counteracts a human cell-speciﬁc restriction factor that inhibits
HIV-1 particle production. Although our present study by no
means excludes the existence of such an assembly/release inhibi-
tor, the data suggest a possible alternative explanation for the
Vpu-mediated enhancement of HIV-1 particle release in human
cells. Namely, Vpu could affect particle production indirectly via
its effects on intracellular targeting of Gag. Since deletion of the
vpu gene subjected plasma membrane-associated Gag to endocy-
tosis and partially shifted virus assembly to internal membranes,
and if these endosomal viruses were only inefﬁciently released
into the extracellular medium, then Vpu-deﬁcient viruses would
be expected to produce less extracellular particles than their wild-
type counterparts. Vpu has also been reported to enhance overall
membrane association of Gag when Gag was expressed from a
T7-driven vaccinia virus expression system (5). Although we did
not rigorously test the distribution of Gag between cytosolic and
membrane fractions in the present study, we, or others (15), have
not observed any dramatic reduction in membrane-associated
Gag with Vpu-deﬁcient proviral expression systems.
The biological signiﬁcance of the plasma membrane versus
the endosomal assembly of HIV-1 is not fully understood at
present, but emerging information suggests that the site of
virus assembly could impact HIV-1 pathogenesis. For example,
intracellular assembly may promote viral persistence since in-
tracellular virions in macrophages retain infectivity for an ex-
tended period of time and can efﬁciently transfer the infection
to lymphocytes upon contact (37). Furthermore, it has been
speculated that the cellular site of assembly might have a direct
impact on immune recognition and infectivity of the formed
virions (12). Thus, understanding the molecular mechanisms
that regulate the choice of viral assembly site is important. Our
results suggest that cell surface versus internal assembly of
HIV-1 in HeLa H1 cells is determined by factors that regulate
endocytic uptake of plasma membrane-associated Pr55gag. Our
results provide compelling evidence that Vpu promotes cell
surface assembly of HIV-1 by inhibiting endocytosis of plasma
membrane-associated Pr55gag and that newly synthesized
Pr55gag proteins reach internal membrane compartments in
HeLa H1 cells via endocytosis from the plasma membrane.
The presence of VLPs in internal compartments in HXB2D-
(Vpu/Env/Nef)-infected cells implies that internalized
Pr55gag proteins can engage in productive particle assembly
and that the internalization process does not merely represent
garbage disposal, i.e., the removal of defective Gag forms from
the cell surface. Since HeLa cells recapitulate the main fea-
tures of HIV-1 assembly in T cells, our results most likely
apply to T cells as well. Unfortunately, we could not directly
test the targeting of Pr55gag in T cells, since, e.g., Jurkat T cells
tended to disrupt during silica coating, and this lead to binding
of silica beads to internal membranes as well (data not shown).
Whether endocytosis from the plasma membrane is also the
mechanism by which Pr55gag is targeted to the MVBs in mac-
rophages is unclear at present, since intracellular targeting of
Pr55gag in HeLa H1 cells and macrophages differs at least in
two aspects. Namely, Gag is apparently targeted to MVBs in
macrophages even when the protein is coexpressed with Vpu
(25, 31, 33) and targeting to MVBs in macrophages appears to
be independent of Pr55gag-Tsg101 interactions (27). Conse-
quently, either the uptake mechanism is different in macro-
phages or, alternatively, the initial membrane insertion does
not occur at the plasma membrane in these cells. We are
currently testing whether the silica coating method can be used
to determine the targeting phenotype of newly synthesized
Pr55gag in macrophages.
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Abstract
Recent results by us and others have shown that the accessory protein Vpu determines plasma membrane versus endosomal accumulation of
the HIV-1 core protein Gag and progeny virions in the HeLa model of HIV-1 infection, since Vpu suppresses endocytosis of cell surface-
associated Gag. In this report, we used pulse-chase studies and subcellular fractionations to investigate endocytosis of newly synthesized Gag in
HeLa H1 cells. The uptake of Gag in ΔVpu-virus background was not blocked by inhibitors of clathrin-mediated endocytosis and
macropinocytosis. The cholesterol-sequestering drug filipin inhibited the uptake, but only if the drug was applied before extensive multimerization
of Gag had taken place. Thus, the uptake mechanism most likely is only indirectly dependent on cholesterol. Our results also indicated that
targeting phenotype of Gag was different in confluent versus subconfluent cell cultures, which could perhaps explain some of the controversies in
intracellular targeting of Gag.
© 2007 Elsevier Inc. All rights reserved.
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Introduction
Assembly of human immunodeficiency virus type 1 (HIV-1)
is directed by the viral core protein precursor Gag (Pr55Gag)
(Göttlinger, 2001; Resh, 2005). Pr55Gag is a myristoylated,
peripheral membrane protein, and it binds to cellular mem-
branes and assembles into enveloped virus-like particles (VLPs)
independently of other viral proteins (Bryant and Ratner, 1990;
Gheysen et al., 1989; Göttlinger et al., 1989; Spearman et al.,
1994; Zhou et al., 1994), but release of progeny virions from
infected cells is enhanced by the viral accessory protein Vpu
(Bour and Strebel, 2003), and by the viral protease present in the
other core protein precursor, the Gag-Pol (Kaplan et al., 1994).
During or shortly after budding, Pr55Gag is cleaved into matrix,
capsid (CA), nucleocapsid, and p6 proteins and two peptides
SP1 and SP2 by the viral protease.
One intriguing aspect of the Gag-mediated assembly of
HIV-1 is that the assembly phenotype is cell type-dependent.
Electron microscopy (EM) and fluorescence microscopy
studies have indicated that Gag and progeny virions concen-
trate within large internal vacuoles in macrophages (Greene
Nguyen et al., 2003; Orenstein et al., 1988; Pelchen-Matthews
et al., 2003; Raposo et al., 2002). These vacuoles have been
assumed to represent late endosomes/multivesicular bodies, but
recent data indicate that they in fact are internally sequestered
plasma membrane domains (Deneka et al., 2007; Welsch et al.,
2007). In contrast, Gag and virus particles have been found
both at the plasma membrane and in internal, endosome-like
compartments in T cells and model cell lines such as 293T,
HeLa, and Cos (see, for example, Grigorov et al., 2006;
Nydegger et al., 2003; Sherer et al., 2003). The intracellular
route by which Gag reaches its cell surface or internal
localization, as well as the intracellular site where virus
assembly is initiated, have been subjects of intense debate.
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Since the virus-filled vacuoles of macrophages have been
found to be continuous with the plasma membrane, the cell
surface is the primary site for HIV-1 assembly in these cells
(Deneka et al., 2007; Welsch et al., 2007). This conclusion is
supported by cell imaging and biochemical studies as well
(Jouvenet et al., 2006). The plasma membrane appears to be the
primary site for HIV-1 assembly in other cell types as well,
since several recent studies have provided strong evidence that
the internal Gag and virus particles in HeLa and 293T cells
originate from uptake of newly assembled virions from the cell
surface (Finzi et al., 2007; Harila et al., 2006; Jouvenet et al.,
2006; Neil et al., 2006). We and others recently identified the
viral accessory protein Vpu as an important determinant for
accumulation of Gag and progeny virions in internal
endosome-like compartments in HeLa H1 and HeLa cells
(Harila et al., 2006; Neil et al., 2006). The results from these
two studies indicated that a newly synthesized Gag was
initially inserted into the plasma membrane. When Gag was
coexpressed with Vpu, the protein remained at the plasma
membrane and progeny virions assembled at the cell surface
were efficiently released into the extracellular medium. In
contrast, Gag expressed in the absence of Vpu produced
progeny virions that remained tethered to the cell surface (Neil
et al., 2006), and the plasma membrane-associated newly
synthesized Gag, most likely in the form of a fully assembled
virion, was efficiently retargeted from the cell surface to an
internal endosome-like compartment by an as-yet-uncharacter-
ized uptake mechanism (Harila et al., 2006; Neil et al., 2006).
However, the initial insertion of newly synthesized Gag into
the plasma membrane is a controversial issue. Biarsenical/
tetracysteine labeling and cell imaging studies have favored
either direct insertion of Pr55Gag into the plasma membrane in
HeLa cells (Rudner et al., 2005), or provided evidence for
trafficking of newly synthesized Gag to the plasma membrane
via an endosomal intermediate (Perlman and Resh, 2006).
Furthermore, cell fractionation studies have indicated that a
newly synthesized Gag in 293T cells is first inserted into the
plasma membrane (Finzi et al., 2007), or that the protein
simultaneously reaches the plasma membrane and endosomal
membranes (Grigorov et al., 2006). Studies using Gag-green
fluorescent protein (Gag-GFP) molecules have suggested that
internalization from the plasma membrane accounts for
intracellular Gag in 293T cells and macrophages (Jouvenet
et al., 2006).
In the present study, we have investigated the endocytic
phenotype of Gag in HeLa H1 cells. Our results indicated that
the endocytosis of Gag in ΔVpu-background was not blocked
by an inhibitor of macropinocytosis [5-(N-ethyl-N-isopropyl)
amiloride], or by RNA interference (RNAi)-mediated knock-
down of clathrin heavy chain (CHC). The uptake was sensitive
to the cholesterol-sequestering drug filipin, but the effect of
filipin was most likely indirect and due to negative impact of the
drug on Gag multimerization and virus assembly. Notably, the
targeting phenotype of Gag in ΔVpu-background was found to
be different in confluent versus subconfluent cell cultures, since
newly synthesized Gag was simultaneously detected at the
plasma membrane and internal membranes in subconfluent cells
whereas targeting to the plasma membrane in confluent cells
clearly preceded the appearance of Gag in internal membranes.
Results
Impact of inhibitors of clathrin-mediated endocytosis and
macropinocytosis on the uptake of cell surface-associated Gag
Our previous results in HeLa H1 cells indicated that a newly
synthesized Pr55Gag was inserted into the plasma membrane,
but when expressed in the absence of Vpu, the protein
subsequently shifted from the cell surface to an internal
endosome-like compartment (Harila et al., 2006). Mammalian
cells have several endocytic routes which can be classified into
three main uptake modes: clathrin-mediated endocytosis,
macropinocytosis, and cholesterol-dependent (raft-mediated)
uptake (Marsh and Helenius, 2006; Pelkmans and Helenius,
2003). We used inhibitors of these three uptake modes to probe
the mechanism of Gag endocytosis in HeLa H1 cells.
RNAi-mediated knock-down of CHC was used to probe
whether the uptake of cell surface-associated Gag in ΔVpu-
virus background occurred by clathrin-mediated endocytosis.
HeLa H1 cells were transfected with CHC-specific siRNAs or
mock-transfected (i.e. treated only with the transfection
reagent), and the following day infected with vesicular
stomatitis virus (VSV) G-protein-pseudotyped NL4-3(Gag/
ΔVpu), a recombinant virus carrying a genome with a defective
Pol region and a defective vpu gene. Western blot analysis of
cell lysates after 24 h postinfection demonstrated that the CHC
siRNA effectively reduced intracellular levels of CHC (Fig.
1A). Biotin-tagged transferrin (TF) was used as a probe to
measure clathrin-dependent endocytosis in the infected CHC
knock-down cells. TF was initially bound to cells at cold, and
the cells were then shifted to 37 °C for 0, 5 or 15 min to allow
endocytosis. After incubation at 37 °C, cells were placed on ice,
and cell surface-associated TF was removed by trypsin. The
amount of trypsin insensitive, endocytosed TF was determined
by Western blot analyses of cell extracts. Both mock- and
siRNA-transfected cells bound ∼equal amounts of TF (Fig. 1B;
tot), and the TF at the cell surface was efficiently removed by
trypsin (the 0 min time point in Fig. 1B). After 5 min of
warming, TF had become fully resistant to trypsin in mock-
transfected control cells, whereas the majority of TF (∼70%) in
CHC siRNA-treated cells remained susceptible to trypsin even
after 15 min at 37 °C. This indicated that clathrin-dependent
endocytosis was compromised in the CHC siRNA-treated cells.
To determine the effect of CHC knock-down on endocytosis of
Pr55Gag, siRNA- or mock-transfected cells were infected with
NL4-3(Gag/ΔVpu), and at 24 h postinfection cells were
metabolically labeled with [35S]methionine for 30 min and
chased for 10 min or 180 min. Intact cells were then coated with
cationic silica beads at +4 °C prior to homogenization, and
crude cell extracts were fractionated on a Nycodenz step
gradient. The gradient consisted of a 70% Nycodenz cushion
and a 60% sample loading zone overlaid with 50% Nycodenz
and buffer solutions. This fractionation method efficiently
separates the plasma membrane from internal membranes, since
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due to the bound silica beads, the plasma membrane-derived
vesicles and membrane sheets pellet through the 70% Nycodenz
cushion during ultracentrifugation, whereas internal membranes
float to the 50% Nycodenz-buffer interphase (for controls, see
Harila et al., 2006). Distribution of labeled Pr55Gag between the
plasma membrane (PM) and internal membrane (I) fractions
was determined by immunoprecipitation and by gel electro-
phoresis analysis of the immunoprecipitates. As shown in Fig.
1C, the CHC siRNAs did not block redistribution of labeled
Pr55Gag from the cell surface to internal membranes. After
10 min of chase, the majority of labeled Pr55Gag was in the PM
fraction in CHC siRNA-transfected cells, whereas the labeled
Pr55Gag had shifted to I fraction in the siRNA-transfected cells
as efficiently as in mock-transfected control cells after 180 min
of chase. Thus, clathrin-mediated endocytosis is not involved in
uptake of plasma membrane-associated Pr55Gag in NL4-3(Gag/
ΔVpu)-infected HeLa H1 cells. Lowering intracellular levels of
CHC did not affect intracellular localization of Pr55Gag
coexpressed with Vpu, since the majority of labeled Pr55Gag
in NL4-3(Gag)-infected cells was found in the PM fraction even
after 150 min of chase (Fig. 1D).
The effect of CHC knock-down was also tested in the context
of Gag and Gag-Pol coexpression. CHC siRNA- or mock-
transfected HeLa H1 cells were infected with NL4-3(ΔVpu/
ΔEnv), a virus carrying defective vpu and env genes, and at
21 h postinfection cells were metabolically labeled with [35S]
methionine for 30 min and chased for 120 min. As shown in
Fig. 1E, only trace amounts of labeled, unprocessed Pr55Gag
remained in mock-transfected and siRNA-transfected cells after
the 120-min chase. Approximately ∼60% of p24 CA was
internal in mock-treated cells, whereas the internal p24
comprised ∼49% of total cell-associated CA in CHC siRNA-
treated cells. This small difference in the intracellular distribu-
tion of CA was reproducible.
The results in Figs. 1C and E suggested that the uptake of
plasma membrane-associated Gag in NL4-3(Gag/ΔVpu)-
infected cells was clathrin-independent, but in NL4-3(ΔVpu/
ΔEnv)-infected cells, a subpopulation of Gag might be
internalized by clathrin-mediated endocytosis. Alternatively,
as there is the strong possibility that Gag is endocytosed as a
fully assembled virion (Neil et al., 2006), the results in Figs. 1C
and E might reflect differential impact of CHC knock-down on
virus assembly in these two cells. To distinguish between these
possibilities, we analyzed production of VLPs from NL4-3
(Gag/ΔVpu)- and NL4-3(ΔVpu/ΔEnv)-infected cells contain-
ing normal or low intracellular levels of CHC. The NL4-3(Gag/
ΔVpu)- or NL4-3(ΔVpu/ΔEnv)-infected cells were metaboli-
cally labeled with [35S]methionine for 180 min and 240 min,
respectively, and VLPs released into the culture supernatant, or
VLPs tethered to the cell surface (=VLPs released after trypsin
treatment of cells) were purified by pelletation through a 20%
sucrose cushion. The amount of labeled Gag in the pellets was
determined by gel electrophoresis. As shown in Fig. 2A, only
trace amounts of labeled Pr55Gag were released into extra-
cellular VLPs from NL4-3(Gag/ΔVpu)-infected cells, but
Fig. 2. Effect of CHC-specific siRNAs on virus assembly. Extracellular VLPs
(−), or VLPs tethered to the cell surface and released by trypsin treatment of cells
(+), were pelleted through a sucrose cushion and analyzed by SDS-
polyacrylamide gel electrophoresis. (A) VLPs from cells that expressed
unprocessed Pr55Gag in the absence of Vpu [NL4-3(Gag/ΔVpu)-infection].
Cells were metabolically labeled for 180 min. (B) VLPs from cells that
expressed Gag and Gag-Pol, but no Vpu [NL4-3(ΔVpu/ΔEnv)-infected cells].
Cells were metabolically labeled for 240 min. Only the CA form is shown, since
the VLPs did not contain significant amounts of unprocessed Pr55Gag or
processing intermediates of Gag.
Fig. 1. RNAi-mediated knock-down of CHC does not inhibit uptake of cell
surface-associated Pr55Gag, but reduces the uptake of Gag when Gag and Gag-
Pol are coexpressed. (A) The CHC-siRNA used effectively reduced the
intracellular levels of CHC. HeLa H1 cells were transfected with CHC-specific
siRNA (+) or mock-transfected (−). CHC levels in postnuclear supernatants
were probed by Western blotting, and GAPDH was used as a control to confirm
that equal amounts of siRNA- and mock-transfected samples were analyzed. (B)
Clathrin-mediated endocytosis was inhibited in the siRNA-transfected cells.
HeLa H1 cells were transfected with CHC-specific siRNA or mock-transfected
prior to infection with NL4-3(Gag/ΔVpu), and clathrin-mediated endocytosis
was probed by measuring the uptake of biotin-tagged transferrin. Transferrin
was bound to cells at 4 °C, and internalized at 37 °C for the indicated times. Cell
surface-associated transferrin was removed by trypsin prior to homogenization,
and the amount of endocytosed, trypsin-resistant transferrin in cell extracts was
determined by Western blotting. Tot sample was not trypsin-treated and it
indicates the amount of transferrin originally bound to cells. (C) CHC knock-
down does not inhibit endocytosis of Pr55Gag expressed in the absence of Vpu.
HeLa H1 cells were transfected with CHC-specific siRNA or mock-transfected
prior to infection with NL4-3(Gag/ΔVpu). Cells were metabolically labeled
with [35S]methionine for 30 min and chased for the indicated times. After the
chase, intact cells were coated with cationic silica beads at 4 °C prior to
homogenization, and crude cell extracts were fractionated on a Nycodenz step
gradient to separate the plasma membrane (PM) from internal membranes (I).
Pr55Gag proteins were immunoprecipitated from the PM and I fractions, and
immunoprecipitates were analyzed by SDS-polyacrylamide gel electrophoresis.
The 10 min CHC sample and the 180 min chase samples are from different
experiments. (D) Intracellular localization of Pr55Gag coexpressed with Vpu is
not affected by the knock-down of CHC. HeLa H1 cells were transfected with
CHC-specific siRNA and infected with NL4-3(Gag). Cells were metabolically
labeled for 30 min and chased for 150 min prior to silica coating and
fractionation. (E) Analysis of the effect of CHC knock-down on uptake of Gag
when Gag and Gag-Pol were coexpressed [NL4-3(ΔVpu/ΔEnv)-infected cells].
Cells were metabolically labeled for 30 min and chased for 120 min prior to
silica coating and fractionation.
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mock- and CHC siRNA-transfected cells contained similar
amounts of labeled Pr55Gag VLPs tethered to the cell surface.
Thus, the knock-down of CHC apparently did not affect virus
assembly in NL4-3(Gag/ΔVpu)-infected cells. In NL4-3
(ΔVpu/ΔEnv)-infection, small amounts of labeled CA were
detected in extracellular VLPs produced from control mock-
transfected cells, but the majority of labeled CA was found in
VLPs tethered to the cell surface (Fig. 2B). Knock-down of
CHC reduced incorporation of labeled CA into both the
extracellular VLPs and into VLPs that were tethered to the cell
surface. Quantitations from two different experiments sug-
gested that total VLP production was ∼3-fold higher in mock-
transfected control cells than in CHC siRNA-transfected cells.
However, this could be an overestimation, since the VLP assay
did not take into account internal (or internalized) VLPs. Since
the mock-transfected and CHC siRNA-transfected cells had
similar amounts of membrane-associated Gag and since there
was no indications that low intracellular levels of CHC caused
any Gag processing defects (Fig. 1E), the CHC siRNAs
apparently did not reduce membrane targeting or higher-order
multimerization of newly synthesized Gag in NL4-3(ΔVpu/
ΔEnv)-infected cells, but produced an as-yet-undefined mod-
erate late assembly defect in these cells. This late assembly
defect might explain why CHC siRNAs gave slightly different
results in NL4-3(Gag/ΔVpu)- and NL4-3(ΔVpu/ΔEnv)-
infected cells in the cell fractionation experiments.
We next tested whether the endocytic uptake of Gag in
ΔVpu-virus background occurred by macropinocytosis. If
macropinocytosis was involved, virus infection would need to
stimulate this uptake mechanism, since macropinocytosis is not
a constitutive feature of HeLa cells. We measured the uptake of
fluorescein-conjugated dextran into noninfected, NL4-3(Gag)-
or NL4-3(Gag/ΔVpu)-infected HeLa H1 cells in order to
determine whether macropinocytosis was upregulated in
infected HeLa H1 cells. Flow cytometric analyses indicated
similar low levels of macropinocytosis for all three cell
populations (data not shown). The effect of 5-(N-ethyl-N-
isopropyl) amiloride, a potent inhibitor of induced macropino-
cytosis (Meier et al., 2002; West et al., 1989), was tested in Fig.
3. NL4-3(Gag/ΔVpu)-infected cells were pulsed for 30 min,
and chased for 180 min in the presence or absence of 100 μM
amiloride. As shown in Fig. 3, amiloride did not block the shift
of labeled Pr55Gag from the PM to the I fraction in NL4-3(Gag/
ΔVpu)-infected cells. Thus, the uptake of Gag in the ΔVpu-
virus background is unlikely to occur by a macropinocytosis-
like activity.
Effect of filipin on the uptake of cell surface-associated Gag
The possible dependence of Pr55Gag endocytosis on
cholesterol was tested by filipin, an antibiotic commonly
used to disrupt cholesterol-dependent raft-like microdomains at
the cell surface. NL4-3(Gag/ΔVpu)-infected HeLa H1 cells
were metabolically labeled with [35S]methionine for 30 min
and chased for 210 min in the presence or absence of filipin
(3 μg/ml). This amount of filipin did not induce extensive
shedding of microvesicles (a common side-effect of removal of
cell surface cholesterol), but the filipin concentration was
sufficient to inhibit cholesterol-dependent endocytic processes,
since the clathrin-mediated uptake of transferrin was inhibited
in filipin-treated cells (data not shown; Subtil et al., 1999). As
shown in Fig. 4A, filipin treatment considerably reduced the
amount of labeled Pr55Gag in I fraction after 210 min of chase:
quantitations from two separate experiments indicated that
approximately 61% of labeled Pr55Gag was detected in the I
fraction in untreated cells whereas only ∼19% of labeled
Pr55Gag was in internal membranes in filipin-treated cells.
Filipin treatment did not change intracellular localization of
Pr55Gag that was coexpressed with Vpu [NL4-3(Gag)-infec-
tion], since, as in untreated cells (Harila et al., 2006) the
majority of labeled Pr55Gag in filipin-treated cells were plasma
membrane-associated after 210 min of chase (Fig. 4B).
The results in Fig. 4A suggested that the endocytic uptake of
Pr55Gag could occur by a cholesterol-dependent mechanism.
However, cholesterol is also required for efficient membrane
binding and higher-order multimerization of HIV-1 Gag (Ono
et al., 2007). Since there are strong indications that Gag is
endocytosed as a fully assembled virion (Neil et al., 2006), the
observed effect of filipin could be due to inability of plasma
Fig. 3. The inhibitor of induced macropinocytosis, 5-(N-ethyl-N-isopropyl)
amiloride, did not block shift of newly synthesized Pr55Gag from the plasma
membrane to internal membranes in NL4-3(Gag/ΔVpu)-infected HeLa H1 cells.
Infected cells were pulsed for 30 min, and chased for 180 min in the presence or
absence of amiloride prior to silica coating and fractionation.
Fig. 4. Filipin reduces retargeting of newly synthesized Gag from the cell surface
to internal membranes in infected HeLa H1 cells. (A) Cells expressing
unprocessed Pr55Gag in the absence of Vpu [NL4-3(Gag/ΔVpu)-infection] were
metabolically labeled for 30 min, and chased for 210 min in the presence or
absence of filipin prior to silica coating and fractionation. (B) Filipin does not
affect intracellular localization of Pr55Gag coexpressed with Vpu. NL4-3(Gag)-
infected cells were pulsed for 30 min and chased in the presence of filipin for
210 min. (C) Analysis of NL4-3(Gag/ΔVpu)-infected cells when filipin was
added after 30 min of chase. Cells were pulsed for 30 min and chased for 30 min
before addition of filipin. The chase in the presence or absence of filipin was
continued for further 180 min. (D) Similar analysis from NL4-3(ΔVpu/ΔEnv)-
infected HeLa H1 cells, which express Gag together with Gag-Pol, and no Vpu.
Filipin was added to the chase medium after 30 min of chase, and chase was
continued for further 180 min. The 30 min sample indicates intracellular
distribution of labeled Gag at the time of filipin addition.
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membrane-associated Gag proteins to efficiently multimerize in
the presence of the drug. To test this possibility, we added filipin
after 30 min of chase, i.e. at the time when maximal membrane
insertion, as well as at least some higher-order multimerization
of labeled Pr55Gag has already occurred (Ono et al., 2007; Tritel
and Resh, 2000). As shown in Fig. 4C, filipin added after 30 min
of chase reduced the amount of labeled Pr55Gag in I fraction at
the 210 min chase point, but the reduction was less than if filipin
was present from the beginning of chase. In the experiment
shown in Fig. 4C, ∼37% and 49% of labeled Pr55Gag was in
internal membranes in filipin-treated and untreated cells,
respectively. However, the efficiency with which filipin
inhibited the uptake of Pr55Gag varied between different
experiments; the relative amount of labeled Pr55Gag in the I
fraction was 12%–32% lower in filipin-treated cells than in
control untreated cells. To further probe the possibility that
filipin exerted its effect primarily through inhibiting multi-
merization of Gag, we also tested the impact of filipin in the
context of Gag and Gag-Pol coexpression, since processing of
Pr55Gag offers a convenient indirect marker for efficient
multimerization of Gag (Kaplan et al., 1994). HeLa H1 cells
were infected with NL4-3(ΔVpu/ΔEnv)-virus, pulsed for
30 min, and filipin was added after 30 min of chase, and the
chase was continued for further 180 min. At the time of filipin
addition (Fig. 4D; 30 min), the PM fraction contained large
amounts of labeled Pr55Gag, whereas the small amounts of
processed CA forms were ∼equally distributed between the PM
and I fractions. After 210 min of chase, only trace amounts of
unprocessed Pr55Gag were present in untreated control cells, and
68% of labeled CAwas in the I fraction. In contrast, the filipin-
treated cells contained significant amounts of plasmamembrane-
associated, unprocessed Pr55Gag at the 210 min chase point, thus
suggesting that filipin affected proper higher-order multimeriza-
tion of Gag. Approximately 47% of total cell-associated labeled
CAwas in internal membranes after 210 min of chase. However,
in another experiment, CA in filipin-treated cells distributed to
the I fraction as efficiently as in untreated control cells (data not
shown). Thus, the effect of filipin varied between different
experiments, but overall, filipin had a relatively minor effect on
intracellular distribution of CA. Therefore, a significant part of
the apparent reduction in Gag uptake in the filipin-treated cells
might be attributable to the inhibitory effects of filipin on higher-
order oligomerization of Gag.
The apparent targeting phenotype of newly synthesized Gag is
different in confluent and subconfluent HeLa H1 cultures
As mentioned in the Introduction, attempts to analyze
intracellular targeting of newly synthesized HIV-1 Gag have
produced contradictory results. The results in our previous
publication (Harila et al., 2006), as well as for example Figs. 1C
and 4D above, clearly indicate that a newly synthesized Gag is
initially inserted into the plasma membrane in HeLa H1 cells.
These results were from confluent HeLa H1 cells, but the
trafficking phenotype of newly synthesized Gag turned out to be
different when we repeated the targeting analyses in subcon-
fluent HeLa H1 cell cultures (∼30–40% confluency). Fig. 5A
shows analysis of confluent and subconfluent HeLa H1 cells
infected with HXB2D-(Gag), a recombinant virus with a
defective Pol region, a defective vpu gene, and a truncated nef
gene. The infected cells were metabolically labeled with [35S]
methionine for 30 min, and chased for 5 min or 240 min. In
confluent cells, the majority of newly synthesized Pr55Gag was
at the plasma membrane after 5 min of chase, but in sub-
confluent cells, labeled Pr55Gag was simultaneously detected in
PM and I fractions. Whereas there was a clear increase of
labeled Pr55Gag in the I fraction in confluent cells after 240 min
of chase, the amount of labeled Pr55Gag in I fraction in
subconfluent cells increased only slightly during a longer chase
(∼60% was internal after 240 min of chase). When expressed in
the presence of Vpu [NL4-3(Gag)-genome], the majority of
newly synthesized Pr55Gag was in the PM fraction in both
subconfluent (Fig. 5B; a 30 min pulse and a 5 min chase) and in
confluent cell cultures (Harila et al., 2006). The simultaneous
detection of Pr55Gag in the PM and I fraction in HXB2D-(Gag)-
infected subconfluent cells could mean that membrane insertion
of newly synthesized Pr55Gag expressed in the absence of Vpu
was random in subconfluent cultures, or, alternatively, that
uptake of plasma membrane-associated Pr55Gag occurred very
rapidly in these cells. To distinguish between these possibilities,
we tested targeting of Pr55Gag/HA in subconfluent cells.
Pr55Gag/HA contains a carboxyterminal HA tag, and this Gag
variant is not endocytosed after insertion into the plasma
membrane when expressed in the absence of Vpu (Harila et al.,
2006). Fig. 5C shows analysis of HXB2D-(GagHA)-infected
subconfluent HeLa H1 cells after a 30 min pulse and a 5 min
chase. The majority of newly synthesized Pr55Gag/HA was
detected in the PM fraction. Similar distribution was observed
after 240 min of chase (data not shown). Taken together, these
results indicate that cell confluency can have an impact on the
Fig. 5. Analysis of intracellular targeting of newly synthesized Pr55Gag in
subconfluent HeLa H1 cell cultures. (A) Confluent or subconfluent cells
expressing unprocessed Pr55Gag in the absence of Vpu [HXB2D-(Gag)-
infection]. Cells were metabolically labeled for 30 min and chased for the
indicated times prior to silica coating and fractionation. In contrast to confluent
cells, newly synthesized Pr55Gag was simultaneously detected in PM and I
fractions in the subconfluent cell cultures. (B) Cells coexpressing Vpu and
unprocessed Pr55Gag [NL4-3(Gag)-infection] were analyzed after a 30 min pulse
and a 5 min chase. Newly synthesized Pr55Gag coexpressed with Vpu was
primarily targeted to the plasma membrane in subconfluent cells. (C) Cells
expressing an endocytosis-defective Pr55Gag/HA [HXB2D-(GagHA)-infected
cells]. Cells were analyzed after a 30 min pulse and a 5 min chase. No Vpu was
expressed in the HXB2D-(GagHA)-infected cells.
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targeting phenotype of newly synthesized Gag when the protein
is expressed in the absence of Vpu.
Discussion
We have previously shown that a newly synthesized HIV-1
Gag is inserted into the plasma membrane in infected HeLa H1
cells, but the final steady-state localization of the protein is
influenced by Vpu; if coexpressed with Vpu, the majority of
Gag stays at the cell surface, but in the absence of Vpu, a
significant fraction of the cell surface-associated Gag proteins is
subsequently endocytosed into an endosome-like compartment
(Harila et al., 2006). Initial analysis of this Vpu-regulated
uptake indicated that the endocytosis of Gag required interac-
tion of Gag with the host protein Tsg101 (Harila et al., 2006; see
also Neil et al., 2006]. In the present study, we have further
studied the endocytic phenotype of Gag in HeLa H1 cells. As
discussed below, our interpretation of the results is that the
uptake of Gag in ΔVpu-virus background is clathrin-indepen-
dent and indirectly cholesterol-dependent, and cell density
influences kinetics of the uptake. This interpretation is based on
the assumption that the plasma membrane-associated Gag is
endocytosed as a fully assembled virion. Neil et al. (2006)
demonstrated that viruses produced in the absence of Vpu have
surface components that tether the nascent virions to the cell
surface after budding, and they suggested that the endosomal
Gag in ΔVpu-background arises from uptake of these tethered
virions. This suggestion was based on the observations that (1)
endosomal particles were mature in morphology, (2) coexpres-
sion of Gag/Gag-Pol with a mutant Rab5a, which reduced the
amount of endosomal Gag, resulted in accumulation of fully
assembled virions at the cell surface, and (3) Gag-mutants
unable to complete budding were only detected at the plasma
membrane. It is difficult to firmly establish whether Gag in
HeLa H1 cells is endocytosed as a fully assembled virion, or as
a smaller assembly intermediate. However, observations that the
uptake of Gag in HeLa H1 cells can be reduced by depletion of
Tsg101, by cycloheximide (data not shown), or by addition of a
HA tag to the carboxyterminus of Pr55Gag (Harila et al., 2006),
are consistent with fully assembled virions being the targets of
the uptake mechanism, since all of these conditions interfere
with virus assembly (data not shown; Garrus et al., 2001;
Martin-Serrano et al., 2001).
We used RNAi-mediated knock-down of CHC to determine
whether the endocytosis of Gag occurred by a clathrin-
dependent or a clathrin-independent mechanism. The results
from these knock-down experiments indicated that the CHC-
specific siRNA used did not inhibit uptake of Pr55Gag in NL4-3
(Gag/ΔVpu)-infected cells, although the endocytosis of trans-
ferrin was measurably inhibited in these knock-down cells.
Overall, the uptake of Pr55Gag in CHC knock-down cells
occurred with similar kinetics and efficiency as uptake of Gag in
mock-transfected cells (i.e. in cells treated only with the
transfection reagent), or in untreated HeLa H1 cells (data not
shown). However, the CHC-specific siRNA produced a
relatively minor, but reproducible reduction in the uptake of
Gag (p24) in NL4-3(ΔVpu/ΔEnv)-infected cells. These results
could mean that the uptake of unprocessed Gag differs from that
of Gag expressed together with Gag-Pol. However, if plasma
membrane-associated Gag is endocytosed as a virion, the
discordant results from NL4-3(Gag/ΔVpu)- and NL4-3
(ΔVpu/ΔEnv)-infected cells could be due to the fact that virus
assembly in NL4-3(Gag/ΔVpu)-infected cells appeared to be
insensitive to knock-down of CHC, whereas low intracellular
levels of CHC clearly reduced virus formation in NL4-3(ΔVpu/
ΔEnv)-infected cells. Therefore, our interpretation of the
experimental data is that the uptake of Gag is clathrin-
independent. This conclusion is in agreement with a recent
report demonstrating that endocytosis of Gag in 293Tcells is not
blocked by chlorpromazine, a drug that inhibits clathrin-
mediated endocytosis (Finzi et al., 2007). At present it is unclear
why the knock-down of CHC reduced virus assembly in NL4-3
(ΔVpu/ΔEnv)-infected cells, but apparently some very late step
in the assembly was affected since processing of Pr55Gag was not
impaired by the CHC siRNA.
Our results from filipin-treated cells demonstrate that
interfering with plasma membrane cholesterol reduces uptake
of cell surface-associated Gag inΔVpu-virus background. HIV-
1 Gag is considered to be a raft-associated protein, and raft-like
microdomains at the plasma membrane have been suggested to
function as platforms for virus assembly (Ding et al., 2003;
Halwani et al., 2003; Holm et al., 2003; Lindwasser and Resh,
2001; Nguyen and Hildreth, 2000; Ono and Freed, 2001; Zheng
et al., 2001). The observed effects of filipin could mean that the
uptake of Gag occurs by a cholesterol-dependent, raft-mediated
mechanism. However, filipin efficiently reduced the uptake
only when added at the beginning of chase. Adding filipin after
30 min of chase produced a less pronounced inhibition.
Furthermore, filipin had a variable and a relatively minor effect
on intracellular distribution of CA. These observations could
indicate that the uptake mechanism of Gag is only indirectly
dependent on cholesterol. It has been shown that cholesterol is
required for efficient membrane binding and higher-order
oligomerization of HIV-1 Gag (Ono et al., 2007), and if virions
tethered to the cell surface are the form in which Gag is
endocytosed, then anything that interferes with virus assembly
affects the uptake of Gag as well. Filipin in our experiments
most likely reduced the overall virus assembly, since processing
of Pr55Gag was impaired in the NL4-3(ΔVpu/ΔEnv)-infected
cells. Thus, the inhibitory effect of filipin on Gag uptake might
reflect reduced virus assembly rather than the uptake mechan-
ism being cholesterol-dependent.
The uptake of Gag in our experimental setting was not
inhibited by 5-(N-ethyl-N-isopropyl) amiloride, an inhibitor of
induced macropinocytosis. Thus, none of the three inhibitors
(filipin, CHC siRNA, amiloride) directed against cholesterol-
dependent uptake, clathrin-mediated endocytosis, or macro-
pinocytosis produced a clear-cut inhibition of Gag uptake in the
ΔVpu-virus background. This raises the possibility that the Gag
uptake could occur by the poorly characterized clathrin- and
lipid raft-independent uptake pathways (Pelkmans andHelenius,
2003). The uptake of Gag is unlikely to be caveolae-mediated,
since (1) intracellular accumulation ofΔVpu-viruses is also seen
in T cells which do not express caveolin (Klimkait et al., 1990),
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and (2) although HeLa H1 cells express caveolin-1, caveolae
structures are rare in these cells, and genistein, an inhibitor of
caveolae-mediated endocytosis (Pelkmans and Helenius, 2003),
does not affect endocytosis of Gag (data not shown). Our further
observations suggest that interaction of the MA domain of Gag
with AP-3 δ subunit, or the Y84G substitution in the MA
domain, does not play a key role in the Vpu-regulated
endocytosis of Gag in HeLa H1 cells (data not shown), although
both the AP-3 δ subunit and the Y84G substitution have
previously been shown to affect targeting of HIV-1 Gag to
endosomal compartments (Dong et al., 2005; Ono and Freed,
2004). We have not been able to test dependence of the Gag
uptake on actin dynamics, since treatment of infected cells with
for example jasplakinolide, latrunculin B, or cytochalasin D
disrupts the cells during silica coating (data not shown).
Our interpretation that uptake of Gag is mediated by a
clathrin-independent mechanism is seemingly contradictory to
the report that dominant negative forms of dynamin, EPS-15,
and Rab5a, all known inhibitors of clathrin-mediated endocy-
tosis, prevent endocytosis of Gag in HeLa cells (Neil et al.,
2006). However, a dominant negative approach and RNAi do
not always give the same results, as exemplified by the
observations that dominant-negative CHMP5, but not depletion
of endogenous CHMP5, inhibits HIV-1 release (Martin-Serrano
et al., 2001; Ward et al., 2005). A dominant-negative mutant can
inhibit a cellular function indirectly, for example, by perturbing
more than one cellular pathway due to inactivation of essential
factors that operate at more than one cellular site. Another
possibility is that the uptake mechanism of Gag is cell type-
dependent. Assuming that Gag is endocytosed as a fully-
assembled virions, our results from e.g. NL4-3(ΔVpu/ΔEnv)-
infections indicate that the endocytosis process is directed by
cellular factors present in the viral envelope, not the viral Env
protein. The HIV-1 envelope contains several different cellular
proteins (Chertova et al., 2006; Hammarstedt and Garoff, 2004),
and subtle cell type-dependent changes in the composition of
the virion envelope could specify the efficiency of ΔVpu-virus
uptake, and perhaps also the mechanism of the uptake.
Our previous (Harila et al., 2006) and present results indicate
that the Vpu-regulated endocytosis of Gag is a key determinant
for the steady-state localization of Gag and VLPs in HeLa H1
cells. Vpu most likely controls targeting of Gag in infected T
cells as well, since deletion of vpu gene results in accumulation
of virions into intracellular compartments of these cells
(Klimkait et al., 1990). In contrast, concentration of Gag and
progeny virions into the internally sequestered plasma mem-
brane domains in macrophages is Vpu-independent (Deneka et
al., 2007; Pelchen-Matthews et al., 2003; Welsch et al., 2007).
However, the intracellular virus-containing vacuoles of macro-
phages and T cells or HeLa H1 cells are different, since the
limiting membrane of Jurkat and HeLa H1 virus-containing
vacuoles is not stained with the cell-impermeant dye ruthenium
red (data not shown), and the vacuoles thus belong to the
endosomal network. In general, intracellular trafficking routes
that control cell surface versus endosomal localization of Gag
and VLPs have been the subject of intense debates. Only few
serious attempts have been made to characterize the intracellular
transport of a newly synthesized Gag (Finzi et al., 2007;
Grigorov et al., 2006; Harila et al., 2006; Jouvenet et al., 2006;
Neil et al., 2006; Perlman and Resh, 2006; Rudner et al., 2005),
and results from these studies are conflicting. Cell fractionation
analyses by us (Harila et al., 2006) and Finzi et al. (2007), as
well as FlAsh/ReAsh imaging studies by Rudner et al. (2005) or
fluorescence microscopy analyses of cells expressing Gag-GFP
(Jouvenet et al., 2006; Neil et al., 2006), indicated that a newly
synthesized Gag in HeLa H1, HeLa, 293 T cells, or
macrophages was initially inserted into the plasma membrane.
In contrast, FlAsh/ReAsh cell imaging studies by Perlman and
Resh (2006) implied a ‘perinuclear’ and endosomal transport
intermediates for cell surface Gag in HeLa, Cos-1, and Jurkat T
cells. Cell fractionation studies by Grigorov et al. (2006) in turn
demonstrated that newly synthesized Gag proteins in 293 Tcells
were simultaneously detected at the plasma membrane and on
endosomal membranes. One explanation for these contradictory
results can be the different expression systems used, since the
above-mentioned studies utilized either proviral expression of
Gag or codon-optimized plasmid-driven expression of Gag. At
least three proteins of HIV-1, Nef, Gag, and Vpu, can
potentially modulate membrane trafficking pathways of the
host cell through interactions with cellular partners (Batonick et
al., 2005; Costa et al., 2006; Dong et al., 2005; Madrid et al.,
2005; Varthakavi et al., 2006), and thus intracellular targeting of
Gag could be different in virus-infected cells and in cells in
which a plasmid-driven expression system is used for synthesis
of Gag. Even the multiplicity of infection and/or the time point
postinfection could impact the apparent targeting phenotype of
Gag. Our present study demonstrates that another important
factor to consider in targeting analyses of Gag is the confluency
of cell cultures; in confluent HeLa H1 cells, newly synthesized
Gag was first detected at the plasma membrane in both Vpu+
and ΔVpu-virus backgrounds, whereas in subconfluent HeLa
H1 cultures, Gag expressed in the absence of Vpu appeared
simultaneously in both the plasma membrane and internal
membrane fractions. The molecular basis of this phenomenon is
unclear at present. It is difficult to determine whether the newly
synthesized internal Gag population in subconfluent cells
represents Gag proteins directly inserted into the internal
membranes, or proteins (rapidly) endocytosed from the cell
surface. We favor the latter alternative, because (1) the majority
of newly synthesized Gag coexpressed with Vpu fractionated
with the plasma membrane fraction, and *2) newly synthesized
Pr55Gag/HA, which is not endocytosed when expressed in the
absence of Vpu, was detected at the plasma membrane in
subconfluent cultures as well. Overall, the results from the
subconfluent cells stress the need to monitor targeting of Gag
with assays that can detect rapid, dynamic changes in
intracellular localization of Gag.
Materials and methods
Cell culture, viruses, and plasmid constructs
HeLa H1 and 293T cells were cultured as previously
described (Harila et al., 2006; Holm et al., 2003). Production
305K. Harila et al. / Virology 369 (2007) 299–308
of VSV G-protein-pseudotyped infectious recombinant HIV-1,
as well as plasmid constructs for NL4-3(Gag/ΔVpu), NL4-3
(Gag), HXB2D-Gag, and HXB2D-GagHA has been previously
described (Harila et al., 2006). Plasmid pNL4-3(ΔVpu/ΔEnv),
a derivative of pNL4-3 (Adachi et al., 1986), contains defective
vpu and env genes, and a truncated vpr gene. The plasmid was
constructed by replacing the 6459-bp ApaI–BamHI fragment of
pNL4-3 with the equivalent ApaI–BamHI fragment of
pHXB2D-(ΔVpu/ΔEnv) (Harila et al., 2006).
Subcellular fractionations
HeLa H1 cells on 10-cm plates were infected with VSV-G-
pseudotyped recombinant HIV-1 (∼1–5 infectious units/cell),
and at ∼21 h [NL4-3(ΔVpu/ΔEnv)-virus] or ∼24 h [NL4-3
(Gag/ΔVpu)-virus], postinfection cells were metabolically
labeled with [35S]methionine for 30 min and chased for various
times as previously described (Holm et al., 2003). After the
chase, cells were brought into suspension by incubation in
phosphate-buffered saline (PBS) containing 0.02% EDTA
(PBS-EDTA), intact cells were coated at 4 °C with cationic
silica beads, and cell extracts were fractionated on a Nycodenz
step gradient as previously described (Harila et al., 2006). Gag
proteins were immunoprecipitated from sodium dodecyl sulfate
(SDS)-solubilized plasma membrane and internal membrane
fractions with mouse anti-HIV-1 CA monoclonal antibody 38:9
(Hinkula et al., 1990), or with a mixture of the 38:9 antibody
and a mouse monoclonal anti-p24 antibody 32/5.17.76 (Abcam,
Ltd.). The HA-tagged Gag was immunoprecipitated with a
rabbit polyclonal anti-HA antibody (Sigma).
In filipin treatment, the chase medium contained 3 μg of
filipin complex (Sigma) per ml. In 5-(N-ethyl-N-isopropyl)
amiloride treatment, 100 μM of the drug (Alexis Biochemicals)
was included into the chase medium. To measure macropino-
cytosis, cells were first preincubated in minimum essential
medium containing 0.2% BSA (MEM-BSA) for 30 min, and
then shifted to MEM-BSA containing 1 mg per ml of lysine-
fixable fluorescein isothiocyanate-conjugated dextran (70,000
Da, Molecular Probes) for 10 min. After extensive washing,
cells were incubated in MEM-BSA for further 5 min. To strip
plasma membrane-associated dextran, cells were placed on ice
and incubated for 5 min in a pH 5.5 buffer containing 100 mM
sodium acetate and 50 mM sodium chloride. After washes with
ice-cold PBS, cells were detached from plates by incubation in
PBS-EDTA on ice for 20 min, fixed with 2% paraformaldehyde,
and analyzed by a fluorescence-activated cell sorter.
VLPs
To analyze the efficiency of VLP production, NL4-3(Gag/
ΔVpu)-infected HeLa H1 cells were metabolically labeled with
[35S]methionine for 180 min, and NL4-3(ΔVpu/ΔEnv)-
infected cells were metabolically labeled for 240 min. Cell
culture supernatants were collected, filtered (0.45 μm), layered
on to a 20% sucrose cushion (w/v, in 25 mM HEPES pH 7.4,
150 mMNaCl, 2 mMMgCl2), and centrifuged at 100,000×g for
60 min. Pellets were analyzed by gel electrophoresis. These
pellets represented constitutively released extracellular parti-
cles. To analyze the amount of VLPs tethered to the cell surface,
cells were washed once with PBS after harvesting culture
supernatants, and incubated with trypsin (0.5 mg/ml) at 37 °C
for 10 min. The reaction was stopped by adding culture medium
containing 7% fetal bovine serum, cells were pelleted and
culture supernatants were filtered, and VLPs were pelleted
through sucrose as described above.
RNAi
Short interfering RNAs (siRNAs) directed against the
clathrin heavy chain (CCUGCGGUCUGGAGUCAACdTdT;
40 pmol per 10-cm plate; Hinrichsen et al., 2003) were
transfected into HeLa H1 cells by using siLentFect (BioRad) in
accordance with the manufacturer's instructions. Mock-trans-
fected cells were treated with siLentFect alone. At about 22 h
posttransfection, the cells were infected and analyzed about
21–24 h postinfection. Intracellular levels of clathrin heavy
chain in mock- and siRNA-treated cells were determined from
postnuclear supernatants of cell extracts by Western blotting
with a polyclonal goat anti-clathrin heavy chain antibody
(C-20; Santa Cruz Biotechnology, Inc.). The polyclonal anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) anti-
body (FL-335; Santa Cruz Biotechnology, Inc.) was used as
a control.
To analyze the effect of CHC knock-down on clathrin-
mediated endocytosis, NL4-3(Gag/ΔVpu)-infected HeLa H1
cells, mock- or siRNA-treated, were washed once with PBS
(with MgCl2 and CaCl2) containing 0.2% bovine serum
albumin (PBS-BSA), and cells were incubated for 30 min on
ice in PBS-BSA containing 500 ng/ml human biotin-tagged
transferrin (Sigma). After washing the unbound transferrin
away, minimum essential medium containing 0.2% BSA was
added to cells and cells were shifted to 37 °C for 0 min, 5 min,
or 15 min. Cells were then placed on ice, treated with acid wash
buffer (0.2 M sodium acetate buffer pH 4.5, 0.5 M NaCl) for
2 min, rinsed with the acid wash buffer, and washed with excess
PBS-BSA and PBS. Cell surface-associated transferrin was
removed by trypsin treatment (20 min on ice). Trypsin was
inactivated by culture medium containing 7% fetal bovine
serum, cells were homogenized, and postnuclear supernatants
of cell extracts were prepared as previously described (Harila et
al., 2006). The amount of trypsin-resistant transferrin–biotin in
postnuclear supernatants was determined by Western blotting
using streptavidin–peroxidase polymer (Sigma).
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